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Abstract 
Objective 
The primary aim was to compare eating behaviours between migraine cases and non-
migraine headache controls. The secondary aim was to assess the relationship migraine 
severity and monthly headache frequency share with eating behaviours, food intake, food 
cravings and adiposity among migraine cases.   
 
Background  
Recent research has highlighted an association between migraine and adiposity, in adults 
and children39-41,46-50. However the direction of causality between migraine and adiposity 
has not yet been established. There are overlapping neurobiological mechanisms in 
migraine, eating behaviours and adiposity116-125. Migraine has been noted to affect 
appetite1,146, but this has not been formally studied. This pilot study explored the 
biologically plausible hypothesis that migraine may lead to obesity, via alterations in 
appetite, food intake and food cravings.   
 
Methods 
A single-centre, cross-sectional, questionnaire-based, clinical migraine population pilot 
study was designed. The two migraine measures were migraine severity as measured by the 
PedMIDAS tool and monthly headache frequency. Eating behaviours were assessed using 
the Dutch Eating Behaviour Questionnaire (DEBQ) and Child Eating Behaviour Questionnaire 
(CEBQ). Food cravings were measured by the Food Craving Inventory (FCI-II) and food intake 
was assessed using the Food Intake Questionnaire (FIQ). Adiposity was indirectly measured 
using BMI z-scores. Local Research Ethics and Trust R&D approvals were granted in June 
2009.        
 
Results  
Sixty children aged 5-17 years were recruited from neurology/general paediatric clinics. 
Insufficient control patients were recruited (n=7). The desire to drink subscale of the CEBQ 
had a significant positive correlation with the PedMIDAS scores (rs= 0.41, p= 0.01). Monthly 
headache frequency had a significant positive correlation with the negative marker food 
scores of the FIQ (rs= 0.27, p= 0.04).     
 
Conclusion 
The primary objective to compare eating behaviours between migraine cases and non-
migraine headache controls was not achieved. Migraine severity (as measured by the 
PedMIDAS scores) is weakly associated with the desire to drink (as measured by the CEBQ). 
Monthly headache frequency is weakly associated with the intake of unhealthy foods eaten 
the day before. It must be noted there is only weak evidence for the conclusions given the 
small sample size of this pilot study.   
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Background 
 
Body mass index as a proxy for adiposity is positively correlated with migraine severity, 
headache frequency and migraine prevalence39-41,46-50. Restrained, emotional, externalised 
and hedonistic driven eating behaviours are strongly associated with increased adiposity 
levels71-81. Migraine, appetite and adiposity share an overlap in neurobiological mechanisms 
that include alterations of serotonin, calcitonin gene related peptide (CGRP), orexin A, leptin 
and hypothalamic pathology116-125. Migraine patients can develop food cravings during the 
prodromal and ictal phase of acute attacks1,46. Preventive migraine treatments such as 
topiramate and pizotifen can affect appetite levels that lead to adverse weight altering 
effects151-154.  
Based on the information presented so far it is possible that there is a causal relationship 
between migraine, eating behaviours and adiposity. However no study hitherto has 
investigated the relationship of all three variables together. Hence this pilot study was 
developed to investigate the relationship that migraine shares with eating behaviours and 
adiposity. This pilot study was also used to identify limitations in the methodology to help 
prepare for a larger future study on “migraine, eating behaviours and adiposity”. This main 
future study will be designed to confirm and extend the findings from this present pilot 
study. Power sample size calculations for the main future study have been presented in this 
thesis.    
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Chapter 1: Introduction 
Chapter 1.1   
Migraines 
Migraine definition  
Migraine is a clinical syndrome that may consist of a headache component with specific 
features and associated symptoms1. The headache phase can typically last 4 to 72 hours, 
which is characteristically a unilateral, pulsatile and intermittent moderate to severe pain. In 
children this headache phase is usually short lived, lasting between 2 to 48 hours2. Migraine 
is commonly associated with symptoms of nausea, vomiting, photophobia and 
phonophobia3. Usually, a minimum of five acute headache attacks with migraine features 
suggest a diagnosis of migraine without aura. Secondary headaches resulting from infection 
and other causes must be excluded prior to making any migraine diagnoses4. The most 
common differential diagnosis for migraine is tension type headache (TTH), which is 
typically a bilateral, pressing or tightening band of pain around the head. The pain is usually 
of mild to moderate intensity, which can be unresponsive to analgesic medications and does 
not worsen with routine physical activity1.   
A migraine aura is any reversible focal neurological symptom that usually develops over 5 to 
20 minutes and can last up to a hour1. The aura may manifest as visual disturbances (e.g. 
visual perception of flickering lights, spots, lines or loss of vision), sensory symptoms (e.g. 
numbness and paraesthesia) or motor weakness5. An aura can be diagnosed when 
alternative causes for the focal neurological symptoms (e.g. transient ischaemic attack) have 
been excluded.  Migraine headaches with aura are less common than migraine headaches 
without aura6.  
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Migraine prevalence 
Migraines and other primary headache disorders can account for up to 27% of all paediatric 
neurology referrals (based on an unpublished audit at Alder Hey Children’s Hospital, 
Liverpool). As outlined in table 1.1.0, migraine prevalence in the UK varies according to age. 
It ranges from 1.2-3.2% in children aged between 3 and 7 years (male predominant 
prevalence) to 28% in adolescents aged between 15 and 19 years (female predominant 
prevalence)7,8.   
 
Age UK migraine prevalence (%) 
3 to 7 years 1.2- 3.2 
7 to 11 years 4- 11 
11 to 15 years 18- 23 
15 to 19 years 28 
Table 1.1.0- Migraine prevalence according to age (listed as percentage figures) 
 
Migraines are ubiquitous to almost every nation and ethnic race, which can have a serious 
impact on employment, social activities and domestic function9. There is an impaired quality 
of life with substantial socioeconomic burdens attributable to increased medical needs, 
reduced employment efficacy and work absences10. The World Health Organisation (WHO) 
has ranked migraines as the 19th most debilitating medical condition worldwide11. Over a 
period of 2 weeks, greater than 900, 000 children with migraine miss 164,454 days off 
school12. 
Migraine pathophysiology  
The current understanding of migraine pathogenesis is still incomplete13. Various 
mechanisms have been proposed in migraine pathology however the exact sequence in 
which these mechanisms occur has not been established14. The current concepts of these 
mechanisms are now discussed.    
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Cortical spreading depression (CSD) 
Cortical spreading depression (CSD) is a self-propagating wave of spontaneous 
depolarisation of neuronal glial cells15. It initially affects neurons located in the occipital 
cerebral cortex but then spreads through adjacent cells towards the frontal cortex in a 
marching sequence16. There is associated release of potassium, nitric oxide and proteases 
that alter the permeability of the blood brain barrier. Consequently cell perfusion is affected 
which causes cerebral blood flow changes during acute migraine attacks17. Cortical 
spreading depression is the key mechanism thought to trigger the onset of aura 
symptoms18.      
 
Trigeminal Pathway 
The trigeminal pathway is formed by a circuit of afferent nerves that densely innervate the 
brain meninges and propagate nociceptive impulses to the sensory cortex for pain 
processing19. During acute migraine attacks there is stimulation of trigeminal afferent fibres 
located along the extra-cranial vessels that transmit nociceptive impulses along the 
trigeminal pathway20. There is subsequent cortical processing, which results in the 
perception of a pain sensation during an acute migraine attack21. Trigeminal nerve 
activation precipitates the release of various neuro-chemicals such as calcitonin gene 
related peptide (CGRP) which potentiates the pain response and causes vasodilatation in 
cerebral blood vessels22. The importance of CGRP in migraine pathology is discussed later in 
chapter 1.4. The putative trigeminal pain pathway is accepted as an integral process to 
migraine pathology however the trigger mechanism behind its activation is still unknown23.   
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Neurogenic inflammation 
Upon trigeminal nerve activation, the release of bioregulatory peptides such as CGRP and 
glutamate induce a state of “sterile neurogenic inflammation”, within the blood vessel walls 
of the meninges. This is characterized by oedema formation (plasma extravasation), 
vasodilation and the release of pro-inﬂammatory mediators such as bradykinin22. This 
inflammatory process has been inhibited by clinically effective anti-migraine agents such as 
ergotamine19. Neurogenic inflammation may promote stronger and more frequent 
trigeminal pain trafficking which leads to the further release of pro-inflammatory 
substances24.      
 
Central sensitisation 
Sensitization occurs when the stimulus needed to generate a nerve response decreases over 
time, while the amplitude of the response to any given stimulus increases25. Central 
sensitisation of the trigeminal nucleus caudalis has been demonstrated during a migraine 
attack. In migraine patients there is a mal-adaptation of pain perception which can result in 
allodynia (the perception of pain to a non-painful stimulus) and hyper-algesia (intensified 
pain in response to a stimulus that ordinarily causes mild pain)26. Even after the headache 
phase of migraine has subsided, allodynia and hyperalgesia can persist for a long period of 
time, which may account for the long duration of some severe migraine attacks27.         
 
Migraine management 
Conservative management of migraine involves identifying and then avoiding the 
exacerbating or trigger factors for acute attacks. These include avoiding stress, keeping good 
sleep hygiene (i.e. regular bedtimes), routine exercise, food diaries to identify potential 
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dietary triggers, staying well hydrated and a balanced diet with regular meal times28. These 
strategies are reported to reduce the pain burden of migraine29.  
Acute pharmacological therapies for migraine are broadly divided into 2 categories of non-
specific treatments and specific treatments1. Non-specific treatments such as paracetamol 
(acetaminophen), non-steroidal anti-inflammatory drugs (NSAID’s) and opioids are 
appropriate for the treatment of mild to moderate migraine attacks. Specific treatments 
include ergotamine and triptan agents (e.g. zolmitriptan and sumatriptan), which are usually 
first line drug treatments for moderate to severe migraine attacks30.     
Preventive therapy is reserved for severe migraine cases. The main goal is to reduce the 
frequency and intensity of migraine attacks thereby improving patient functioning and 
quality of life31. Pizotifen is a serotonin antagonist routinely used as a first line preventive 
medication for migraine patients aged over 2 years32. Beta blockers such as timolol and 
propranolol are first line agents for migraine prophylaxis, but are contraindicated in asthma 
patients33. Topiramate, originally an anticonvulsant now used as an anti-migraine agent, is 
shown to more than halve monthly headache frequency34. The proposed pharmacology of 
topiramate ranges from the blockade of voltage-sensitive sodium channels to enhancing 
GABA-evoked chloride currents35. 
  
Migraine co-morbidities 
Migraine patients are at three times greater risk of developing depression and generalised 
anxiety compared with non-headache controls36. Sleep disturbances, bruxism (clenching of 
the jaw and teeth grinding), co-sleeping with parents and snoring are associated with 
migraines in children37. Binge eating disorders have been associated with migraine in the 
female population, which has been hypothesised to be based on a common neuro-chemical 
overlap in serotonin dysfunction38. Adiposity as measured by body mass index has been 
correlated with migraine severity and headache frequency39,40,41.    
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Chapter 1.1.1   
Migraine and Adiposity 
 
This pilot study was particularly interested in the relationship between migraine and 
adiposity39-41. Previous studies on migraine, headaches and adiposity have been reviewed in 
this chapter (see tables, 1.1.1 to 1.1.7) using a simplified criterion (see table 1.1.0a) which 
was adapted from the STROBE criteria and checklist42 (STrengthening the Reporting of 
OBservational studies in Epidemiology). The STROBE tool is a validated criterion for 
reviewing observational studies43. See appendix 5.1.1a for the search methods used to 
identify the studies that have been reviewed and appendix 5.1.1b for an outline of the 
original STROBE criteria.  
    
Criteria 
 
Item No. 
 
Recommendation 
 
Title 1 Indicate the study’s design with a commonly used term in the title or the abstract. 
Objective 2 State specific objectives, including any pre-specified hypotheses. 
Study Design 3 Present key elements of study design early in the paper. 
Participants & 
settings 4 
Describe the setting, locations, and relevant dates, including periods of recruitment, 
exposure, follow-up, and data collection. 
Variables 
5 
Clearly define all outcomes, exposures, predictors, potential confounders, and effect 
modifiers. Give diagnostic criteria, if applicable. 
Main results 6 An outline of the main study findings.  
Bias & limitations 7 Describe any potential sources of bias and outline the study limitations. 
Table 1.1.0a- Adapted STROBE criteria used to used to review the headache and adiposity 
studies. 
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Author Scher et al (2003)
39 
Title 
 
Factors associated with the onset and remission of chronic daily headache (CDH) in a population-
based study. It must be noted that Scher et al
39
 defined CDH cases as patients that suffered from 180 
annual headaches or more.  
Objectives This study aimed to identify risk factors for chronic daily headache (CDH) prevalence, incidence and 
remission in a US adult population. 
Study Design Prospective cohort study 
Participants A total of 55, 255 potential cases and controls were telephone interviewed at baseline. A total of 
1,932 participants were telephone interviewed at 11 months follow-up. Patients were aged 18-65 
years.   
Variables Annual headache frequency, duration of headaches and speed of headache were reviewed at both 
telephone interviews to assess for progression or remission of headaches. 
Patients were categorised as either CDH cases (180+ annual headaches) or controls (2-104 annual 
headaches). 
Body mass index was calculated as; [weight (pounds)/ height (inches)
2
] x 703). Height and weight 
measurements were self reported over telephone interviews. Patients were also categorised as 
normal weight (BMI<25), overweight (BMI≥25) or obese (BMI≥ 30). 
Data 
source/Measurement 
All information for each variable was ascertained through the telephone interviews.  
Hence there was a high possibility of under-reported weight and BMI and over-reported height as 
they were not objectively measured by a researcher, but instead were self reported
44
. 
Study size No description is given of how the study sample size was calculated.  
Descriptive data 28% of controls and 20% of cases were male. 71% of controls and 80% of cases were cases. The mean 
age was 40 years for cases and 41 years for controls.     
Main results Chronic daily headache was significantly associated with obesity (odds ratio= 5.53).  
Bias and limitations The time elapsed from baseline to follow up was 2 months longer for controls than cases because the 
study quota for controls was filled more quickly than cases. This meant that control patients had a 
longer time period for any changes in headache features/characteristics to occur by the time of 
follow-up.       
At baseline headache frequency was evaluated by the number of headaches per year, whilst at follow 
up headache frequency was determined by the number of headache days per year. Hence headache 
frequency may have been under reported at follow up. 
Headache diagnoses were not stated and hence the application of results to sub populations of 
specific headache disorders such as migraine is not possible.   
Other comments The large sample size indicates there was a high power in which to detect true positive significant 
results. 
As patients were prospectively followed up this is one of few studies to investigate adiposity as a risk 
factor for headaches.  
Table 1.1.1- Review of the Sher et al (2003)39 study using an adaptation of the STROBE 
review42   
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Author Bigal et al (2005)
40  
Title Obesity and migraine: A population study  
Objectives The objective was to investigate the association BMI has with migraine prevalence, headache 
frequency/pain severity and associated migraine symptoms.  
Study Design Although clearly a cross sectional study, not once was the exact study design mentioned in the 
methods. 
Settings Households in 3 large metropolitan US areas were selected for telephone interview using random 
digit dialling methods (not otherwise specified in study article).  
Participants 3, 791 migraine patients aged 18 to 89 years 
Variables Body mass index (BMI), migraine prevalence, headache frequency, headache duration, headache 
related disability, presence of photophobia/phonophobia, nausea/vomiting.    
Data 
source/Measurement 
BMI was calculated as following; [weight (pounds)/ height (inches)
2
]x 703. Height and weight 
measurements were self reported in telephone interviews. Subjects were grouped according to 
BMI; underweight (<18.5), normal weight (18.5-24.9), overweight (25-29.9), obese (30-34.9) and 
morbidly obese (≥35). 
The second edition of the International Classification of Headache Disorders (ICHD-II)
1
 was used as 
a guide to making migraine diagnoses.  
Headache disability was assessed using a 10-point likert scale (0= no disability and 10= severely 
disabling).   
Chronic daily headache patients defined as greater than 15 headache days a month were excluded 
from data analysis.  
Main results BMI and the frequency of migraine attacks were associated. Obese individuals were three times 
more likely to suffer from 10-15 headache days a month than normal weight patients.  
The proportion of subjects with severe migraine pain increased with BMI, which was twice as high 
in the morbidly obese compared to the normal weight adults. Obesity was associated with more 
frequent headache related one day absences from school and work.  
Headache features such as photophobia and phonophobia were also more prevalent in obese 
individuals. Exacerbation of headaches from physical activity was twice as common in morbidly 
obese patients compared with versus normal weight individuals.  
Bias and Limitations This study used telephone interviews to obtain self reported height and weight measurements. This 
method was prone to under reporting of BMI and weight, as well as over reporting of height. There 
was no strict inclusion criteria applied to the recruitment process. This study did however comment 
on potential confounding factors such as food triggers, exercise and depression, that were not 
controlled in the study.  
Using the ICHD as a foundation for making headache diagnoses may have increased the accuracy of 
identifying true positive migraine patients but diagnoses were still self-reported.   
Interpretations and 
generalisability 
The large sample of patients used indicates there was a high power to detect true positive 
significant results. Females were over represented due to interviews conducted during business 
working hours. Data was however stratified for sex, age, educational background and ethnicity.  
Table 1.1.2- Review of the Bigal et al (2005)40 study using an adaptation of the STROBE 
review42 
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Author Bigal et al (2006)
41 
Title Obesity is a risk factor for transformed migraine but not chronic tension-type headache.  
Background In order to understand the Bigal et al (2006)
41 
study a background to the diagnoses of transformed 
migraine (TM) and chronic tension type headache (CTTH) must be given. Transformed migraine is defined 
as 15 or more monthly headaches (that each last a minimum of 4hours) with at least 12 migraine attacks in 
the prior year (Silberstein and Lipton criteria
45
). Chronic tension type headache is defined according to the 
ICHD-II
 
as 15 or more tension type headaches a month
1
.    
Objective To investigate the relationship chronic migraine and chronic tension type headache have obesity.   
Study Design Cross-sectional study 
Participants  There were 1,264 chronic daily headache (CDH) cases (≥15 monthly headaches lasting a minimum of 4 
hours) and 25, 585 controls (<15 monthly headaches), aged 18 to 89 years. CDH patients were further 
divided into two groups of TM patients (n= 401) and CTTH patients (n= 863).  
Variables Headache induced disability was assessed by the number days absent from school or work in the past 3 
months.  
Based on a pain scale numbered 1 to 10, headaches were categorised as mild (1 to 3), moderate (4 to 7) or 
severe (8 to 10). Headache frequency, duration and associated symptoms were also assessed.  
All headache outcome measures were assessed as a function of BMI.     
BMI was calculated as ([weight (pounds)/ height (inches)
2
]x703). Height and weight measurements were 
self reported over telephone interviews. 
Subjects were grouped according to BMI; underweight (<18.5), normal weight (18.5-24.9), overweight (25-
29.9), obese (30-34.9) and morbidly obese (≥35). 
Main results Chronic daily headache prevalence was significantly higher in the obese and severely obese groups.  
BMI was positively correlated with transformed migraine prevalence (TM was twice more likely to occur in 
morbidly obese patients compared with normal weight individuals).   
BMI greater than 25 was associated with a higher proportion of headache associated disability  
The proportion of patients reporting 50% of their headache attacks resulting in severe pain was higher 
among all individuals with a BMI> 25.  
Morbidly obese patients were at 1.9 times greater risk of suffering from severe headache attacks 
compared with normal weight individuals.               
Bias and 
limitations 
This study has analysed data derived from the same patient sample that was telephone interviewed in the 
Bigal et al (2005)
40
 study. Based on the methodology details it appears that this study (Bigal- 2006
41
) use 
the same sample of patients but differ in the information extrapolated from the available data. At no point 
is this explicitly stated in either of the two studies. Based on the methodology of data collection and 
patient sample the limitations for this study are the same as for the Bigal et al (2005)
40
 study. 
Headache diagnoses were self-reported by patients and not based on a clinical diagnosis from a physician.  
Potential confounders such as exercise and food triggers were not measured in this study.   
Headache induced disability was assessed by the number work/school day absences in the last 3 months. 
However this method would have been invalid for unemployed adults.   
Table 1.1.3- Review of the Bigal et al (2006)41 study using an adaptation of the STROBE 
review42   
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Author Pinhas-Hamiel et al (2008)
46 
Title Headaches in overweight children and adolescents referred to a tertiary care centre in 
Israel.  
Objective This study aimed to assess the association between obesity and primary headaches in 
children and adolescents.     
Study Design Pinhas-Hamiel et al (2008)
46
 described the study as a cross-sectional study, when in fact 
the methodology was of a case-control study. 
Settings Obese children were recruited from a hospital obesity clinic and non-obese children 
(controls) were recruited from community general paediatric clinics. 
Participants  273 children aged 9 to 17 years old.  
Variables Participants were assessed for the presence of any headache disorders using a short 
questionnaire adapted from the International Headache Society (IHS) diagnostic 
criteria.  
Monthly headache frequency, duration of headache attacks, character of pain (location, 
pulsation & severity) and the presence of any associated symptoms such as nausea, 
vomiting and photophobia.  
Height and weight measurements were obtained from the national Israeli database 
(however this point is not clearly stated in the study).  
Body mass index was calculated as weight in kilograms divided by height in metres 
squared (kg/m
2
). Specific details about how height and weight measurements were 
taken were not outlined in the study.   
Patients were categorised according to the following groups: Overweight (BMI> 95
th
 
percentile), at risk of being overweight (BMI between 85
th
 to 95
th
 percentile) or normal 
weight (BMI< 85
th
 percentile).  
Main results The proportion of subjects with headaches in the overweight group was 17.9% versus 
10.3% in the normal weight group.  
Children with headaches were significantly heavier (p=0.03) than headache free 
subjects.  
Headaches were present in 17.9% of the “overweight” children, in 15.6% of the “at risk 
of being overweight” children and in 10.3% of the “normal weight” children.  
After adjusting for age and blood pressure, overweight girls were four times more likely 
to suffer headaches than normal weight girls. 
Bias and limitations Children with eating disorders were excluded from the study indicating that some 
potential confounding factors were acknowledged, however food triggers and 
depression were unaccounted for in the study.      
Children recruited from obesity clinics may have received weight altering treatment in 
the form of exercise prescription, medication or dietary intervention. Such factors may 
have biased results considering their relationship to both adiposity (as measured by 
BMI) and headaches.  
It is not clearly stated whether height and weight were measured at clinic visits or 
obtained from a national database as implied by the wording used in the article.  
Table 1.1.4- Review of the Pinhas-Hamiel et al (2008)46 study using an adaptation of the 
STROBE review42   
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Author Hershey et al (2009)
47 
Title Obesity in the paediatric headache population: A multicenter study 
Objective The aims of this study were to examine the relationship between weight and headache 
frequency/disability, and also assess the effect of weight change on headache outcomes 
within a paediatric headache population.    
Study Design Retrospective audit 
Participants and 
setting 
913 children aged 3 to 18 years were recruited from headache specialty clinics located in 5 
hospitals, 2 private practice groups and the American headache society. 
Variables Height and weight measurements were taken at clinic visits, which were later converted to 
BMI percentiles. Further details of how height and weight measurements were taken were 
not outlined in the study. Overweight was defined as a BMI over the 85
th
 percentile.  
Disability from headaches was measured using the PedMIDAS questionnaire. This tool 
measured the total number of days absent from social, domestic, school and sporting 
activities in the last 3 months. Monthly Headache frequency was also noted in the initial 
clinic visit.  
As part of routine care, dietary advice was provided to all patients at the initial clinic visit. 
The correlates for BMI percentile, disability and frequency of migraine attacks were analysed 
at baseline and then at 3 months and 6 months follow up. 
Main results There was a very weak positive correlation between headache frequency and BMI (r= 0.1, 
p=0.003). Headache related disability was associated with BMI percentiles.  
At 3 months follow up weight loss in the overweight group was observed in association with 
decrements in headache frequency (p≤ 0.01). At 6 months follow-up, BMI reduction in 
overweight children was associated with a reduction in the frequency of headache attacks 
(p≤ 0.01).  
Weight loss in the overweight children at both 3 and 6 months follow-up was associated with 
reduced monthly headache frequency.  
Bias and limitations Some patients were given preventative medications such as topiramate which can induce 
weight loss
48
, and hence may have biased results.    
At 3 months post baseline 700 patients (76.7%) were not followed up, the reasons for which 
were unexplained. At 6 months another 39 patients were not followed up. The discrepancy 
in sample sizes from 913 patients at baseline to 213 patients at 3 months and then 174 
patients at 6 months suggest that any change witnessed at follow up will have been 
amplified due to the considerably smaller sample sizes.  
The fact that the clinics offered dietary advice at the initial visit may have provoked to some 
extent the weight loss documented. Considering some form of dietary intervention was put 
in place, there was no measure of whether eating played any part in the results produced. A 
change in appetite may have masked the relationship between BMI and headaches, 
specifically that of migraine. 
Table 1.1.5- Review of the Hershey et al (2009)47 study using an adaptation of the STROBE 
review42   
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Author Kinik et al (2009)
49 
Title Obesity and paediatric migraine 
Objective This study aimed to assess the impact of obesity on the severity and frequency of migraine 
attacks.    
Study Design Retrospective case series 
Participants and 
settings 
Medical records were reviewed for 124 children aged 4 to 17 years who previously attended a 
Turkish Neurology clinic, from March 2000 to September 2006. 
Variables Patient files were reviewed for information on the frequency, duration and severity of 
migraine (headache) attacks, as well as the presence of any associated symptoms (aura, 
nausea, vomiting, photophobia and phonophobia).   
124 patients that fulfilled the criteria for a migraine diagnosis according to the ICHD-II
1
 were 
included in the final analysis (see appendix 5.1.9 for details on the ICHD-II criteria for migraine 
diagnosis).    
Data on migraine severity as quantified by a 10 point visual analogue scale (mild/moderate 
headaches= 1 to 7 points; severe headaches= 8 to 10 points) and monthly attack frequency 
were ascertained from the case files.   
Body mass index (BMI) values previously calculated as weight in kilograms divided by height in 
metres squared (kg/m
2
) were also extracted from case notes. Further details of how height 
and weight measurements were taken were not outlined in the study. Relative BMI (relBMI) 
values were then calculated using the formula; (raw BMI value x100)/ (50
th
 percentile of BMI 
value adjusted for age and sex). Patients were categorised according to three adiposity groups; 
normal weight (relBMI <110), overweight (110≤relBMI≤120) and obese (relBMI>120).  
Main results Results showed that obese children suffered more frequent migraine attacks compared with 
normal weight and overweight subjects (p= 0.02). Relative BMI had a very weak positive 
correlation with headache frequency (r= 0.2, p= 0.03). Migraine severity and associated 
symptoms did not share any significant relationship with relative BMI.  
Bias and limitations Given that some anti-migraine medications can alter weight48 this study eliminated one 
confounding factor by excluded patients on any form of medication.  
 
The migraine diagnoses were made by specialist neurologists in accordance with the validated 
IHS criteria
1
. This indicates a high probability that the migraine diagnoses were clinically valid. 
Given that migraine severity was not assessed through use of a validated tool, it may not have 
been accurately measured and would account for the insignificant correlations between 
migraine severity and BMI.  
Study limitations and potential biases were not outlined in this study.   
Table 1.1.6- Review of the Kinik et al (2009)49 study using an adaptation of the STROBE 
review42    
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Author Nelson et al (2010)
50 
Title Headache and Biomarkers Predictive of Vascular Disease in a Representative 
Sample of US Children  
Objective The aim of this study was to examine the association of childhood headache 
disorders with markers of risk for cardiovascular and cerebrovascular disease, 
such as obesity.         
Study Design Cross-sectional study 
Participants and settings Data previously collected from the National Health Examination and Nutrition 
Survey (NHANES) from 1999 through to 2004, was analysed. Information was 
provided on 11,770 U.S resident children aged 4 to 19 years. 
Patients included in the review had their headache status previously 
determined by asking the following closed question; “in the last 12 months 
have you had frequent or severe headaches including migraine?”  
Records on body mass index (BMI) calculated as weight in kilograms divided by 
height in metres squared (kg/m
2
), was used as one of the markers for vascular 
risk. Further details of how height and weight measurements were taken were 
not outlined in the study.   
BMI data was organised into cumulative quintiles and the population of 
headache sufferers in each quintile was assessed.  
Variables Headache status, headache severity/frequency, BMI and serum biomarkers 
such as: triglyceride levels, total cholesterol, C- reactive protein, etc.     
Main results Mean BMI was higher in children suffering headaches (22.71kg/m2) compared 
with non-headache controls (20.19kg/ m
2
). Generally across all age groups BMI 
values were higher among headache sufferers compared with non-headache 
controls.    
The prevalence of children with BMI in the highest quintile was 35% higher in 
headache sufferers compared with controls. Children with headaches were 
twice more likely to be in the highest BMI quintile (odds ratio= 2) compared 
with non-headache patients. 
Bias and limitations Information of basic headache status provided from the NHANES database did 
not distinguish between migraine and other specific variant headache causes. 
Hence this study did not establish a conclusion specific to migraine and 
adiposity. The NHANES study did not stipulate whether BMI was analysed 
based on percentiles or standardised z-scores.  
Results were adjusted for age, sex, ethnicity, socioeconomic status and the 
presence of co-morbidities such as asthma.  
Table 1.1.7- Review of the Nelson et al (2010)50 study using an adaptation of the STROBE 
review42   
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The above studies39-41,46-50 aimed to investigate obesity as a risk factor for migraine and 
primary headaches. Although these studies demonstrated a relationship between obesity 
and migraine their study designs were not robust enough to establish the direction of 
causality between obesity and migraine. Thus it could be argued that migraine can act as a 
risk factor for obesity. This pilot study aimed to investigate whether paediatric migraine 
patients had higher adiposity levels because of higher levels of obesogenic eating 
behaviours in comparison to non-migraine paediatric headache patients. The concept of 
eating behaviours is now described in chapter 1.2.          
 
 
Chapter 1.2 
Eating behaviours and appetite 
 
General concept of eating 
Food ingestion is a behaviour that is subject to internal and external determinants51. 
Physiological homeostatic mechanisms represent one aspect of the internal factors that 
influence feeding52. The behaviour of eating can be viewed as part of a homeostatic 
mechanism to replenish and maintain energy stores, as supported by glucoprivation studies 
that evidence hypoglycaemia as a potent hunger stimulus53. However the obesity disorder 
undermines the concept of homeostatic appetite control, due to the accumulation of 
excessive adiposity levels that surpass the required quantum for energy replenishment54. 
Recent studies have highlighted the role of eating behaviours such as restrained, external 
and emotional eating that can lead to increased adiposity levels55.     
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Eating behaviours can be determined by functions of psychological factors, emotional 
states, availability of environmental food cues, responsiveness to foods, the enjoyment of 
food, speeds of eating and food preferences56. In turn these factors are subject to influences 
from the perceived palatability of food, which forms one element of the reward gained from 
consuming certain foods57. Obesogenic eating behaviours result in hyperphagia that 
subsequently increase adiposity levels58. Key concepts surrounding eating behaviours are 
now discussed in this chapter.  
 
Hedonic eating concept 
The desire to eat is driven by the perceived rewards gained from eating59. This reward 
system consists of two parts: food hedonism (“like”) and food motivation (“want”)60. 
Motivation is the behavioural incentive and drive for pursuing a desired stimulus (i.e. “how 
much we want to eat a certain food item”). It can manifest in the form of cravings for 
particular foods with the perceived pleasures to be gained rated very highly61. The 
motivation to eat is mediated by the mesotelencephalic dopamine pathways, the nucleus 
accumbens and the amygdala62.  
The behaviour of eating is largely driven by the palatable pleasures gained from food 
consumption63. Hedonism is a concept of food intake stimulated by the perceived pleasures 
to be gained from food consumption64. Adiposity levels as measured by BMI are positively 
correlated with hedonism as measured by pleasantness ratings for food items65. Obese 
individuals share a heightened hedonic response to food, which is likened to the behaviour 
of compulsive gamblers and drug addicts that are pre-occupied with their habit even when 
not engaging in the activity. Similarly obese hedonistic eaters are shown to eat in the 
absence of hunger, without the need for food cues66. The activation of brainstem opioid and 
GABA receptors involved in the behaviour of addiction has been associated with increased 
levels of hedonistic eating behaviour67.   
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In overview, the theory of reward is based on the desire to consume a food item (hedonism) 
and the decision of whether the motivation (“want”) and effort to seek the reward is 
worthwhile68. Obese adults have been shown to work harder for a palatable reward than 
lean individuals, indicating obese subjects work harder for food rewards69.  
 
Emotional eating (psychosomatic theory) 
States of anxiety, fear or anger are able to influence appetite. The physiological response to 
emotional arousal is the inhibition of gastric motility and the liberation of glucose from liver 
glycogen stores70. However some individuals lack interoceptive awareness and are unable to 
recognise whether they are hungry or satiated. As a result they overeat in response to any 
high emotional arousal, usually resulting in the over-consumption of high calorie energy 
dense foods; this phenomenon is known as “emotional eating” and has been positively 
correlated with adiposity71. 
  
Restrained eating 
Continuous food restriction in people that diet initiates physiological defences in the form of 
lowered metabolic rate and the arousal of persistent hunger72. When self control is 
undermined by disinhibitors such as alcohol or emotional arousal (e.g. anger, anxiety, etc) 
the cognitive resolve to diet is abandoned and food is excessively consumed73; this 
phenomenon is known as “restrained eating”. Restrained eaters have strong hedonistic 
drives for appetite, desensitised responses to internal satiety signals and higher adiposity 
levels compared with non-restrained eaters74.                   
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External eating (externality theory)  
Recent literature highlights the importance of environmental influences on diet. Readily 
available and widely advertised energy dense high fat foods at affordable prices provide a 
constant exposure to food cues75. The theory of external eating states that certain people 
are more sensitive to external food cues than others, and eat in response to those stimuli, 
regardless of their internal state of hunger and satiety76. Overweight individuals are 
demonstrated to be hyper-responsive to external food related cues such as the sight or 
smell of food77. The provision of food cues has been shown to induce rapid rates of food 
ingestion which are associated with greater adiposity levels78.      
Children hedonistically respond to cues for food items that appear highly palatable, which 
can over ride internal satiety cues79. Energy dense food brands are widely advertised to 
millions through TV and radio marketing. Food brand organisations specifically target youths 
because of their spending power, purchasing influence and role as future adult consumers80. 
In recent decades children have developed a greater freedom in food choice with a common 
practice to eat outside the house or “on the go” which facilitates the development of 
external eating in a food cue rich environment81.    
Restrained, emotional, external and hedonistic eating behaviours are all associated with 
obesity and higher adiposity levels in children and adults71,74,78,65. Chapter 1.3 now outlines 
background information on adiposity and the obesity disorder.   
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Chapter 1.3 
Obesity 
 
 
Obesity definition and prevalence 
The World Health Organisation (WHO) defines obesity as an abnormal or excessive level of 
adiposity that presents a risk to health82. Body mass index (BMI) is commonly used as an 
indirect measure of adiposity among large scale populations83. It is calculated by dividing a 
person’s weight in kilograms by the square of their height in metres. In adults, a BMI value 
of greater than 25kg/m2 indicates an individual is overweight and a value greater than 
30kg/m2 is an indicator of obesity84.             
It is estimated that up to 1.6 billion people worldwide are overweight, of which almost 400 
million people are obese85. The WHO projects that by 2015, 2.3 billion adults may be at risk 
of becoming overweight with a constituent 700 million people at risk of becoming obese86. 
Fifty percent of adult obesity is suggested to stem from an early onset during early 
adolescence87. Paediatric overweight and obesity rates have accelerated in prevalence by 
120% between years 1986 and 199888. An amalgamation of global statistics in 2007 revealed 
that at least 20 million children under the age of 7 were overweight85. The UK prevalence of 
overweight children aged 2 to 5 years is 31% and 29% for males and females respectively89. 
The reported prevalence of overweight children in Liverpool is 27% among males and 31% 
among females90. By the year 2050 UK childhood obesity rates are estimated to rise by 19% 
and annual NHS weight related costs are anticipated to inflate by £15.8 billion as predicted 
by the foresight report91.   
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Quality of life and obesity related morbidities 
Huge health, fiscal and wider societal effects have accompanied the rapid global rise in 
obesity92. Severely obese children have a lower health related quality of life compared with 
normal weight controls93. Cancer patients reflect similar quality of life ratings as those for 
obese children. Increased parental distress, peer victimisation and depressive symptoms are 
associated with reports of low quality of life in obese children94.  
Excess weight gain at a young age increases the risk of obesity related morbidities in later 
adult life. Childhood obesity is associated with asthma, sleep apnoea and non-insulin 
dependent diabetes95,96. Other obesity related paediatric morbidities include orthopaedic 
problems such as Blount’s disease (a growth disorder of the tibia), skin fungal infections and 
hepatic steatosis97. Obese children are at increased risk of psychological problems such as 
negative self esteem, social withdrawal, depression, anxiety and feelings of chronic 
rejection98. The development of such psychological issues overlaps with eating disorders 
and eating behaviours99.  
   
Obesity Mechanisms 
As illustrated by figure 1.3.1, weight is determined by factors that affect energy intake and 
energy expenditure which are subject to specific brain mechanisms100,101. Up to 40% of the 
variation in BMI can be attributed to genetics and up to 60% can be attributed to 
environmental factors102. Some people are genetically predisposed to developing obesity 
when exposed to an environment which encourages weight gain, such as a sedentary 
lifestyle and the access to high calorie foods103. The rapid rate of increase in obesity 
prevalence suggests that the cause is more due to the changing environment rather than 
genetic pre-selection104.      
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Multiple genes contribute to the manifestation of the obesity phenotype105. The BMI of 540 
child adoptees followed up at adulthood was more similar to their biological parents than 
that of the adoptive carers106. Homozygous expression of the fat mass and obesity gene 
(FTO gene) is associated with higher adiposity levels compared with low risk alleles107. 
Messenger RNA from the FTO gene is expressed in the arcuate nucleus of the hypothalamus 
and has been shown to influence weight via alterations in appetite108,109.    
 
Figure 1.3.1 - Overview of energy balance (this diagram has been used with the 
permission of Liverpool University, Psychology Department)  
 
Over the past few decades the western world has adopted a more sedentary life style that 
has progressively escalated to a state where energy output is very minimal and 
disproportionate to energy intake110. New advances in labour saving technology such as cars 
and computers have deterred people from physical activities that used to be part of 
everyday life111. There has been a shift from cooking fresh foods to fast food 
consumerism112. The importance of diet and energy expenditure as key determinants of 
adiposity levels113 can be demonstrated by the Pima Indians that separated over 700 years 
ago with one colony settling in Arizona and the other settling in Mexico. The Arizona Pima 
Indians were exposed to a diet more rich in animal fats and simple sugars than the Mexican 
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Pima Indians, who had a more traditional lifestyle involving greater physical activity. Despite 
the genetic similarities, the difference in diet and lifestyle over time has led to a higher 
prevalence of obesity among the Arizona Pima Indians compared with the Mexican Pima 
Indians114. 
Eating behaviours that influence appetite are associated with obesity56 and are regulated by 
hormonal and neural mechanisms115. Serotonin116,117, calcitonin gene related peptide 
(CGRP)118,119, orexins120,121 and leptin122,123 are hormones that share a common 
neurobiological overlap in both migraine and obesity pathologies. The hypothalamic areas 
involved in appetite regulation124 have been linked to migraine pathology125. The 
neurobiological overlap between migraines, appetite and adiposity are now reviewed in the 
following chapter 1.4.       
 
Chapter 1.4 
Neurobiological overlap between migraines, appetite and 
obesity 
Serotonin 
Serotonin, also known as 5-Hydroxytriptamine (5-HT) is a mono-amine neurotransmitter 
primarily found in the gastrointestinal tract and central nervous system126. Low serum 
serotonin levels and high CSF (cerebrospinal fluid) concentrations of the serotonin 
metabolite, 5-hydroxyindoleacetic acid (5-HIAA), are found in migraine patients between 
acute attacks. Conversely during acute migraine attacks there are elevated plasma levels of 
serotonin and low serum concentrations of 5-HIAA116. This implies migraine is a chronic 
state of low serotonin availability with short bursts of serotonin increase during times of 
acute attacks.   
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Serotonin is a satiety inducer that forms part of a homeostatic mechanism that inhibits 
excessive food consumption117. Large serotonin deposits are found in the sub-oesophageal 
ganglia of leeches that function to regulate food ingestion and satiation127. Serotonin 
injections into hypothalamic nuclei that express 5-HT receptors significantly reduce appetite 
levels and increase eating speeds117. Given that migraine patients suffer from a chronic state 
of serotonin deficiency116, there may be a lack of appetite regulation from serotonin and 
thus migraine patients may have larger appetite levels that in the long term could lead to 
increased adiposity levels117.            
 
Calcitonin Gene Related Peptide (CGRP) 
CGRP is a 37 amino acid neuropeptide formed from the alternative splicing of the 
calcitonin/CGRP gene located on chromosome 11128. CGRP facilitates nociceptive 
transmission and has potent vasodilatory effects129. During acute migraine attacks there are 
elevated levels of serum CGRP found in the external jugular and cubital veins, as well 
increased concentrations of salivary CGRP118. Patients administered CGRP drug infusions can 
develop a late onset non-aura migraine headache130. Blockade of the CGRP receptor using 
the CGRP antagonist BIBN4096 has been shown to attenuate headache pain131.          
Precipitates of mRNA encoding CGRP are distributed along several brain areas important in 
eating behaviour132. The central administration of CGRP in animal models stimulates a 
ravenous appetite that can lead to excessive food consumption119. Serum CGRP 
concentrations are significantly higher among obese individuals compared with normal 
weight controls133. Fat ingestion is linked to CGRP secretion, a possible mechanism by which 
CGRP levels are associated with obesity83. Based on the information presented so far, 
migraine patients may develop larger appetite levels during acute migraine attacks (due to 
the increased secretion of CGRP) which in frequent occurrence could lead to high adiposity 
levels in the long term.        
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Orexins 
Orexins are neuro-peptides formed from the proteolytic cleavage of the amino acid prepro-
orexin. There are two isoforms, orexin A which acts on the orexin-1 receptor and orexin B 
which acts on the orexin-2 receptor134. The orexinergic system has broad projections to 
hypothalamic areas such as the periaqueductal grey and paraventricular nucleus135. In 
animal studies, the injection of orexin A causes a heightened appetite response and a slow 
satiety onset, with subsequent reversal of symptoms upon administration of the orexin-1 
receptor antagonist120. The involvement of orexins in nociceptive processing has recently 
been implicated with evidence of orexin A showing analgesic properties in animal models136. 
Migraine patients have a significantly higher concentration of orexin A in their CSF fluid 
compared with matched controls121. The chronic pain state in migraine patients may 
stimulate a high release of orexin A as a compensatory mechanism to reduce pain levels136 
that in turn increases appetite and elevates adiposity levels120.    
 
Leptin 
Leptin, a 16-kDA polypeptide hormone secreted from the adipose cells is a product of the 
OB gene, heavily involved in appetite regulation and metabolism122. Leptin profoundly raises 
bodily metabolic rate, increases thermogenesis and dramatically reduces appetite137. Leptin 
reduces appetite by sensitizing the brain to satiety signals from the stomach and 
duodenum138. Obese patients are thought to suffer from a state of “leptin resistance” where 
cells are unresponsive to the usual effects of leptin. It is likened to the underlying principle 
of non-insulin dependent diabetes. It is proposed that hypothalamic receptors become 
desensitised or leptin receptor density is down regulated, which ultimately leads to leptin 
resistance with increased food intake139. Migraine patients are subject to significantly low 
serum leptin levels when compared with healthy matched controls123. This last piece of 
evidence suggests that because migraine patients have low leptin levels they may be 
inclined to develop aberrant hyperphagic eating patterns which can result in higher 
adiposity levels123,137. 
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The hypothalamus 
The hypothalamus is involved in analgesic processing. Hypothalamic corticolimbic 
connections are implicated in the affective and cognitive aspects of pain perception140. 
Electrical stimulation of the paraventricular nucleus evokes anti-nociceptive effects141. 
Chronic migraine is associated with sleep disorders such as insomnia and narcolepsy that 
share a common pathology of hypothalamic dysfunction. The trigeminal pathway can act as 
a trigger for hypothalamic activation142,143. Positron emission tomography (PET) scanning 
has revealed clear hypothalamic activation during the early phases of acute migraine 
attacks125.  
The ventro-medial hypothalamus has a strong role in satiety. Localised lesions in this brain 
area can cause progressive weight gain through constant overeating patterns and the loss of 
metabolic control from connections with the paraventricular nucleus124. The lateral 
hypothalamus coordinates food seeking behaviour through metabolic hunger signalling and 
is heavily involved in the underlying mechanism of food reward. Isolated neuro-toxic lesions 
of the lateral hypothalamus result in a long term decrease in food intake with subsequent 
weight loss144. The lateral hypothalamus and the midline thalamus relay energy balance 
information to brain areas involved in behavioural action145; these areas are also involved in 
migraine pathology100. It is possible that migraineurs suffer from hypothalamic pathology 
that increases appetite levels and results in increased adiposity levels124,125,144.           
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Chapter 1.5 
Migraine and appetite 
 
 
Migraine and food cravings/ binge eating 
Food cravings (defined as an intense desire to consume a particular food item that is 
difficult to resist) can develop in migraine patients as part of a premonitory phase prior to 
the onset of an acute attack146. Although a physiological mechanism has not yet been 
identified, the ICHD-II delineates fasting and skipping meals as potential triggers for acute 
migraine attacks1. Blau et al demonstrated that 45% of migraine patients can still consume 
food in states of nausea during an acute migraine attack, which can actually shorten 
headache duration and alleviate symptoms of nausea147. Brewerton et al found that 59% of 
34 female migraine patients exhibited binge eating behaviour according to the eating 
disorders inventory (EDI)148. Binge eating behaviour has also been shown to have a positive 
correlation with restrained eating149 and adiposity150. It is possible that migraine patients 
with binge eating habits may also have restrained eating patterns which can cause greater 
adiposity levels to develop.       
 
Migraine treatment and adverse weight altering effects 
Topiramate, originally an anti-epileptic drug used to treat migraine is commonly associated 
with adverse weight loss151. Topiramate suppresses the lateral hypothalamus via its 
antagonistic effects on the kainite and glutamate receptors, whereby inducing an anorectic 
response with subsequent weight loss. In overview, topiramate suppresses hunger so that 
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appetite and food intake are reduced152,153.  The use of pizotifen, another prophylactic anti-
migraine medication, is of limited use in obese patients due to the potential adverse effect 
of weight gain. Maggioni et al found up to 86% of migraine subjects each gained a minimum 
of 4kg in weight after a 6 month pizotifen treatment period154. Pizotifen has an antagonistic 
effect on 5-HT2C receptors which is believed to stimulate and increase appetite levels that 
cause subsequent weight gain151. No study has hitherto successfully elucidated the 
mechanism behind these weight altering adverse drug reactions, although current literature 
suggests that there is a disruption in appetite which is the key mechanism by which weight 
is affected.    
 
 
Chapter 1.6 
Conclusion 
 
BMI as an indirect measure of adiposity is positively associated with migraine prevalence, 
migraine severity and headache frequency39-41,46-50. Restrained, emotional, externalised and 
hedonistic driven eating behaviours are strongly associated with increased adiposity levels 
and obesity development71-81. Migraine patients can develop food cravings during the 
prodromal and ictal phases of acute migraine attacks1,146. Particular migraine treatments, 
such as topiramate and pizotifen, can adversely alter weight through effects on appetite151-
154. There is a substantial neurobiological overlap of serotonin, calcitonin gene related 
peptide (CGRP), orexin A, leptin and hypothalamic related pathology between migraines, 
appetite and adiposity116-125. As can be seen in figure 1.6.1, the direction of the relationship 
between migraines, eating behaviours and adiposity has not yet been established and 
requires further investigation.   
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Figure 1.6.1  
Diagram to outline the relationship between migraines, eating behaviours and adiposity 
 
 
Based on the information presented so far, it is possible that a causal relationship may exist 
between migraines, eating behaviours and adiposity. However no study hitherto has 
investigated the relationship of all three variables together. Hence this pilot study was 
developed to investigate the relationship that migraine shares with eating behaviours and 
adiposity. The following section outlines the methodology used in this pilot study. This pilot 
study was also used to identify limitations in the methodology to help prepare for a larger 
future study on “migraines, eating behaviours and adiposity”. This main future study will be 
designed to confirm and extend the findings from this present pilot study. Power sample 
size calculations for the main future study have been presented in this thesis.    
 
Migraine Eating Behaviours Adiposity 
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Chapter 2.0  
Study Methodology 
It must be noted that the methodology for this pilot study was originally designed by a 
previous MPhil student from August 2008 to August 2009. The second researcher (the 
author of this thesis) took over the pilot study in August 2009 and made no contribution to 
designing the methodology of this pilot study. Instead the second researcher was mainly 
involved with the patient recruitment, data collection, data analysis and reporting process.     
 
Chapter 2.1 
Study Objectives 
 
Primary objective: 
 To assess whether eating behaviours differ between migraine cases and non 
migraine control headache patients. 
Secondary objectives: 
 To assess whether food cravings, food intake and adiposity levels differ between 
migraine cases and non migraine control headache patients.  
 To assess the relationship eating behaviours, food cravings, food intake and 
adiposity levels have with migraine severity and monthly headache frequency among 
migraine cases.     
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 To assess the relationship behavioural issues have with eating behaviours, food 
cravings, food intake, adiposity levels, migraine severity and monthly headache 
frequency among migraine cases. This is to account for the confounding effects that 
behavioural issues may have on any relationships observed in the study. 
 After this pilot study has been completed the final aim is to evaluate potential 
changes/improvements in the methodology for the main future study on “Migraines, 
Eating behaviours and Adiposity in children”.      
 
Chapter 2.2 
Study Design 
Overview of Study design 
A single-centre, cross-sectional, questionnaire-based, clinical migraine population pilot 
study was designed. The primary outcome was to identify an association between measures 
of migraine severity and headache frequency with obesity related eating behaviours. The 
independent variables were monthly headache frequency and migraine severity as 
determined by the Paediatric Migraine Disability Assessment questionnaire (PedMIDAS). 
Eating behaviours were assessed using the Dutch Eating Behaviour Questionnaire for 
adolescents (DEBQ-adolescent version), the Children’s Dutch Eating Behaviour 
Questionnaire (DEBQ-C) and the Child Eating Behaviour Questionnaire (CEBQ). Food 
cravings were evaluated by the Food Cravings Inventory (FCI-II) and food intake on the 
previous day was assessed using the Food Intake Questionnaire (FIQ). Adiposity was 
indirectly measured using BMI z-scores. Behavioural problems were evaluated using the 
Child Behaviour Checklist (CBCL). Local Research Ethics and Trust R&D approvals were 
granted in June 2009 for this pilot study to be conducted at Alder Hey Children’s NHS 
Foundation Trust.    
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Patient sample      
A major reason for conducting a pilot study is to determine what type and quantity of data 
is required to either prove or disprove a hypothesis, to assess the feasibility of patient 
recruitment and also to perform a sample size calculation for a larger study155.  The number 
of patients to be included in a pilot study depends on the parameter(s) to be estimated156. 
Gillian et al conducted a study on the design and analysis of pilot studies and recommended 
using 30 patients or greater to estimate a parameter157.  The degree of association between 
the measure of migraine severity and of restrained eating, emotional eating and external 
eating, respectively, were intended to be the 3 main parameters of focus in this pilot study. 
Hence following various discussions with a statistician, a total of 90 patients were decided 
as the target sample size; 60 migraine cases and 30 non migraine headache controls. It must 
be noted that the decision about the sample size was made by the previous researcher of 
this pilot study and the justification given is based on that of the previous researcher.  
 
Patient recruitment  
Headache referral patients aged 5 to 17 years were approached for recruitment at 
neurology outpatient clinics and general paediatric clinics at Alder Hey Children’s 
Foundation Trust Hospital, Liverpool. The recruiting agent attended the patient’s clinic 
consultation to gain confirmation of their headache diagnosis, which was then compared 
with a migraine pro-forma. Parents and children that were approached after the clinic were 
given general information on the pilot study and if interest for participation was expressed 
they were then briefed in more depth about the study in a private room. Fully informed 
consent was gained from the parent on the child’s behalf. The relevant questionnaires were 
then administered and filled out. Usually an average of one hour was spent recruiting each 
patient in this manner. 
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Patients 
Headache patients seen in clinic that were diagnosed with migraine by the treating clinician 
were approached for recruitment as migraine cases. Newly referred migraine patients aged 
5 to 17 years were used as cases. Most of the migraine headache patients at Alder Hey 
neurology clinics and general paediatric clinics are commenced on prophylactic or acute 
rescue medication usually after their first clinic consultation. They are then usually followed 
up for review at clinic at a later date to assess whether the drug treatment was successful. 
By the time the patient has attended a follow up clinic the medication may have already 
taken effect on migraine neurobiology and also caused an alteration in weight if treated 
with pizotifen or topiramate. Therefore it was decided to focus on newly referred headache 
patients because in comparison to follow up patients they were less likely to be taking any 
prophylactic medication151-154. Headache patients aged 5 to 17 years not suffering from 
migraine or any secondary organically induced headaches, were targeted as control 
patients.     
 
Patient exclusion criteria   
Patients younger than 5 years were excluded. The maximal age of Alder Hey outpatients 
was 17 years and hence was also the maximal age of patients that could be recruited. 
Patients with a secondary organic cause (e.g. brain tumours) for their headaches were 
excluded from the study. Brain tumours are a very distinct category of disease associated 
with an over-expression of leptin receptors and appetite disturbances158. By excluding 
organic neurological disorders the control group could consist of patients with a similar 
neurobiology. It was necessary for patients to be drug naive, due to the possibility that 
certain prophylactic medications can affect weight through altered appetite behaviours151-
154 (see chapter 1.5: Migraine treatment and adverse weight altering affects). 
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Chapter 2.3 
Questionnaire tools used in study 
This study was conducted as a joint partnership between Consultant Neurologists based at 
Liverpool Alder Hey Children’s Hospital and the Liverpool University Psychology appetite 
research team. The appetite research team were highly involved in the questionnaire tool 
selection process. The tools used in this pilot study are now outlined.      
 
Assessment of eating behaviours 
It was important to use a psychometric tool which accurately measured eating behaviours. 
Much of the literature on eating behaviours presented so far has been contributed and 
tested by the Dutch Eating Behaviour Questionnaire (DEBQ)70-78. Through rigorous 
background reading and literature searching the DEBQ was confirmed as a reliable and valid 
tool for measuring eating behaviours159. For these reasons the DEBQ was chosen as an 
appropriate measure for eating behaviours in this pilot study.     
There are two versions of the DEBQ:  
 Dutch Eating Behaviour Questionnaire for adolescents (DEBQ- adolescent version) 
for targeted for use in children aged 12 or older160.  
 Children’s Dutch Eating Behaviour Questionnaire (DEBQ-C) targeted for use in 
children aged 7 to 12 years161.  
Both tools were used considering the inclusion criteria for age was 5 to17 years. It was 
predicted that some of the younger children may lack capacity to competently report on 
their own eating behaviours. In addition to this the DEBQ-C was not designed for children 
aged below 7 years. Thus after discussion with the appetite research team, it was decided to 
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incorporate a parent reported tool for assessing eating behaviours. In doing so both 
perspectives from the child and parent were acknowledged and eating behaviours were also 
measurable in children below 7 years. The Children’s Eating Behaviour Questionnaire (CEBQ) 
was the tool of choice because of its robust structure, wide use and validated measure of 
eating behaviours162. The DEBQ (adolescent version), DEBQ-C and CEBQ are now discussed 
in more depth.     
 
Dutch Eating Behaviour Questionnaire for adolescents (DEBQ- adolescent 
version)160 
The Dutch Eating Behaviour Questionnaire for adolescents (DEBQ- adolescent version) 
measured the levels of emotional, external and restrained eating behaviours. It was 
designed for adults and adolescents aged at least 12 years. It consisted of 33 closed 
questions; 13 for emotional eating, 10 for external eating and 10 for restrained eating. “Do 
you have a desire to eat when depressed or discouraged” is an example emotional eating 
question that was used in the DEBQ (adolescent version). “If you see or smell something 
delicious, do you have the desire to eat” is an example external eating question that was 
used in the DEBQ (adolescent version). “Do you try to eat less at mealtimes” is an example 
restrained eating question that was used in the DEBQ (adolescent version)160. Each question 
was answered by ticking off an answer on a 5-point scale provided at the side of each 
question; never (1), rarely (2), sometimes (3), often (4) or always (5).  The number in each 
bracket was the score given for the chosen option which allowed a quantitative analysis of 
the DEBQ160.  
The DEBQ has demonstrated excellent validity. All three sub-scales have featured a high 
level of reliability as reflected by the Cronbach’s alpha scores; emotional (0.92), external 
(0.8) and restrained (0.95)163. The DEBQ has been widely used in various obesity and eating 
disorder studies in adults and adolescents164.     
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Children’s Dutch Eating Behaviour Questionnaire (DEBQ-C)161 
The Children’s Dutch Eating Behaviour Questionnaire (DEBQ-C) was developed to measure 
the levels of emotional, restrained and external eating patterns in children aged 7 to 12 
years old. The items used in this tool were derived from the simplification of questions used 
in the DEBQ (adolescent version). It was tailored to the shorter attention span of younger 
children by limiting the tool to 20 questions. Answers were chosen from a simplified 3-point 
scale provided at the side of each question; “no (1)”, “maybe (2)” or “sometimes (3)”. The 
number in each bracket was the score given to the corresponding answer chosen, which 
allowed quantitative analysis of the DEBQ-C161.  
The DEBQ-C has demonstrated high reliability scores that range from 0.72 to 0.82. 
Cronbach’s co-efficients at 0.8 for emotional eating, 0.68 for external eating and 0.72 for 
restrained eating have indicated high internal consistency of the scales161. As there were no 
reports of the DEBQ-C being used in any studies since its recent inception in 2008 this pilot 
study was the first to use the DEBQ-C outside of its initial development by Van Strien et al77.            
To allow the combined analysis of results from both the DEBQ (adolescent version) and 
DEBQ-C, the scores were adjusted for age and sex to produce standardised DEBQ z-scores. 
This was done on advice from the lead author of both the DEBQ (adolescent version) and 
DEBQ-C, Dr Tatjana Van Strien. The standardised DEBQ z-scores as opposed to the DEBQ 
(adolescent version)/DEBQ-C raw scores were used in the data analysis. In this thesis, it 
must be noted that the term DEBQ refers to data in the form of z-scores that were a 
collection of the DEBQ (adolescent version) and DEBQ-C raw scores.        
The reference scores used to standardise the female DEBQ (adolescent version) scores were 
taken from a  study on 724 Dutch secondary school girls aged between 12 to 16 years (mean 
age was 15.6 years and mean BMI was 20.1kg/m2)165. The reference scores used to 
standardise the male DEBQ (adolescent version) scores were taken from a study on 104 
Dutch secondary school boys aged 15 to 17 years (mean age was 17 years and mean BMI 
was 20.3kg/m2)73. The reference values used to standardise the DEBQ-C scores were 
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extrapolated from the initial study in which the DEBQ-C was developed and validated. The 
sample consisted of 767 Dutch children (382 boys and 385 girls) aged 7 to 12 years with a 
mean age of 9.6 years161.   
 
Child Eating Behaviour Questionnaire (CEBQ)166 
The child eating behaviour questionnaire (CEBQ) was a parent reported tool developed to 
assess 8 different domains of obesogenic eating behaviours in children aged 5-12 years. It 
consisted of 35 statements on food responsiveness (FR), emotional overeating (EOE), 
enjoyment of food (EF), desire to drink (DD), satiety responsiveness (SR), slowness of eating 
(SE), emotional under eating (EUE) and food fussiness (FF). Each statement was worded 
from the parent’s perspective166.   
The food responsiveness (FR) subscale assessed how responsive the child is to eating, 
(“given the choice my child would eat most of the time” is an example FR statement that 
was used in the CEBQ). The emotional over eating and under eating subscales assessed 
whether the child over or under ate, respectively, in response to emotional stress. An 
example emotional overeating statement that was used in the CEBQ is “my child eats more 
when worried”. An example emotional under eating statement that was used is “my child 
eats less when angry”. The enjoyment of eating subscale assessed children’s appetite by 
their desire and appreciation for food (an example statement that was used is “my child 
loves food”). The desire to drink subscale assessed general thirst levels (an example 
statement that was used is “if given the chance my child would always have a drink”). 
Satiety responsiveness determined children’s sensitivity to internal satiety cues (an example 
statement that was used is “my child cannot have a meal after eating a snack”). The 
slowness of eating subscale assessed how quickly a child usually finishes their meal (an 
example statement that was used is “my child takes longer than 30 minutes to finish a 
meal”. Food fussiness determined how selective a child was with their choice of foods (an 
example statement that was used is “my child refuses new foods at first”)166.   
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Parents had to choose from 5 options that best described how applicable statements in 
each CEBQ subscale were to their child. The options given per statement were; never (1), 
rarely (2), sometimes (3), often (4) or always (5). The number in each bracket represents the 
score given for each option to allow quantitative analysis of the CEBQ166.      
The CEBQ has demonstrated high test-retest reliability and high internal validity, as 
supported by its Cronbach’s alpha scores; 0.56 (FR), 0.71 (EOE), 0.78 (EF), 0.82 (DD), 0.5 (SR), 
0.57 (SE), 0.58 (EUE) and 0.7 (FF)166. The CEBQ has previously been used in a genetic study 
on the appetitive effects of the FTO gene on satiety responsiveness and enjoyment of food 
scales58. The CEBQ has been accepted as a suitable tool for use in studies measuring 
obesogenic eating behaviours162.   
It is important to note that the raw scores produced by the DEBQ (adolescent version) and 
DEBQ-C were not interchangeable or directly comparable with the CEBQ raw scores. Raw 
scores from the CEBQ were converted to standardised CEBQ z-scores. Reference scores used 
to standardise the CEBQ raw scores were  based on the Wardle et al study166 in which the 
CEBQ was initially developed and validated; it recruited 208 children aged 3 to 12 years old 
(mean age= 5 years). Instead of using the raw scores, the CEBQ subscale z-scores were used 
in the main statistical data analysis, because they were adjusted for age and sex.     
 
Assessment of food intake     
Following various discussions with the appetite research team it was important to assess 
what type of foods are eaten by migraine patients. The most accurate method would have 
been for each child to keep a food diary167. However this would have required following up 
patients for a second visit, which was an unfeasible prospect for recruiting 90 patients, 
considering the time limit in this pilot study168.  
There were a range of food frequency questionnaires (FFQ) which were also considered as 
potential measures of food intake.  Different versions of the FFQ were able to assess what 
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types of specific foods are eaten and allow the calculation of nutrient intake169. However 
each available FFQ such as that used by Fumagalli et al170 was presented in a complex 
format with a long list of questions which would have been difficult to understand and time 
consuming to answer for young children. While a food frequency questionnaire would have 
given more rigorous data with regards to nutrition171, it was not necessary for the objectives 
in this pilot study.  
 
Food Intake Questionnaire (FIQ) 
The Food Intake Questionnaire (FIQ) was chosen to measure food intake because it was 
presented in a simple format for children to report on, it could be numerically graded which 
allowed quantitative analysis and it had a high content validity with respect to typical foods 
eaten on the previous day172.  
The FIQ, originally developed in the early 1980’s, recorded the types of foods eaten on the 
previous day according to a set list of food items in the tool. It was designed to investigate 
the dietary habits of large numbers of school children. It asked “yesterday did you eat any 
amount of the following foods”. Various foods were then listed at the end of this question 
and patients had to answer “yes (1)” or “no (0)” to whether they were eaten the day before. 
The number in each bracket was the score given for the answer chosen. It was the same 
scoring system as that used previously by Hackett et al173. This produced raw scores that 
were used in the FIQ data analysis.   
Commonly eaten food items such as bread, cereal, chocolates, meats and dairy products 
were listed in the FIQ. The food items were broadly classified according to whether they 
were negative marker foods (unhealthy foods dieticians would recommend eating less of) or 
positive marker foods (healthy foods dieticians would recommend eating more of). The 
negative marker food items were divided into either negative marker sugary foods or 
negative marker fatty foods. Positive marker food items were categorised as foods that 
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were high in fibre (positive marker fibre foods) and those that were not173. This pilot study 
used FIQ negative marker food scores as a marker for the intake of unhealthy foods and FIQ 
positive marker food scores were used as a marker for the intake of healthy foods.  
The FIQ has been used in various studies designed to explore the areas of diet that need 
improving in children172. When compared to a 3 day food diary the FIQ has displayed high 
criterion validity174. Thus even though the FIQ did not determine nutritional consumption, 
the food categories in the FIQ were representative of foods usually eaten by people. Results 
from the FIQ have been reproducible at 3 equal intervals over a 3 month period. The FIQ has 
also shown high face validity based on strong agreements between professional dietician 
opinions on foods considered as positive and negative markers175.     
The FIQ was designed for self completion by children aged 11 years or older. Although this 
pilot study intended to recruit children younger than 11 years, based on the simple format 
of the FIQ, it was decided to be age appropriate. Any children that struggled to understand 
the FIQ were given help by the parents or researcher. The question of whether alcohol was 
consumed on the previous day was not asked to children below the age of 11 years, as it 
was not appropriate.    
 
Assessment of food cravings   
As discussed in chapter 1.5 food cravings can develop during acute migraine attacks147. 
Hence it was important to address food cravings as an important hedonistic aspect to eating 
behaviours60 in this pilot study. After detailed discussions with the appetite research team 
the Food Craving Inventory (FCI-II) was chosen to assess the strength of food cravings 
because it has been highly validated by previous obesity studies176. FCI-II Cronbach’s alpha 
scores of 0.81 for high fats, 0.83 for sweets, 0.76 for carbohydrates and 0.7 for fast food fats 
suggested a high level of internal consistency and reliability177.  
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Food Cravings Inventory (FCI-II) 
The FCI-II was a self reported tool which listed 28 food items subdivided into 4 different 
food groups:  
1. High fats (e.g.- fried chicken, sausages, etc)  
2. Fast food fats (e.g.- pizza, chips, etc)  
3. Carbohydrates (e.g.-  pasta, cereal, etc)   
4. Sweets (e.g.- cakes, chocolate, etc)  
As described by Weingarten and Elston178,179 cravings are “an intense desire to consume a 
particular food or food type that is difficult to resist”. The Food Cravings Inventory (FCI-II) 
used this definition to ask whether in the last month there were cravings for any of the 
listed food items178. However to address the trait form of migraine the one month time 
frame was not applied and cravings were assessed generally over an unlimited time period. 
The patient had to choose from 5 options provided next to each food item which acted an 
indicator of the strength of craving; never (1) / rarely (2) / sometimes (3) / often (4) /always 
(5). The number in each bracket was the score given for the chosen option, which enabled a 
quantitative assessment of the strength of food cravings.  
 
Assessment of Migraine severity and headache frequency 
Trait versus State forms of migraine 
Migraine patients suffer a chronic disease process which is the stable and diffuse form of 
migraine that can be regarded as a “trait”. During bouts of acute migraine attacks the 
patients exhibit an immediate unstable form of the disease and are exhibiting the “state” 
form of migraine180. This concept of trait and state forms of disease can be applied to other 
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chronic conditions such as asthma. Asthmatics suffer from a disease pathology that is covert 
until overtly manifested through an acute asthma attack. Outside of these acute attacks 
there is still an active disease process present in a chronic but stable form which is only 
recognised or brought to light when expressed via an acute attack. The chronic underlying 
process of asthma is the “trait” form of asthma and the acute attacks are the “state” forms 
of asthma181. In exactly the same way migraine patients suffer from a disease pathology 
which is an on-going chronic but concealed “trait” process, the abnormality of which is only 
revealed during the onset of an acute migraine attack180. It was therefore important to 
measure migraine severity and monthly headache frequency using a tool that addressed the 
trait (chronic) form of migraine.  
 
Deliberation of tool choice 
The International Headache Society (IHS) scale would have assessed the effects of acute 
headache attacks on activities. However because this tool would have focussed on acute 
attacks it would not have accurately represented the trait form of migraine182. The number 
of rescue medications used by each migraine patient was another option for measuring 
migraine severity. However this was not feasible because of the exclusion criteria of any 
prophylactic medications. The headache Impact Test 6 score (HIT-6) was a six item 
questionnaire which assessed headache effects on usual activities, social functioning, 
cognition and emotional distress. However the HIT-6 was chosen because it had never been 
used in paediatric subjects and was very expensive to purchase183. The Paediatric Quality of 
Life tool would have assessed levels of disability, but was not selected because it focused 
largely on quality of life rather than migraine severity and did not measure headache 
frequency184. Ultimately the PedMIDAS questionnaire was chosen because it was cheap, 
quick to administer, easily understood by young children and it measured migraine severity 
as the trait form of migraine185.  
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Paediatric Migraine Disability Assessment Scale (PedMIDAS)185    
The Paediatric Migraine Disability Assessment Score (PedMIDAS) assessed the effect of 
headaches on activities of daily living. It was derived from the adult Migraine Disability 
Assessment Score (MIDAS), extensively used in migraine research. The PedMIDAS consisted 
of 6 questions that are outlined in table 2.3.1185.  
 
Question No PedMIDAS question 
1 How many full school days were missed in the last 3 months due to headaches? 
2 How many partial days of school were missed in the last 3 months due to 
headaches? 
3 How many days in the last 3 months did you function at less than half your ability 
in school because of headaches? 
4 How many days were you not able to do things at home (i.e. chores, homework, 
etc) due to headaches? 
5 How many days did you not participate in other activities (i.e. play, go out, sports, 
etc) due to headaches? 
6 How many days did you participate in these activities but functioned at less than 
half your ability due to headaches? 
Table 2.3.1- Questions from the PedMIDAS tool 
 
The number of days answered for each question were all added together to produce a total 
PedMIDAS score, which this pilot study used as a measure of migraine severity. As outlined 
in table 2.3.2, a grading system based on PedMIDAS score cut off limits as adapted from 
Hershey et al, was used to categorise patients into one of four migraine severity grades186. 
The PedMIDAS also measured the number of headaches in the last 3 months which was 
divided by three to produce a monthly headache frequency value. As outlined in table 2.3.3, 
a grouping system adapted from Katsarava et al was used to categorise patients into one of 
three monthly headache frequency groups187.  
The PedMIDAS has been used as a migraine severity measure in 2 prior headache studies by 
Hershey et al. The first investigated the role of topiramate treatment in migraine188 and the 
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second researched the influence of obesity on headaches47; both studies reported the tool 
as a valid measure of migraine disability. The PedMIDAS tool has shown high test-retest 
reliability (r= 0.8) and has been reported as a valid measure of headache severity when 
compared with self reported and clinician assessed headache severity scales185. The 
PedMIDAS measured overall functional disability rather than just the effects from acute 
attacks186 and for this reason the PedMIDAS was appropriate as a measure of migraine 
severity in the chronic trait form of migraine.      
 
PedMIDAS categories Severity scale Total PedMIDAS scores 
Grade 1 Little to nothing 0 to 10 
Grade 2 Mild 11 to 30 
Grade 3 Moderate 31 to 50 
Grade 4 Severe > 50 
Table 2.3.2- The four migraine severity grades classed according to the total PedMIDAS 
scores32 
 
Category Monthly headache frequency 
Group 1 0 to 4 
Group 2 5 to 10 
Group 3 >10 
Table 2.3.3- The three groups of monthly headache frequency 
 
Migraine pro-forma and migraine classification 
A migraine pro-forma was designed specifically for this pilot study to check whether 
migraine cases fulfilled a systematic criterion for a migraine diagnosis. This pro-forma was 
adapted from two sources of diagnostic criteria, a book by Guidetti et al called “Headache 
and Migraine in Childhood and Adolescence”189 and the International Classification of 
Headache Disorders (ICHD-II)1. The pro-forma assessed the duration, frequency and 
intensity of acute headache attacks, exacerbating and relieving headache factors and the 
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presence of associated symptoms such as nausea, vomiting, photophobia and phonophobia. 
The presence of any aura symptoms and family history of migraine were also assessed. This 
pilot study used the same criteria as the ICHD-II1 to class migraine cases as either “migraine 
headache without aura” or “migraine headache with aura”. See appendix in chapter 5.1.3 
for a copy of the pro-forma used in this pilot study.      
 
Behavioural problems: Child Behaviour Checklist (CBCL)190   
The child behaviour checklist (CBCL) was a parent reported psychometric tool that assessed 
psychological difficulties in children aged 4 to 18 years. The first section of the CBCL 
assessed the child’s social competence by their ability to socialise with friends and siblings, 
and take part in school and extracurricular/sport activities. The second section of the CBCL 
consisted of a series of statements about whether the child suffered from internalising and 
externalising behavioural problems. The parent had to choose from a list of 3 options that 
described how applicable the statement was to their child; these options included “not true 
(0)”, “somewhat/sometimes true (1)” or “very true/often true (2)”. The number in each 
bracket was the score given for the answer chosen to allow a quantitative analysis of the 
CBCL190.  
Internalising problems were symptoms that the child may have experienced such as anxiety, 
depression, withdrawal or somatic complaints. An example internalising statement was “my 
child feels worthless or inferior”. Externalising problems were the overt manifestations of 
internal issues, such as rule breaking or aggressive behaviour. An example externalising 
statement was “my child argues a lot”190.   
The CBCL raw scores were converted to standardised age and sex adjusted T-scores. The T-
scores were based on CBCL scores obtained from a normative sample of 2,368 non-
handicapped children aged 4 to 18 years. T-scores produced from this pilot study were 
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assessed for whether they fitted the profile of normal, subclinical and clinical behavioural 
problems190.  
Emotional and behavioural problems are associated with childhood migraine. In a cohort of 
47 paediatric migraine patients, maternal CBCL reports for internalising T-scores were 
significantly higher among migraineurs compared with controls, 57.18 (S.D 10.15) Vs 49.84 
(S.D 8.83), respectively, p = 0.001191. Obesity and adiposity are associated with childhood 
behavioural problems. In a cohort of 155 children, internalising CBCL T-scores in obese cases 
with higher adiposity levels were much higher than non-obese controls, 58.9 (10.9 S.D) Vs 
55.4 (10.4 S.D), respectively. Externalising T-scores were 52.6 (SD 10.6) for obese individuals 
with higher adiposity levels and 48.1.1 (9.5 S.D) for controls192. These studies indicated that 
behavioural problems are associated with migraine, adiposity and obesity. Hence when 
designing the pilot study behavioural problems were recognised as a potential confounding 
factor between migraines, adiposity and obesity; so following discussions with the appetite 
research team it was decided to implement a measurement tool for measuring behavioural 
issues.   
Psychiatrists have previously recognised the CBCL as a clinically meaningful tool with high 
validity. Confirmatory factor analysis has demonstrated that the factor structure of a 
clinician reported CBCL and parent reported CBCL are closely related193. Test–retest 
reliability correlations for the total CBCL T-scores are between 0.82 and 0.95, reflecting good 
reliability194. The CBCL has been extensively used in previous studies on migraines and 
obesity89,90. For these reasons the CBCL was implemented in this pilot study for measuring 
behavioural problems.     
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Measurement of adiposity 
Magnetic resonance imaging (MRI), computed tomography (CT) and dual x-ray 
absorptiometry (DXA) were considered very accurate measures of adiposity. However these 
methods would have been unsafe in paediatric research, expensive and required expert 
handling.195. Bioelectrical impedance analysis (BIA) was another potential method for 
measuring adiposity; it would have estimated levels of body fat by measuring the 
oppositional flow of electrical current through body tissue196. A specific BIA instrument 
would have been required which was not purchasable due to limited funding. It was found 
that some BIA equations provided inaccurate estimates of body fat composition in obese 
patients197. Factors that could have biased BIA readings such as body position, skin 
temperature, previous exercise and food intake would have needed to be controlled198; 
which was not possible in this pilot study. Although other methods for determination of 
body composition may have provided more accurate estimates of body fat, BMI was safe, 
simple, inexpensive to obtain and highly validated based on its wide use to characterize 
child  adiposity levels in large-scale epidemiologic studies199.     
Skin fold thickness was another technique considered for adiposity measurement. Skin fold 
thickness measurements taken from the triceps, calf or sub-scapular region would have 
needed to be converted by age and gender specific equations to produce body fat 
estimates.200 It was found that some equations had not been validated and those that were, 
still produced body fat estimations that differed from those produced by  gold standard DXA 
or CT scans201. Cohn et al found estimates of body fat from skin fold measurements to have 
a weak correlation with that of total body nitrogen composition (used as a determinant of 
fat free body mass and hence also fat mass)202. Janz et al were unable to cross validate the 
Slaughter equation based on triceps and calf skin fold thickness estimates in children203. A 
skin fold calliper would have been very sensitive to inter and intra user variability because 
skin folds can be easily over or under compressed128. Changes in body fat distribution 
according to pubertal development could have biased skin fold measurements, especially in 
young girls204. For these reasons skin fold callipers were not used to measure adiposity.   
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Body Mass Index 
In children aged 5 to 19 years, BMI (kg/m2) is highly correlated with total body fat mass as 
measured by dual energy x-ray absorptiometry (r = 0.85 for girls and 0.89 for boys)205. BMI 
as an indirect measure of adiposity is practical, easy to obtain, reliable and has been 
extensively used in various obesity studies206. For these reasons BMI was implemented an 
appropriate measure of adiposity with regards to the aims of this pilot study.          
Higher readings of BMI signify higher levels of adiposity205. Body mass Index (BMI) was 
measured for each and every patient recruited into this pilot study; it was calculated as 
weight in kilograms divided by height in metres squared (kg/m2). Height (cm) and weight 
(kg) measurements were routinely taken for all patients attending neurology and general 
paediatric clinics at Alder Hey hospital. Roughly 10 minutes before their appointment was 
due, the healthcare worker on duty for the clinic would call the patient into a private room 
to take height and weight measurements. A stadiometer was used to measure height in 
centimetres; the child would remove their shoes and socks, and stand with a straight 
posture with their eyes parallel to the floor. Weight was measured using standard weighing 
scales; the child would remove their shoes and socks, as well as any excess layers of clothing 
such as a coat. Height and weight measurements were documented in the patient’s case 
files, which were then reviewed after the patient left the clinic to calculate BMI.    
Based on their raw BMI value each patient was grouped according to a BMI status of normal 
weight, overweight or obese. The BMI groups were adapted from a study by Cole et al that 
developed age/sex adjusted international cut off points for raw BMI values that 
corresponded with overweight and obesity, based on a sample of 97,876 males and 94,851 
females aged 0 to 25 years207. In this pilot study raw BMI values were converted to 
standardized z-scores so that were adjusted for age and sex. The BMI z-scores were 
calculated using reference values retrieved from the same study by Cole et al155 that 
developed the BMI groupings. 
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Outcome Questionnaire/ tool Subscale 
Migraine 
severity/ 
headache 
frequency 
PedMIDAS (Paediatric Migraine Disability 
Assessment Score): All ages(child reported)  
 
 
 
Total PedMIDAS score (migraine 
severity) 
 
 
Monthly headache frequency 
Eating behaviours Dutch Eating Behaviour Questionnaire for 
adolescents (DEBQ- adolescent version): 12+ 
years (child/patient reported)                    
 
Children's Dutch Eating Behaviour 
Questionnaire (DEBQ-C): 7 – 12 years (child 
reported)  
 
Emotional eating 
 
 External eating 
 
 Restrained eating 
 
 
Food Responsiveness (FR) 
Children's Eating Behaviour Questionnaire  Emotional Over Eating (EOE) 
(CEBQ): 5- 12 years (parent reported) Enjoyment of Food (EF) 
  Desire to Drink (DD) 
  Satiety Responsiveness (SR) 
  Slowness of Eating (SE) 
  Emotional Under Eating (EUE) 
  Food Fussiness (FF) 
Food cravings 
 
High Fats 
Food Craving Inventory (FCI-II):  Sweets 
5-16 years (child reported) Carbohydrates 
  Fast food fats 
Food Intake 
 
Negative Marker foods 
Food Intake Questionnaire (FIQ):  Negative Sugary foods 
(child reported) Negative Fatty foods 
  Positive marker foods 
  Positive Fibre foods 
 
Behavioural 
issues 
 
Internalising Behaviours 
CBCL (Child Behaviour Checklist): Externalising Behaviours 
1.5-5 years and 6-18 years (parent reported) 
 
Total behaviours  
(Internalising and Externalising 
combined) 
Adiposity Body Mass Index (BMI)  Raw BMI values and BMI z-scores 
Table 2.3.4- Summary of questionnaires used in this pilot study   
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Chapter 2.4 
Statistical Data Analysis 
 
Parametric distribution of data 
Data produced for each variable in this pilot study was assessed for whether it was of 
parametric or non-parametric distribution. This was done via the following steps: 
1. Skewness scores were calculated for each data set.  
2. The standard error of the skewness score was calculated for each data set. 
3. The skewness score was divided by its standard error.  
A value greater than 1.96 indicated the data set was non-parametric and thus any statistical 
analysis done on this data set required use of a non-parametric test. A value less than 1.96 
indicated that the data set was parametric and thus any statistical analysis done on this data 
set required a parametric test.   
 
Statistical analysis 
This pilot study intended to perform three main types of statistical analyses:  
1. Data produced from each subscale of the DEBQ, CEBQ, FIQ and FCI-II, and BMI z-
scores were intended to be compared between migraine cases and non-migraine 
headache controls. If data for both the migraine cases and controls were of 
parametric distribution, then an unpaired two-sample t-test would have been used 
to compare data. If one of the data sets being compared was of a non-parametric 
distribution then a Mann-Whitney U test would have been used to compare data.   
Author: Shashi Singh                 
 ~ 53 ~ 
 
2. The following correlations were intended to be performed:  
o The correlation that PedMIDAS scores have with each subscale of the DEBQ, 
CEBQ, FIQ, FCI-II, CBCL and BMI z-scores. 
o The correlation that monthly headache frequency values have with each 
subscale of the DEBQ, CEBQ, FIQ, FCI-II, CBCL and BMI z-scores. 
o The correlations that the CBCL subscale T-scores have with each subscale of 
the DEBQ, CEBQ, FIQ, FCI-II and BMI z-scores.  
The Pearson’s correlation test would have been used if both the data sets being 
analysed were of a parametric distribution. The Spearman’s rank correlation test 
would have been used if one or both of the data sets being analysed were of a 
non-parametric distribution.  
3. Data produced from each subscale of the DEBQ, CEBQ, FIQ and FCI-II, and BMI z-
scores were intended to be compared between the four migraine severity grades 
and between the three monthly headache frequency groups.  If the data being 
compared was of a parametric distribution then the ANOVA (analysis of variance) 
test was used for statistical analysis. If the data being compared was of a non-
parametric distribution then the Kruskal-Wallis test was used for statistical analysis.  
If data for one of the subscales in a questionnaire was non-parametrically distributed then a 
non-parametric test was performed for each and every subscale of that questionnaire tool. 
For example if data (z-scores) for the restrained eating subscale of DEBQ was of a non-
parametric distribution then any statistical analyses performed on all three subscales of the 
DEBQ would be done using non-parametric tests. All statistical tests in this pilot study were 
performed using Statistical package for the Social Sciences computer software (SPSS).     
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False discovery correction test     
A probability level below or equal to 0.05 (p≤ 0.05) was considered to statistically significant 
for rejecting the null hypothesis in the statistical tests. This pilot study conducted multiple 
tests, which increased the probability of finding a significant result. Hence it was decided 
that to help resolve this issue a false discovery correction test must be applied to correct 
and lower the probability level (p-value) of statistical significance. The Bonferroni correction 
test was chosen because it was the most stringent type of correction test with respect to 
reducing the risk of making any false positive discoveries208. The Bonferroni test corrected 
the p-value by dividing the probability value (0.05) by the number of tests performed for a 
specific outcome measure. The corrected p-values were calculated only for the tests that 
compared data between the four PedMIDAS based migraine grades and between the three 
headache frequency groups. The probability values for the correlation tests were not 
corrected because the size of the correlation coefficient was the main focus of the 
correlation test, rather than the probability value. This was done on the advice from the 
statistician. In this pilot study the corrected p-values were calculated as follows: With 
respect to the outcome variable the number of subscales in a questionnaire was totalled.  
This total was multiplied by two (one for each of the measures of migraine severity and 
headache frequency) to give the total number of statistical tests performed requiring 
correction. The end product of this calculation was then divided into the uncorrected p-
value of 0.05), which then produced the final corrected p-value. See table 2.4.1 for 
corrected p-value calculations.  
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Variable 
 
 
 
 
Questionnaire/ 
Outcome 
measure 
 
 
No. of 
subscales in 
questionnaire/ 
assessment 
method 
No. of 
variance 
tests done 
for each 
subscale 
No. of 
variance tests 
done for each 
questionnaire 
 
Corrected P-
value for 
variance test 
Eating behaviour 
 
 
DEBQ (adolescent 
and child version 
combined) 
3 
 
 
2 (3x2)=   6 
 
 
(0.05/6)= 0.008 
Eating behaviour CEBQ 8 2 (8x2)= 16 (0.05/16)= 0.003 
Food intake FIQ 5 2 (5x2)= 10 (0.05/10)= 0.005 
Food cravings FCI-II 4 2 (4x2)= 8 (0.05/8)= 0.006 
Adiposity BMI z-scores 1 2 (1x2)= 2 (0.05/2) = 0.025 
Table 2.4.1 Outline of corrected p-value calculations. 
 
Chapter 2.5  
Intended hypotheses for study results 
Restrained, external and emotional eating as measured by the DEBQ (adolescent version)209 
and DEBQ-C161 are each positively correlated with adiposity. The FR, EOE, EF and DD 
subscales of the CEBQ are all positively correlated with adiposity, whilst SR, SE, EUE and FF 
subscales of the CEBQ are negatively correlated with adiposity166.  Adiposity measured by 
BMI is positively correlated with migraine severity and headache frequency (see previous 
review of studies on headache obesity relationships39-41,46-50).   
The consumption of unhealthy foods that have a high sugar and/or fat content is associated 
with adiposity210. In this pilot study the FIQ negative marker food scores were used as a 
marker for the intake of unhealthy foods (on the previous day) and FIQ positive marker food 
scores were used as a marker for the intake of healthy foods (on the previous day)174. Food 
cravings are associated with adiposity211 and migraine147. Behavioural problems are 
associated with migraines, eating behaviours and obesity126, 127.  
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Given this information the following hypotheses were generated: 
 
 Compared with controls, migraine cases will have significantly higher:  
o DEBQ restrained/ emotional/ external eating z-scores 
o FR, EOE, EF and DD subscale z-scores of the CEBQ  
o FIQ scores for the intake of unhealthy foods (negative marker, negative 
sugary, negative fatty foods) 
o FCI-II scores for high fat foods, sweets, carbohydrates and high fat fast foods 
o BMI z-scores 
 
 Compared with controls, migraine cases will have significantly lower:  
o SR, SE, EUE and FF subscale z-scores of the CEBQ  
o FIQ scores for the intake of healthy foods (positive marker and positive fibre 
foods) 
 
 Migraine severity (PedMIDAS scores) and monthly headache frequency will each 
have a significantly positive correlation with:  
o DEBQ restrained/ emotional/ external eating z-scores 
o FR, EOE, EF and DD subscale z-scores of the CEBQ  
o FIQ scores for the intake of unhealthy foods (negative marker, negative 
sugary, negative fatty foods) 
o FCI-II scores for high fat foods, sweets, carbohydrates and high fat fast foods 
o BMI z-scores 
 
 Migraine severity (PedMIDAS scores) and monthly headache frequency will each 
have a significantly negative correlation with:  
o SR, SE, EUE and FF subscale z-scores of the CEBQ  
o FIQ scores for the intake of healthy foods (positive marker and positive fibre 
foods) 
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 The following variables will significantly differ between the four migraine severity 
grades and will also significantly differ between the three monthly headache 
frequency groups: 
o All of the DEBQ subscales z-scores (restrained/ emotional/ external eating) 
o All of the CEBQ subscale z-scores (FR/EOE/EF/DD/SR/SE/EUE/FF) 
o All of the FIQ subscale scores (negative marker/negative sugary/negative 
fatty/ positive marker/positive fibre foods) 
o All of the FCI-II subscale scores (high fat/sweets/carbohydrates/high fat fast 
foods) 
o BMI z-scores 
 
 CBCL subscale T-scores (internalising/externalising/total) will have a significantly 
positive correlation with:  
o Migraines severity (pedMIDAS scores) 
o Monthly headache frequency 
o DEBQ restrained/ emotional/ external eating z-scores 
o FR, EOE, EF and DD subscale z-scores of the CEBQ  
o FIQ scores for the intake of unhealthy foods (negative marker, negative 
sugary, negative fatty foods) 
o FCI-II scores for high fat foods, sweets, carbohydrates and high fat fast foods 
o BMI z-scores 
 
 CBCL subscale T-scores (internalising/externalising/total) will have a significantly 
negative correlation with:  
o SR, SE, EUE and FF subscale z-scores of the CEBQ  
o FIQ scores for the intake of healthy foods (positive marker and positive fibre 
foods
  
Chapter 3.0- Results 
Chapter 3.1 
Distributions of study variables 
 
As outlined from table 3.1.1, data for the total PedMIDAS scores were not normally 
distributed. Any analyses performed with the PedMIDAS scores had to be in the form of 
non-parametric tests. Hence all of the correlations made with the total PedMIDAS scores 
were done using the Spearman’s rank correlation test (see table 3.1.2). Data for the monthly 
headache frequency values followed a parametric distribution. However given that the data 
for monthly headache frequency and PedMIDAS scores were intended to be analysed using 
the same type of statistical tests, all analyses performed with the monthly headache 
frequency data were also done using non-parametric tests; Hence all correlations made with 
monthly headache frequency were done using the Spearman’s rank correlation test (see 
table 3.1.2).      
Data for the four migraine severity grades and three monthly headache frequency groups 
followed a parametric distribution. This indicated that if a variable were compared between 
these migraine groups, a parametric test could be used on the condition that the data for 
the variable being compared also followed a parametric distribution. It must be noted that 
the same type of statistical test (based on whether it was parametric or non-parametric) 
had to be used for each subscale from the same questionnaire. Hence if one subscale from a 
questionnaire produced non-parametric data, then all subscales would need to be analysed 
using a non-parametric test. With this in mind, as outlined in table 3.1.1, at least one 
subscale from each of the main questionnaires used in this pilot study (DEBQ, CEBQ, FCI-II 
and FIQ) produced data that was of a non-parametric distribution. Thus data from each 
subscale of the DEBQ, CEBQ, FCI-II and FIQ were compared between the four migraine 
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severity grades and between the three headache frequency groups using the Kruskal-Wallis 
test (see table 3.1.3). It also meant that the same variables were correlated with the CBCL 
subscale T-scores using the Spearman’s rank correlation test.           
Data for the BMI z-scores followed a parametric distribution. For this reason, BMI z-scores 
were correlated with CBCL subscale T-scores using the Pearson’s correlation test and were 
compared between the four migraine severity grades and between the three monthly 
headache frequency groups using the ANOVA analysis.   
Variable Parametrically Distributed? 
PedMIDAS scores  No 
Monthly headache frequency  Yes 
Four migraine severity grades (I, II, III and IV) Yes 
Three monthly headache frequency groups (1, 2 and 3) Yes 
BMI Z-scores  Yes 
DEBQ Emotional Eating Z-score  No 
DEBQ External eating Z-score  Yes 
DEBQ Restrained eating Z-score No 
CEBQ Food Responsiveness (FR) Z-score   Yes 
CEBQ Emotional Over Eating (EOE)  Z-score  No 
CEBQ Enjoyment of Food (EF) Z-score Yes 
CEBQ Desire to Drink (DD) Z-score  Yes 
CEBQ Satiety Responsiveness (SR) Z-score  Yes 
CEBQ Slowness of Eating (SE) Z-score  Yes 
CEBQ Emotional Under Eating (EUE) Z-score  Yes 
CEBQ Food Fussiness (FF) Z-score  Yes 
FCI-II High Fats raw scores  Yes 
FCI-II Sweets raw scores  No 
FCI-II Carbohydrates raw scores  Yes 
FCI-II Fast Food Fats raw scores Yes 
FIQ- NEG- Food Markers raw scores  No 
FIQ- NEG- Sugary Food Markers raw scores  Yes 
FIQ-- NEG- Fatty Food Markers raw scores  No 
FIQ- POS+ Food Markers raw scores  Yes 
FIQ- POS+ Fibre Food Markers raw scores  No 
CBCL Externalising T-scores  Yes 
CBCL Internalising T-scores  Yes 
CBCL Total T- scores  Yes 
Table 3.1.1- Parametric status of data collected on the various study outcome measures                      
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Variable PedMIDAS scores Monthly headache frequency 
BMI Z-scores Spearman’s rank Spearman’s rank 
DEBQ Emotional Eating Z-score Spearman’s rank Spearman’s rank 
DEBQ External eating Z-score Spearman’s rank Spearman’s rank 
DEBQ Restrained eating Z-score Spearman’s rank Spearman’s rank 
CEBQ Food Responsiveness (FR) Z-score Spearman’s rank Spearman’s rank 
CEBQ Emotional Over Eating (EOE)  Z-score Spearman’s rank Spearman’s rank 
CEBQ Enjoyment of Food (EF) Z-score Spearman’s rank Spearman’s rank 
CEBQ Desire to Drink (DD) Z-score Spearman’s rank Spearman’s rank 
CEBQ Satiety Responsiveness (SR) Z-score Spearman’s rank Spearman’s rank 
CEBQ Slowness of Eating (SE) Z-score Spearman’s rank Spearman’s rank 
CEBQ Emotional Under Eating (EUE) Z-score Spearman’s rank Spearman’s rank 
CEBQ Food Fussiness (FF) Z-score Spearman’s rank Spearman’s rank 
FCI-II High Fats raw scores Spearman’s rank Spearman’s rank 
FCI-II Sweets raw scores Spearman’s rank Spearman’s rank 
FCI-II Carbohydrates raw scores Spearman’s rank Spearman’s rank 
FCI-II Fast Food Fats raw scores Spearman’s rank Spearman’s rank 
FIQ- NEG- Food Markers raw scores Spearman’s rank Spearman’s rank 
FIQ- NEG- Sugary Food Markers raw scores Spearman’s rank Spearman’s rank 
FIQ-- NEG- Fatty Food Markers raw scores Spearman’s rank Spearman’s rank 
FIQ- POS+ Food Markers raw scores Spearman’s rank Spearman’s rank 
FIQ- POS+ Fibre Food Markers raw scores Spearman’s rank Spearman’s rank 
CBCL Externalising T-scores Spearman’s rank Spearman’s rank 
CBCL Internalising T-scores Spearman’s rank Spearman’s rank 
CBCL Total T- scores Spearman’s rank Spearman’s rank 
Table 3.1.2- Correlation tests used in analysis according to parametric status of data 
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Variable PedMIDAS migraine 
severity  grades 
Monthly headache 
frequency groups 
BMI Z-scores ANOVA test ANOVA test 
DEBQ Emotional Eating Z-score Kruskal-Wallis test Kruskal-Wallis test 
DEBQ External eating Z-score Kruskal-Wallis test Kruskal-Wallis test 
DEBQ Restrained eating Z-score Kruskal-Wallis test Kruskal-Wallis test 
CEBQ Food Responsiveness (FR) Z-score Kruskal-Wallis test Kruskal-Wallis test 
CEBQ Emotional Over Eating (EOE)  Z-score Kruskal-Wallis test Kruskal-Wallis test 
CEBQ Enjoyment of Food (EF) Z-score Kruskal-Wallis test Kruskal-Wallis test 
CEBQ Desire to Drink (DD) Z-score Kruskal-Wallis test Kruskal-Wallis test 
CEBQ Satiety Responsiveness (SR) Z-score Kruskal-Wallis test Kruskal-Wallis test 
CEBQ Slowness of Eating (SE) Z-score Kruskal-Wallis test Kruskal-Wallis test 
CEBQ Emotional Under Eating (EUE) Z-score Kruskal-Wallis test Kruskal-Wallis test 
CEBQ Food Fussiness (FF) Z-score Kruskal-Wallis test Kruskal-Wallis test 
FCI-II High Fats raw scores Kruskal-Wallis test Kruskal-Wallis test 
FCI-II Sweets raw scores Kruskal-Wallis test Kruskal-Wallis test 
FCI-II Carbohydrates raw scores Kruskal-Wallis test Kruskal-Wallis test 
FCI-II Fast Food Fats raw scores Kruskal-Wallis test Kruskal-Wallis test 
FIQ- NEG- Food Markers raw scores Kruskal-Wallis test Kruskal-Wallis test 
FIQ- NEG- Sugary Food Markers raw scores Kruskal-Wallis test Kruskal-Wallis test 
FIQ-- NEG- Fatty Food Markers raw scores Kruskal-Wallis test Kruskal-Wallis test 
FIQ- POS+ Food Markers raw scores Kruskal-Wallis test Kruskal-Wallis test 
FIQ- POS+ Fibre Food Markers raw scores Kruskal-Wallis test Kruskal-Wallis test 
Table 3.1.3- Type of test used to compare a variable between the migraine groups according 
to whether or not the data was of a parametric distribution  
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Study participants  
A total of 83 consecutive new referral migraine patients and 10 control non-migraine 
headache patients were approached for recruitment into this pilot study. However of the 93 
patients approached only 67 patients in total were successfully recruited (60 migraine cases 
and 7 controls). The other 26 patients were unable to take part because of parental time 
constraints, i.e. the parents were unable to give up 45-60 minutes for the recruitment 
process. Data collected for the 7 control patients were not used in the final results analysis 
because the sample size was too small to enable accurate statistical judgments on 
hypothesis testing. Hence this pilot study was unable to meet the primary and secondary 
objectives to compare eating behaviours, food intake, food cravings and adiposity between 
migraine cases and controls. The results analysed in this pilot study were based solely on the 
60 migraine cases recruited.       
 
Category Characteristic N % (of N = 60) 
Gender Female 34                      57 
Male 26 43 
Age Patients aged 5 to 12 years 37 62 
Patients aged 13 to 16 years 23 38 
BMI status Normal weight 46 77 
Overweight 9 15 
Obese 5 8 
Race Caucasian 58 97 
Mixed Race* 2 3 
Diagnosis Migraine 60 100 
Non-migraine (Control) 0 0 
Table 3.1.4- Patient characteristics. *Non-Caucasian patients did not state their specific 
ethnicity, but instead broadly stated that they were mixed race. 
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The ratio of male to female patients recruited was 26:34. Other studies have reported 
migraine prevalence at a 2:3, male to female ratio12. The youngest and eldest patients 
recruited were 6 years and 16 years, respectively. As can be seen from table 3.1.4, there 
was a larger proportion of children aged 5 to 12 years (n=39), compared with children aged 
13 to 16 years (n=21).  The majority of the patients were of normal weight (n= 46) and only 
5 patients were actually obese.   
 
Chapter 3.2  
Migraine results 
Migraine characteristics   
As can be seen from table 3.2.1 the majority of patients were diagnosed as migraine with 
aura (n= 41, 69%), with the remaining patients diagnosed as migraine without aura (n= 19, 
31%). Blurry vision was the most commonly reported aura symptom. Less frequently, the 
perception of flashing lights, bright coloured or back spots were stated as visual auras. 
Paraesthesia and numbness affecting the arms, legs and/or face were most commonly 
reported as a sensory aura. One patient also experienced a familiar smell as a sensory aura 
and one patient reported facial droop as a motor aura. Motor weakness affecting the upper 
and/or lower limbs was least frequently reported as a migraine aura.  
The headache pain experienced by patients was typically unilateral and intermittent in 
nature. Some patients also suffered from less typical bilateral continuous headaches. As 
outlined in table 3.2.2, the mean headache duration for the overall study sample (n=60) was 
7 hours, the shortest time being half an hour and the longest headache lasting up to 72 
hours. Most patients had a family history of migraines, most frequently along the maternal 
side of the family. See table 3.2.1 for further information on migraine characteristics.  
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Migraine feature N % (of N = 60) 
Nausea 41 69 
Vomiting 32 53 
Photophobia 50 83 
Phonophobia 49 82 
Presence of an aura 41 69 
Visual aura 36 61 
Sensory aura 22 37 
Motor aura 8 14 
Family history of migraine 44 74 
Table 3.2.1- Information on the migraine-associated symptoms suffered and family history 
of migraine  
 
 
Category Headache Duration (hours) 
Mean 7 
Median 2 
Mode 1 
Minimum 0.5 
Maximum 72 
1st quartile 0.5 
2nd quartile 2 
3rd quartile 6 
4th quartile 72 
Table 3.2.2- Information on the duration of headaches suffered by the migraine study 
sample 
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Migraine variables 
The PedMIDAS tool produced four main separate variables:  
1. Total PedMIDAS scores used as a proxy for migraine severity  
2. Four PedMIDAS migraine severity grades based on total PedMIDAS scores186: 
o Grade I (little to nothing):  Total PedMIDAS score 0 to 10 
o Grade II (mild):   Total PedMIDAS score 11 to 30 
o Grade III (moderate):   Total PedMIDAS score 31 to 50 
o Grade IV (severe):   Total PedMIDAS score greater than 50  
 
3. Monthly headache frequency 
4. Three monthly headache frequency groups187: 
o Group 1:  Less than 4 monthly headaches  
o Group 2:  4- 10 monthly headaches 
o Group 3:  Greater than 10 monthly headache 
 
Distribution of PedMIDAS scores and monthly headache frequency values 
As can be seen from table 3.2.3, the mean PedMIDAS score for the total 60 patients was 
28.8 (s.d= 32.0), which fitted the profile of mild migraine severity (grade II). The minimum 
PedMIDAS score of zero which was reported by four patients in this pilot study, indicated 
these patients suffered from headaches that had no effect on their social, academic or 
domestic activities, as determined by the PedMIDAS tool. The maximum PedMIDAS score 
reported in this pilot study (PedMIDAS= 161) was scored by one patient, who also reported 
the maximum monthly headache frequency of 30 headaches a month. Two patients 
suffered from only 1 headache a month (the minimum reported monthly headache 
frequency); however these were not the same patients that scored the minimum PedMIDAS 
score of zero.        
Author: Shashi Singh                 
 ~ 66 ~ 
 
Distribution Migraine severity  (PedMIDAS score) Monthly Headache Frequency 
Mean 28.8 9 
Median 21.0 8 
Std. Deviation 32.0 6 
Minimum 0.0 1 
Maximum 161.0 30 
Table 3.2.3- Distribution of PedMIDAS scores and monthly headache frequency 
 
Category Characteristic 
 
 
Mean raw 
PedMIDAS 
scores (s.d) 
Mean monthly 
headache 
Frequency (s.d) 
Gender Female (n=34) 30.2 (36.5) 8 (5) 
Male (n= 26) 26.8 (25.3) 10 (7) 
Age 6 to 12 years (n= 37) 22.2 (21.4) 8 (6) 
13 to 16 years (n=23) 39.4 (42.4) 10 (7) 
BMI status Normal weight (n=46) 28.8 (34.5) 8 (6) 
Overweight (n=9) 30.7 (23.5) 11 (8) 
Obese (n=5) 25.4 (22.6) 9 (3) 
Race Caucasian (n=58) 28.2 (32.3) 9 (6) 
Mixed Race (n=2) 47.0 (15.6) 12 (6) 
Table 3.2.4- Mean PedMIDAS scores and monthly headache frequency according to patient 
characteristics  
 
As can be seen from table 3.2.3 the mean monthly headache frequency for the total study 
sample was 9 (s.d= 6) which fitted the category of 4 to 10 headaches a month (group 2). The 
median value for headache frequency was 8 monthly headaches. Only 6 patients (10%) met 
the criteria for a chronic daily headache diagnosis (≥15 monthly headaches), whilst the 
remaining majority of 54 children (90%) suffered from episodic migraine (≤15 monthly 
headaches).  
The number of patients distributed among each migraine severity grade and headache 
frequency group were plotted on histograms that can be seen in figures, 3.2.1 and 3.2.2. 
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Figure 3.2.1 shows the frequency of patients in each migraine severity grade decreases as 
the severity grade increases. Figure 3.2.2 shows there are more patients that suffer 4 to 10 
monthly headaches than in the other two headache frequency groups.  
Figure 3.2.1 
Distribution of patients according to the four migraine severity grades 
 
           0 to 10        11 to 30   31 to 50              Greater than 50 
          (Grade I)                    (Grade II)                (Grade III)                   (Grade IV) 
Migraine severity grades according to PedMIDAS scores 
 
Figure 3.2.2  
Distribution of patients according to the three monthly headache frequency groups 
 
Less than 4             Between 4 to 10               More than 10                                                                                
     (Group 1)                     (Group 2)                         (Group 3) 
             Monthly headache frequency 
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PedMIDAS scores and monthly headache frequency according to BMI status 
As outlined in table 3.2.4, according to BMI status, the highest mean PedMIDAS score was 
found in the overweight category (PedMIDAS= 30.7) and the highest mean monthly 
headache frequency was also found in the overweight category (11 headaches per month). 
The lowest mean PedMIDAS score was found in the obese category (PedMIDAS= 25.4) and 
the lowest mean monthly headache value was found in the normal weight category (8 
headaches per month). See table 3.2.4 for further details on PedMIDAS scores according to 
age, BMI status and gender.  
 
Chapter 3.3  
Body Mass Index Results 
 
Distribution of BMI raw scores BMI z-scores 
Body mass index z-scores were plotted as a histogram on figure 3.3.1, which shows a non-
skewed distribution of BMI z-scores. The data for BMI z scores was of a parametric 
distribution. As can be seen from table 3.3.1, the mean BMI z-score of 0.62 for this study 
sample was closely related to the median value of 0.57.   
Statistic BMI Z-scores 
Mean 0.62 
Std. Deviation 1.14 
Median 0.57 
Skewness 0.50 
Minimum -1.70 
Maximum 3.57 
Table 3.3.1- Distribution of BMI z-scores 
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Figure 3.3.1  
Distribution of BMI z-scores as a box plot 
 
 
 
BMI z-score correlations with migraine severity and monthly headache 
frequency 
The spearman’s rank correlation coefficient between BMI z-scores and total PedMIDAS 
scores was rs= 0.09 (p= 0.46). The spearman’s rank correlation coefficient between BMI z-
scores and monthly headache frequency was rs= 0.21 (p= 0.10). Given that none of these 
correlations were significant at the probability level of 0.05, the hypothesis that “BMI z-
scores will have a significantly (p≤ 0.05) positive correlation with PedMIDAS scores and 
monthly headache frequency”, was rejected.       
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Distributions of BMI z-scores according to the migraine categories 
BMI z-values were plotted as histograms according to the four grades of migraine severity 
and the three groups of monthly headache frequency. Figure 3.3.2 shows that the mean 
BMI z-score increased with every migraine severity grade up until grade III, but then 
decreased in grade IV. Figure 3.3.3 shows that the mean BMI z-score increased with every 
monthly headache frequency group.     
 
 
Figure 3.3.2 
Distribution of BMI z-scores according to the four migraine severity grades  
 
      0 to 10           11 to 30        31 to 50                    Greater than 50 
                                                               (Grade I)                          (Grade II)                       (Grade III)                       (Grade IV) 
                Migraine severity grades according to PedMIDAS scores 
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Figure 3.3.3  
Distribution of BMI z-scores according to the three monthly headache frequency groups 
            
 
                                                              Less than 4                          Between 4 to 10                                 More than 10                                                                                
                                                                (Group 1)                    (Group 2)                                    (Group 3) 
                          Monthly headache frequency 
 
 
Comparison of BMI z-scores between the migraine groups 
As outlined in table 3.3.2, the F-value of 0.28 for the difference in BMI z-scores between the 
four migraine severity grades was insignificant at the corrected probability level of 0.025 
(p=0.84). For this reason the hypothesis, “BMI z-scores will significantly differ between the 
four grades of migraine severity”, was rejected.  
The F-value of 0.99 for the difference in BMI z-scores between the three headache 
frequency groups was insignificant at the corrected probability level of 0.025 (p=0.38). For 
this reason the hypothesis, “BMI z-scores will significantly differ between the three groups 
of headache frequency”, was rejected.        
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ANOVA test result 
 
 
Grouping Variable: Four 
grades of PedMIDAS migraine 
severity 
Grouping Variable: Three 
monthly headache frequency 
groups 
F- value 0.28 0.99 
p-value 0.84 0.38 
Table 3.3.2- ANOVA test results for the comparison of BMI z-scores between the migraine 
groups 
 
 
Chapter 3.4    
Dutch Eating Behaviour Questionnaire (DEBQ) results 
Of the 60 patients recruited, 23 children aged between 12 to 16 years completed the DEBQ 
(adolescent version) and 35 children aged between 7 to 12 years completed the DEBQ-C. 
Two children were unable to complete either tool because they were younger than 7 years. 
However as previously stated, the DEBQ (adolescent version) and DEBQ-C raw scores were 
converted to age and sex adjusted standardised DEBQ z scores.   
 
Distribution of DEBQ z-scores 
Statistical description DEBQ- Em Z-score DEBQ- Ext Z-score DEBQ- Rest Z-score 
Mean 0.08 -0.48 0.15 
Median -0.33 -0.53 0.04 
Mode -0.71 -0.49 -1.13 
Minimum -1.49 -3.31 -1.35 
Maximum 5.29 2.29 3.03 
Table 3.4.1- Distribution of DEBQ z-scores (Em= emotional eating, ext= external eating, rest= 
restrained eating) 
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Table 3.4.1, shows that the mean emotional eating z-score of 0.08 was very different to the 
mode (z-score= -0.71) and median (z-score= -0.33) emotional eating z-scores. For the 
external eating z-scores, the difference between the mean value -0.48, median value of -
0.53 and mode value -0.49, was very small. With respect to restrained eating subscale, the 
mean z-score of 0.15 was very different to the mode z-score value of -1.13.    
Figure 3.4.1 shows that the distribution of emotional eating z-scores was positively skewed. 
This is consistent with the fact that this data set was of a non-parametric distribution. Figure 
3.4.2 illustrates how the external eating z-scores were normally distributed which supported 
the calculation that this dataset was of a parametric distribution. Figure 3.4.3 illustrates 
there was a positively skewed distribution of restrained eating z-scores. This supports the 
calculation that this data set was of a non-parametric distribution.    
 
Figure 3.4.1  
Box and whisker plot of DEBQ emotional eating z-scores 
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Figure 3.4.2  
Box and whisker plot of DEBQ external eating z-scores 
     
 
Figure 3.4.3  
Box and whisker plot of DEBQ restrained eating z-scores 
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DEBQ/DEBQ-C raw scores according to mean reference range 
As outlined in tables 3.4.2, the mean raw emotional eating score for children issued with the 
DEBQ (adolescent version) in females was 1.85 (s.d= 0.46) and 1.62 (s.d= 0.62) in males, 
both of which were within normal limits of the reference range values. The mean DEBQ 
(adolescent version) raw external eating score in boys at 2.3 (s.d= 0.67) was below the 
reference mean. The mean DEBQ (adolescent version) external eating raw score of 2.36 
(s.d= 0.43) in girls was within normal limits. The mean DEBQ (adolescent version) restrained 
eating scores, 1.62 (s.d= 0.6) for males and 2.38 (s.d= 0.99) for females, were both within 
normal ranges.      
As can be seen in table 3.4.3 the mean DEBQ-C raw scores for emotional, external and 
restrained eating for boys and girls were all greater than the average reference ranges (the 
average reference ranges can be seen in table 3.4.4). This indicates a high level of each type 
of eating behaviour was present among children aged 7 to 12 years in this pilot study.   
 
DEBQ for adolescents subscale 
 
Mean raw score for girls 
 
Mean raw score for boys 
 
DEBQ- Emotional eating 1.85 (0.46) 1.62 (0.60) 
DEBQ- External eating  2.36 (0.43) 2.30 (0.67) 
DEBQ- Restrained eating 2.38 (0.99) 1.62 (0.60) 
Table 3.4.2- Mean DEBQ (adolescent version) raw scores for girls and boys separately 
 
 
DEBQ-C subscale  
 
Mean raw score for girls 
 
Mean raw score for boys 
 
DEBQ (children)- Emotional eating  1.53 (0.63) 1.42 (0.48) 
DEBQ (children)- External eating 2.04 (0.70) 2.06 (0.51) 
DEBQ (children)- Restrained eating 1.66 (0.58) 1.62 (0.49) 
Table 3.4.3- Mean DEBQ-C raw scores for girls and boys separately 
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DEBQ Subscale Female reference value range Male reference value range 
DEBQ (adolescent version)- Emotional eating 1.69-2.13 1.24-2.84 
DEBQ (adolescent version)- External eating  2.57-3.57 2.19-4.31 
DEBQ (adolescent version)- Restrained eating 1.85-2.55 0.92-2.12 
DEBQ-C (child version)- Emotional eating  1.24 1.27 
DEBQ-C (child version)- External eating 2.00 1.90 
DEBQ-C (child version)- Restrained eating 1.64 1.53 
Table 3.4.4- Reference value ranges outlined for each of the DEBQ and DEBQ-C subscales 
 
Emotional, external and restrained eating scores for each of the 58 DEBQ questionnaires 
composed of both the adolescent and child versions were categorised according to whether 
they were below, above or within normal reference ranges. The reference ranges were 
calculated by the same studies from which the z-scores were calculated and are outlined in 
chapter 2.3 of this thesis (section on the DEBQ tool) and the values are listed in table 
3.4.473,165. As outlined in table 3.4.5, there was a high number of children with raw external 
eating scores below (n= 30, 52%) and above (n=23, 40%) the normal reference mean range. 
Only 5 (8%) patients had an external eating score within the normal reference range. This 
indicated a large proportion of children in this pilot study had very low and very high 
external eating levels. With respect to restrained eating, only 14 patients had a raw score 
within the normal reference range, which again indicated many of the patients had very 
high (n= 22) and very low (n= 22) restrained eating levels. There were fewer patients with 
raw emotional eating scores outside of the normal reference range. 
DEBQ/DEBQ-C 
Subscale 
No. of patients with a 
raw score < reference 
mean (% of N=58) 
No. of patients with a raw 
score within reference range 
(% of N= 58) 
No. of patients with a 
raw score > reference 
mean  (% of N= 58) 
Emotional 22 (38) 18 (31) 18 (31) 
External 30 (52) 5 (8) 23 (40) 
Restrained 22 (38) 14 (24) 22 (38) 
Table 3.4.5- The population of patients with DEBQ and DEBQ-C scores below, within or 
above the normal reference range DEBQ/DEBQ-C values 
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Correlations between DEBQ subscale z-scores  and PedMIDAS scores 
As can be seen from table 3.4.6, there were no significant correlations (p≤ 0.05) between 
any of the DEBQ subscale z-scores and PedMIDAS raw scores. Based on this finding the 
hypothesis, “emotional, external and restrained eating z-scores of the DEBQ will have a 
significantly (p≤ 0.05) positive correlation with PedMIDAS (migraine) severity scores” was 
rejected.   
 
DEBQ Subscale PedMIDAS 
rs (p-value) 
Monthly Headache Frequency 
rs (p-value) 
Emotional eating z-scores 0.19 (0.14) 0.07 (0.59) 
External eating z-scores -0.07 (0.63) -0.01 (0.90) 
Restrained eating z-scores 0.05 (0.72) 0.3 (0.83) 
Table 3.4.6- Spearman rank correlation results between DEBQ subscale z-scores and 
PeMIDAS scores/monthly headache frequency    
 
Correlations between DEBQ subscale z-scores and monthly headache 
frequency 
As can be seen from table 3.4.6, there were no significant correlations between any of the 
DEBQ subscale z-scores and monthly headache frequency. Based on this finding the 
hypothesis, “emotional, external and restrained eating z-scores of the DEBQ will have a 
significantly (p≤ 0.05) positive correlation with monthly headache frequency” was rejected.   
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Distribution of DEBQ z-scores according to migraine severity/ headache 
frequency groups 
Mean DEBQ subscale z-scores were plotted as histograms according to the four PedMIDAS 
migraine severity grades and the three monthly headache frequency groups. These are 
shown in figures 3.4.4 to 3.4.9. Figure 3.4.4 shows the highest mean emotional eating z-
scores were in migraines grades II (11-30 PedMIDAS scores, mean= 0.54) and III (31-50 
PedMIDAS scores, mean= 0.42). Figures 3.4.5 and 3.4.6 show the highest mean external 
eating z-score (mean= -0.19) and restrained eating z-score (mean= 0.56) were each in 
migraine severity grade III. As illustrated in figures 3.4.7 to 3.4.9, the lowest headache 
frequency group (< 4 monthly headaches) had the highest mean emotional eating (mean= 
0.5), external eating (mean= -0.2) and restrained eating (0.26) z-scores.  
 
Figure 3.4.4  
Histogram of mean emotional eating z-scores plotted according to the four migraine severity 
grades  
 
           0 to 10          11 to 30        31 to 50 Greater than 50 
          (Grade I)                       (Grade II)                     (Grade III)                    (Grade IV) 
Migraine severity grades according to PedMIDAS scores 
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Figure 3.4.5  
Histogram of mean external eating z-scores plotted according to the four migraine severity grades 
 
              0 to 10          11 to 30      31 to 50               Greater than 50 
                                                (Grade I)                    (Grade II)                   (Grade III)                (Grade IV) 
Migraine severity grades according to PedMIDAS score 
 
Figure 3.4.6  
Histogram of mean restrained eating z-scores plotted according to the four migraine severity 
grades 
 
           0 to 10          11 to 30        31 to 50               Greater than 50 
                           (Grade I)                      (Grade II)                    (Grade III)                  (Grade IV) 
Migraine severity grades according to PedMIDAS scores 
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Figure 3.4.7  
Histogram of mean emotional eating z-scores plotted according to the three monthly headache 
frequency groups 
 
Less than 4               Between 4 to 10                   More than 10                                                                                
(Group 1)       (Group 2)            (Group 3)                          
Monthly headache frequency 
 
 
Figure 3.4.8  
Histogram of mean external eating z-scores plotted according to the three monthly headache 
frequency groups 
 
Less than 4                       Between 4 to 10                  More than 10 
                    (Group 1)          (Group 2)               (Group 3)                          
Monthly headache frequency 
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Figure 3.4.9  
Histogram of mean restrained eating z-scores plotted according to the three monthly headache 
frequency groups 
 
                                                                          Less than 4                         Between 4 to 10                      More than 10 
                                                                            (Group 1)       (Group 2)                (Group 3)                          
Monthly headache frequency 
 
Comparison of DEBQ subscale z-scores between the four migraine severity 
grades  
As can be seen from table 3.4.7, the chi squared values for emotional, external and 
restrained eating z-scores were insignificant at the corrected probability level of 0.008. For 
this reason, the hypothesis “emotional eating, external eating and restrained eating z-scores 
will significantly (p≤ 0.008) differ between the four grades of migraine severity (I, II, II, IV)”, 
was rejected.  
Kruskal-Wallis test result: 
PedMIDAS migraine 
severity groups 
DEBQ- Emotional 
eating z-scores 
 
DEBQ- External eating 
z-scores 
 
DEBQ- Restrained 
eating z-scores 
 
Chi-square 3.86 0.98 1.98 
p-value 0.28 0.81 0.58 
Table 3.4.7- Kruskal-Wallis test results for the comparison of emotional, restrained and 
external eating z-scores between the four PedMIDAS migraine severity grades 
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Comparison of DEBQ subscale z-scores between the three headache 
frequency groups         
As can be seen from table 3.4.8, the chi squared values for emotional, external and 
restrained eating z-scores were all insignificant at the corrected probability level of 0.008. 
For this reason the hypothesis, “emotional eating, external eating and restrained eating z-
scores will significantly (p≤ 0.008) differ between 3 groups of monthly headache frequency”, 
was rejected.  
 
Kruskall- Wallis test result: 
Monthly Headache 
Frequency categories 
DEBQ- Emotional 
eating z-scores 
 
DEBQ- External eating 
z-scores 
 
DEBQ- Restrained 
eating z-scores 
 
Chi-square 1.07 2.71 1.09 
p-value 0.59 0.26 0.58 
Table 3.4.8- Kruskal-Wallis test results for the comparison of emotional, restrained and 
external eating z-scores between the three headache frequency groups 
 
DEBQ z-score correlations with Child Behaviour Checklist (CBCL) T-scores   
As outlined by table 3.4.9, at the probability level of 0.05, none of DEBQ subscale z-scores 
were significantly correlated with any of the CBCL subscale T-scores. For this reason the 
hypothesis, “CBCL subscale T-scores will have a significantly (p≤ 0.05) positive correlation 
with emotional, external and restrained eating z-scores of the DEBQ” was rejected.  
DEBQ Subscale CBCL Externalised 
Behaviours T-scores 
rs (p- value) 
CBCL Internalised 
Behaviours T-scores 
rs (p- value) 
CBCL Total T-scores 
rs (p- value) 
Emotional Eating z-scores  -0.06 (0.65) 0.19 (0.16) 0.05 (0.73) 
External eating z-scores  0.01 (0.95) 0.15 (0.27) 0.01 (0.94) 
Restrained eating z-scores  -0.12 (0.36) -0.08 (0.55) -0.09 (0.49) 
Table 3.4.9- Spearman rank test results for the correlations between DEBQ subscale z-scores 
and CBCL subscale T-scores 
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Chapter 3.5 
Child Eating Behaviour Questionnaire (CEBQ) results 
 
A total of 37 patients fitted the age criteria (5-12 years) for the CEBQ, of these 19 were 
female and 20 were male. As outlined in table 3.5.1, the mean CEBQ z-scores for the 
enjoyment of food (mean= -0.12, median= -0.11), desire to drink (mean= -0.13, median= -
0.19) and food fussiness (mean= -0.09, median= -0.07) were very similar to their respective 
median scores.        
 
CEBQ subscale Mean (s.d) Median Minimum Maximum 
Food responsiveness (FR) -0.26 (0.95) -0.38 -1.63 1.75 
Emotional over eating(EOE) -0.14 (1.09) -0.50 -1.33 2.83 
Enjoyment of food (EF) -0.12 (1.14) -0.11 -2.94 1.75 
Desire to drink (DD) -0.13 (0.97) -0.19 -1.73 1.75 
Satiety responsiveness (SR) -0.23 (1.12) -0.43 -2.43 1.86 
Slowness of eating (SE) -0.70 (1.23) -0.86 -3.00 1.64 
Emotional under eating (EUE) -0.99 (1.27) -0.86 -3.00 1.79 
Food fussiness (FF) -0.09 (1.21) -0.07 -2.33 2.33 
Table 3.5.1- Distribution of CEBQ subscale z-scores 
 
 
As outlined in table 3.5.2, the mean z-score for every CEBQ subscale was lower among 
females except for the food fussiness subscale, which had a higher mean z-score of 0.04 
among females compared with a mean z-score of -0.21 among males. As outlined in table 
3.5.2, the mean CEBQ z-scores were higher among the group of children aged 13 to 16 years 
for the FR, EF, DD and FF subscales, compared with children aged 5 to 12 years. Whilst 
children in the 5 to 12 year age group had higher mean CEBQ z-scores for the EOE, SR, SE 
and EUE subscales, compared with the 13 to 16 year age group.      
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Category Characteristic 
 
FR 
Mean 
(s.d) 
EOE 
Mean 
(s.d) 
EF 
Mean 
(s.d) 
DD 
Mean 
(s.d) 
SR 
Mean 
(s.d) 
SE 
Mean 
(s.d) 
EUE 
Mean 
(s.d) 
FF 
Mean 
(s.d) 
Gender 
Female 
-0.3 
(1.05) 
-0.26 
(1.17) 
-0.12 
(1.08) 
-0.36 
(0.93) 
-0.47 
(0.90) 
-1.01 
(1.24) 
-1.17 
(1.44) 
0.04 
(1.04) 
Male 
-0.23 
(0.86) 
-0.02 
(1.02) 
-0.11 
(0.97) 
-0.11 
(1.30) 
-0.11 
(1.30) 
-0.41 
(1.17) 
-0.83 
(1.08) 
-0.21 
(1.37) 
Age 
5-12 yrs 
-0.34 
(0.93) 
-0.08 
(1.14) 
-0.17 
(1.14) 
-0.20 
(0.94) 
-0.16 
(1.11) 
-0.54 
(1.21) 
-0.91 
(1.13) 
-0.22 
(1.21) 
13-16 yrs 
0.28 
(0.96) 
-0.50 
(0.66) 
0.26 
(1.19) 
0.37 
(1.13) 
-1.14 
(0.93) 
-1.78 
(0.75) 
-1.54 
(2.04) 
0.80 
(0.85) 
Table 3.5.2- Mean CEBQ subscale z-scores according to gender and age 
 
 
 
Distribution of CEBQ subscale z-scores 
The standardised z-score data for food responsiveness (FR), enjoyment of food (EF), desire 
to drink (DD), satiety responsiveness (SR), slowness of eating (SE), emotional under eating 
and food fussiness (FF) subscales all followed a parametric distribution. Emotional 
overeating (EOE) was the only CEBQ subscale with data of a non-parametric distribution.  
Box and whisker plots were used to plot z-scores for each CEBQ subscale. Box and whisker 
plots for food responsiveness (fig- 3.5.1), emotional over-eating (fig- 3.5.2), desire to drink 
(fig- 3.5.4) and emotional under-eating (fig- 3.5.7) subscales are all positively skewed. The 
box and whisker plot for the enjoyment of food (fig- 3.5.3) subscale is negatively skewed. 
Figures 3.5.5 (satiety responsiveness), 3.5.6 (slowness of eating) and 3.5.8 (food fussiness) 
do not appear to be skewed.       
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Figure 3.5.1- Box plot of the food responsiveness (FR) z-scores 
 
 
 
Figure 3.5.2- Box plot of the emotional over-eating (EOE) z-scores 
 
 
 
Author: Shashi Singh                 
 ~ 86 ~ 
 
Figure 3.5.3- Box plot of the enjoyment of food (EF) z-scores 
 
 
 
 
Figure 3.5.4- Box plot of the desire to drink (DD) z-scores 
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Figure 3.5.5- Box plot of the satiety responsiveness (SR) z-scores 
 
 
 
 
Figure 3.5.6- Box plot of the slowness of eating (SE) z-scores 
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Figure 3.5.7- Box plot of the emotional under-eating (EUE) z-scores 
 
 
 
 
Figure 3.5.8- Box plot of the food fussiness (FF) z-scores 
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Frequency of patients with CEBQ subscale raw scores below/above the 
reference mean 
The number of girls and boys with a raw score above or below the reference mean were 
calculated for each CEBQ subscale as can be seen from tables 3.5.3 and 3.5.4. The mean 
CEBQ raw score reference values are listed in table 3.5.5. Girls had a high proportion of raw 
scores below the reference mean for food responsiveness (n= 13; 68%), emotional 
overeating (n= 14; 74%), desire to drink (n=14; 74%), satiety responsiveness (n= 15, 79%), 
slowness of eating (n= 14; 74%) and emotional under-eating (n= 16; 84%).  
 
CEBQ subscale: Girls 
 
No. of patients with a raw CEBQ score 
below reference mean (% of N= 19) 
No. of patients with a raw CEBQ score 
above reference mean (% of N= 19) 
Food responsiveness (FR) 13 (68) 6 (32) 
Emotional over eating(EOE) 14 (74) 5 (26) 
Enjoyment of food (EF) 8 (42) 11 (59) 
Desire to drink (DD) 14 (74) 5 (26) 
Satiety responsiveness (SR) 15 (79) 4 (21) 
Slowness of eating (SE) 14 (74) 5 (26) 
Emotional under eating (EUE) 16 (84) 3 (16) 
Food fussiness (FF) 9 (47) 10 (53) 
Table 3.5.3- Number of girls with CEBQ subscales scores below/above reference mean 
 
 
CEBQ subscale: Boys 
 
No. of patients with a raw CEBQ score 
below reference mean (% of N= 18) 
No. of patients with a raw CEBQ score 
above reference mean (% of N= 18) 
Food responsiveness (FR) 14 (80) 4 (20) 
Emotional over eating(EOE) 12 (65) 6 (35) 
Enjoyment of food (EF) 11 (60) 7 (40) 
Desire to drink (DD) 7 (40) 11 (60) 
Satiety responsiveness (SR) 9 (50) 9 (50) 
Slowness of eating (SE) 11 (60) 7 (40) 
Emotional under eating (EUE) 14 (80) 4 (20) 
Food fussiness (FF) 10 (55) 8 (45) 
Table 3.5.4- Number of boys with CEBQ subscale scores below/above reference mean  
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Boys had a large proportion of raw scores below the reference mean for food 
responsiveness (n= 14; 80%) and emotional under-eating (n= 14; 80%). Boys also had an 
equal number of raw scores above and below the reference mean for the satiety 
responsiveness subscale. There were 7 more boys than girls (60% versus 26%, respectively) 
with a desire to drink raw score above the reference mean. There were 6 more boys than 
girls with a satiety responsiveness score above the reference mean (50% versus 21%, 
respectively).   
CEBQ subscale Normal reference value in males Normal reference value in females 
Food responsiveness (FR) 2.3 2.2 
Emotional over eating(EOE) 1.8 1.8 
Enjoyment of food (EF) 3.6 3.6 
Desire to drink (DD) 2.9 2.9 
Satiety responsiveness (SR) 3.1 3.1 
Slowness of eating (SE) 3.0 3.1 
Emotional under eating (EUE) 3.1 3.0 
Food fussiness (FF) 3.1 2.9 
Table 3.5.5- Reference normal raw score values for each CEBQ subscale 
Correlation between CEBQ subscale z-scores and PedMIDAS scores 
As outlined in table 3.5.6, at the probability level of 0.05, the CEBQ desire to drink z-scores 
had a weak but significantly positive correlation with the PedMIDAS scores (rs= 0.41, p= 
0.01). Based on this finding the hypothesis that “the desire to drink (DD) z-scores of the 
CEBQ will have a significantly (p≤ 0.05) positive correlation with PedMIDAS severity scores”, 
was accepted. On advice from the statistician involved in this pilot study, a correlation 
coefficient equal to or greater than 0.7 was considered a strong correlation. Given that the 
correlation coefficient (rs) was 0.41 the correlation between the desire to drink subscale and 
PedMIDAS scores was considered to be quite weak. This point is further demonstrated in 
figure 3.5.9 by the weak association of dots in the scatter graph of PedMIDAS scores plotted 
against the CEBQ desire to drink (DD) z-scores.  
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Figure 3.5.9 
Scatter graph of PedMIDAS scores plotted against CEBQ desire to drink (DD) z-scores 
 
 
As can be seen in table 3.5.6, at the probability level of 0.05 the remaining CEBQ subscales 
were not significantly correlated with the PedMIDAS scores. For this reason the hypothesis 
of “standardised z-scores for food responsiveness (FR), emotional overeating (EOE) and 
enjoyment of food (EF) subscales of the CEBQ will have a significantly (p≤ 0.05) positive 
correlation with PedMIDAS scores” was rejected. The hypothesis of “standardised z-scores 
for satiety responsiveness (SR), slowness of eating (SE), emotional under eating (EUE) and 
food fussiness (FF) subscales of the CEBQ will have a significantly (p≤ 0.05) negative 
correlation with PedMIDAS scores” was also rejected. 
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Correlation between CEBQ z-scores and monthly headache frequency 
As can be seen in table 3.5.6, none of the CEBQ subscale z-scores were significantly (p≤ 0.05) 
correlated with monthly headache frequency. Based on this finding the hypothesis of  “z-
scores for food responsiveness (FR), emotional overeating (EOE), enjoyment of food (EF) 
and desire to drink (DD) subscales of the CEBQ will have a significantly (p≤ 0.05) positive 
correlation with monthly headache frequency” was rejected. The hypothesis of “z-scores for 
satiety responsiveness (SR), slowness of eating (SE), emotional under eating (EUE) and food 
fussiness (FF) subscales of the CEBQ will have a significantly (p≤ 0.05) negative correlation 
with monthly headache frequency” was also rejected.   
 
CEBQ subscale 
PedMIDAS  
rs (p-value) 
Monthly Headache Frequency 
rs (p-value) 
Food Responsiveness   0.24 (0.14) 0.21 (0.20) 
Emotional Over Eating  0.26 (0.11) 0.23 (0.16) 
Enjoyment of Food  0.15 (0.36) 0.21 (0.20) 
Desire to Drink  0.41 (0.01)* 0.22 (0.17) 
Satiety Responsiveness 0.01 (0.95) -0.12 (0.45) 
Slowness of Eating  -0.15 (0.36) -0.20 (0.22) 
Emotional Under Eating    0.29 (0.07) 0.03 (0.88) 
Food Fussiness Z-Score  0.15 (0.35) -0.17 (0.32) 
Table 3.5.6- Results for each of the CEBQ subscale spearman rank correlations with 
PedMIDAS scores and monthly headache frequency. *= significant finding (p≤ 0.05).   
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Distribution of z scores/raw scores according to the migraine groups  
 
Standardised z-scores for each subscale of the CEBQ were plotted as histograms according 
to the four PedMIDAS migraine severity grades and three monthly headache frequency 
groups, which can be seen in figures 3.5.10 to 3.5.25.   
As illustrated by figures 3.5.10, 3.5.11, 3.5.16 and 3.5.17, the mean z-scores for food 
responsiveness and desire to drink subscales increased with each migraine severity grade 
and headache frequency group. Grade I migraine severity (PedMIDAS scores< 10) and 
monthly headache frequency group 1 each had the lowest mean z-score for the emotional 
overeating and the enjoyment of food subscales (see figures 3.5.12 to 3.5.15). As illustrated 
by figures 3.5.18 and 3.5.19, satiety responsiveness had the highest mean z-score in 
migraine severity grade II (11 to 30 PedMIDAS scores), and in monthly headache frequency 
group 2 (4 to 10 monthly headaches). Figures, 3.5.20 and 3.5.21 demonstrate the slowness 
of eating mean z-scores were highest in migraine severity grade I and in the second monthly 
headache frequency group (<4 monthly headaches). The mean emotional under-eating z-
scores were highest in the migraine severity grade III and in the monthly headache 
frequency group 3 (see figures 3.5.22 and 3.5.23). Mean food fussiness z-scores were 
highest in migraine severity grade IV and in monthly headache frequency group 1 (see 
figures 3.5.24 and 3.5.25).         
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Figure 3.5.10 
A histogram to show the distribution of the food responsiveness (FR) z-scores as mean values 
among the four migraine severity grades  
 
               0 to 10         11 to 30     31 to 50               Greater than 50 
            (Grade I)                  (Grade II)                   (Grade III)                  (Grade IV) 
                   PedMIDAS scores (migraine severity grades) 
 
 
Figure 3.5.11 
A histogram to show the distribution of the food responsiveness (FR) z-scores as mean values 
among the three monthly headache frequency groups 
 
                        Less than 4                      Between 4 to 10                  More than 10 
Group 1            Group 2                  Group 3 
                Monthly headache frequency 
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Figure 3.5.12 
A histogram to show the distribution of the emotional over-eating (EOE) z-scores as mean values 
among the four migraine severity grades  
 
         0 to 10       11 to 3                 31 to 50              Greater than 50 
        (Grade I)                    (Grade II)              (Grade III)                 (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
 
 
Figure 3.5.13 
A histogram to show the distribution of the emotional over-eating (EOE) z-scores as mean values 
among the three monthly headache frequency groups 
 
                                                                         Less than 4                          Between 4 to 10                     More than 10 
              (Group 1)               (Group 2)                            (Group 3) 
                 Monthly headache frequency 
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Figure 3.5.14 
A histogram to show the distribution of the enjoyment of food (EF) z-scores as mean values among 
the four migraine severity grades  
 
           0 to 10          11 to 30      31 to 50              Greater than 50 
          (Grade I)                      (Grade II)                   (Grade III)                    (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
 
Figure 3.5.15 
A histogram to show the distribution of the enjoyment of food (EF) z-scores as mean values among 
the three monthly headache frequency groups 
 
                                                                      Less than 4                             Between 4 to 10                          More than 10 
                                                                        (Group 1)         (Group 2)                   (Group 3) 
Monthly headache frequency 
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Figure 3.5.16 
A histogram to show the distribution of the desire to drink (DD) z-scores as mean values among 
the four migraine severity grades  
 
          0 to 10         11 to 30       31 to 50 Greater than 50 
         (Grade I)                       (Grade II)                   (Grade III)                     (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
 
Figure 3.5.17 
A histogram to show the distribution of the desire to drink (DD) z-scores as mean values among 
the three monthly headache frequency groups 
 
                Less than 4                      Between 4 to 10                      More than 10 
                                                                          (Group 1)                             (Group 2)                 (Group 3)                                           
Monthly headache frequency 
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Figure 3.5.18 
A histogram to show the distribution of the satiety responsiveness (SR) z-scores as mean values 
among the four migraine severity grades 
 
            0 to 10         11 to 30      31 to 50  Greater than 50 
           (Grade I)                     (Grade II)                   (Grade III)                      (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
 
Figure 3.5.19 
A histogram to show the distribution of the satiety responsiveness (SR) z-scores as mean values 
among the three monthly headache frequency groups 
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Figure 3.5.20 
A histogram to show the distribution of the slowness of eating (SE) z-scores as mean values among 
the four migraine severity grades 
 
                                    0 to 10            11 to 30         31 to 50              Greater than 50 
                 (Grade I)           (Grade II)        (Grade III)    (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
 
 
Figure 3.5.21 
A histogram to show the distribution of the slowness of eating (SE) z-scores as mean values among 
the three monthly headache frequency groups 
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Figure 3.5.22 
A histogram to show the distribution of the emotional under-eating (EUE) z-scores as mean values 
among the four migraine severity grades 
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          PedMIDAS scores (migraine severity grades) 
 
Figure 3.5.23 
A histogram to show the distribution of the emotional under-eating (EUE) z-scores as mean values 
among the three monthly headache frequency groups 
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Figure 3.5.24 
A histogram to show the distribution of the food fussiness (FF) z-scores as mean values among the 
four migraine severity grades 
 
        0 to 10       11 to 30        31 to 50             Greater than 50 
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          PedMIDAS scores (migraine severity grades) 
 
Figure 3.5.25 
A histogram to show the distribution of the food fussiness (FF) z-scores as mean values among the 
three monthly headache frequency groups 
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Comparison of CEBQ z-scores between the four migraine severity grades  
 
As can be seen from table 3.5.7, the chi-squared value for each subscale of the CEBQ was 
insignificant at the corrected probability level of 0.003, indicating that none of the CEBQ 
subscale z-scores significantly differed between the four migraine severity grades. For this 
reason the hypothesis of “CEBQ subscale (FR/EOE/DD/EF/SR/SE/EUE/FF) z-scores will 
significantly (p<0.003) differ between the four grades of migraine severity (I, II, II, IV)” was 
rejected.      
CEBQ Subscale 
 
Grouping variable: PedMIDAS migraine severity grades 
Chi-square value (p-value) 
Food Responsiveness (FR) z-scores 2.87 (0.41) 
Emotional Over Eating (EOE) z-scores 2.17 (0.54) 
Enjoyment of Food (EF) z-scores 1.43 (0.69) 
Desire to Drink (CEBQ scores) 9.57 (0.02) 
Satiety Responsiveness (SR) z-scores 0.87 (0.83) 
Slowness of Eating (SE) z-scores 0.70 (0.87) 
Emotional Under Eating (EUE) z-scores 1.96 (0.58) 
Food Fussiness (FF) z-scores 2.91 (0.40) 
Table 3.5.7- Kruskal-Wallis test results for comparison of CEBQ subscale z-scores between 
the four migraine severity grades  
 
Comparison of CEBQ z-scores between the three monthly headache frequency 
groups     
As can be seen from table 3.5.8, the chi squared value for each subscale of the CEBQ was 
insignificant at the corrected probability level of 0.003, indicating that none of the CEBQ 
subscale z-scores significantly differed between the three monthly headache frequency 
groups. For this reason the hypothesis, “CEBQ subscale (FR/EOE/DD/EF/SR/SE/EUE/FF) z-
scores will significantly (p<0.003) differ between the three groups of headache frequency 
(groups 1-3)” was rejected.       
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CEBQ Subscale 
 
Grouping variable: Monthly Headache frequency groups 
Chi-square value (p-value) 
Food Responsiveness (FR) z-scores 1.82 (0.40) 
Emotional Over Eating (EOE) z-scores 2.25 (0.33) 
Enjoyment of Food (EF) z-scores 1.47 (0.48) 
Desire to Drink (CEBQ scores) 2.29 (0.32) 
Satiety Responsiveness (SR) z-scores 4.27 (0.12) 
Slowness of Eating (SE) z-scores 2.39 (0.30) 
Emotional Under Eating (EUE) z-scores 0.31 (0.86) 
Food Fussiness (FF) z-scores 2.57 (0.28) 
Table 3.5.8- Kruskal-Wallis test results for comparison of CEBQ subscale z-scores between 
the three monthly headache frequency groups 
 
CEBQ subscale z-score correlations with CBCL subscale T-scores 
As can be seen from table 3.5.9, there were no significant correlations (at the probability 
level of 0.05) between any of the CEBQ subscale z-scores and CBCL subscale T-scores. For 
this reason the hypothesis that “CBCL subscale T-scores will have a significantly (p≤ 0.05) 
positive correlation with food responsiveness, emotional overeating, enjoyment of food and 
desire to drink subscales of the CEBQ”, was rejected. The hypothesis that “CBCL subscale T-
scores will have a significantly (p<0.05) negative correlation with satiety responsiveness, 
slowness of eating, emotional under-eating and food fussiness subscales of the CEBQ” was 
also rejected.  
CEBQ Subscale  Externalised T-scores 
rs (p- value) 
Internalised T-scores 
rs (p- value) 
Total T-scores 
rs (p- value) 
FR z-scores                                      0.17 (0.30) 0.18 (0.27) 0.16 (0.33) 
EOE z-scores  0.10 (0.54) 0.20 (0.22) 0.04 (0.81) 
 EF z-scores  0.00 (0.10) -0.65 (0.69) 0.18 (0.91) 
 DD z-scores  0.20 (0.23) 0.17 (0.30) 0.13 (0.45) 
SR z-scores  0.05 (0.79) 0.15 (0.36) 0.04 (0.81) 
SE  z-scores  -0.13 (0.43) 0.16 (0.34) -0.05 (0.76) 
EUE z-scores  0.05 (0.78) 0.26 (0.11) 0.09 (0.59) 
FF z-scores   0.06 (0.69) 0.02 (0.92) -0.06 (0.73) 
Table 3.5.9- Correlations between CEBQ subscale z-scores and CBCL subscale T-scores. 
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Chapter 3.6 
Food cravings inventory (FCI-II) results 
 
All 60 patients that were recruited completed the food cravings inventory (FCI-II). The raw 
FCI-II scores produced from each subscale were used in the study analyses. Standardised z-
values were not calculated because there were no normal range reference values based on 
child population samples. However mean adult FCI-II age specific results from a study by 
Burton et al212 were used as reference values (as outlined in table 3.6.2) that were 
compared with the mean FCI-II raw scores produced in this pilot study.        
 
Distribution of the food cravings inventory (FCI-II) raw scores 
Data for the high fats, carbohydrates and fast food fat subscales followed a parametric 
distribution, while data for the sweets subscale was of a non-parametric distribution. The 
mean raw scores for each FCI-II subscale as calculated from the total patient sample (n= 60) 
are listed in table 3.6.1. The mean score for the high fats subscale was 1.92, which was the 
exact same value as the reference mean score for the high fats subscale (see table 3.6.2). 
The overall mean score for the fast food fats subscale was 2.55, which was higher than the 
reference fast food fats mean value of 1.91.  
The mean score for the sweets subscale at 2.31 was higher than the respective reference 
mean of 2.05. The mean score for the carbohydrates subscale at 2.39 was higher than the 
respective reference mean 2.22. Further details on the distribution of the FCI-II subscale raw 
scores can be seen in table 3.6.1.        
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Categories FCI-II- High Fats 
raw mean scores 
FCI-II- Sweets raw 
mean scores 
FCI-II- Carbohydrates 
raw mean scores 
FCI-II- Fast Food Fats 
raw mean scores 
Mean 1.92 2.31 2.39 2.55 
Std. Deviation 0.69 0.85 0.89 1.03 
Median 1.94 2.25 2.38 2.50 
Minimum 1.00 1.00 1.00 1.04 
Maximum 3.50 4.38 4.30 5.03 
Table 3.6.1- Distribution of FCI-II subscale raw scores for all 60 patients recruited 
 
 
FCI-II Subscale Mean reference score 
High fats 1.93 
Sweets 2.05 
Carbohydrates 2.22 
Fast food fats 1.91 
Table 3.6.2- Mean FCI-II subscale reference values  
 
Category Characteristic 
 
N 
 
High Fats 
Mean  (s.d) 
Sweets 
Mean (s.d) 
Carbohydrates 
Mean (s.d) 
Fast food fats 
Mean (s.d) 
Gender Female 34 1.78 (0.64) 2.22 (0.70) 2.30 (0.79) 2.43 (0.96) 
Male 26 2.10 (0.73) 2.40 (1.00) 2.51 (1.02) 2.70 (1.12) 
Age 6 - 12 years 37 1.99 (0.76) 2.37 (1.00) 2.42 (0.96) 2.66 (1.15) 
13 -16 years 23 1.80 (0.58) 2.20 (0.60) 2.35 (0.79) 2.38 (0.82) 
Table 3.6.3- Mean FCI-II subscale raw scores according to age and gender 
 
As can be seen in table 3.6.3, for every subscale of the FCI-II, the mean male raw score was 
greater than the mean female raw score. The greatest gender difference in mean raw scores 
was for high fat foods (male mean = 2.1; female mean = 1.78). The average score for every 
subscale was higher among younger children aged 6 to 12 years compared with older 
patients aged 13 to 16 years. The greatest difference between these two age groups was 
within the fast food fats subscale; children aged 6-12 years had a mean score of 2.66 versus 
2.38 in children aged 13 to 16 years.  
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Box plots for the distribution of FCI-II high fat (figure- 3.6.1), sweet food (figure- 3.6.2), 
carbohydrate (figure- 3.6.3) and fast food fat (fig- 3.6.4) food scores, each display a 
positively skewed appearance.  
 
Figure 3.6.1- A box plot to illustrate the distribution of the FCI-II high fat food scores 
 
 
Figure 3.6.2- A box plot to illustrate the distribution of the FCI-II sweet food scores 
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Figure 3.6.3- A box plot to illustrate the distribution of the FCI-II carbohydrate food scores 
 
 
 
 
 
Figure 3.6.4- A box plot to illustrate the distribution of the FCI-II fast food fat scores 
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Frequency of patients with raw scores below/above reference ranges 
As can be seen in table 3.6.4, there was an equal distribution of patients with a raw score 
above and below the reference mean for the high fats subscale. There were a slightly higher 
proportion of patients that had raw scores above the reference mean than below it, in the 
sweets and carbohydrates FCI-II subscales. In the fast food fats subscale two thirds (n=20) of 
the total sample had a raw score above the reference mean.    
FCI-II sub scale Frequency of patients with raw scores 
below reference mean (% of N= 60) 
Frequency of patients with raw scores 
above reference mean (% of N= 60) 
High fats 30 (50) 30 (50) 
Sweets 25 (42) 35 (58) 
Carbohydrates 27 (45) 33 (55) 
Fast food fats 20 (33) 40 (67) 
Table 3.6.4- Frequency of patients with FCI-II subscale raw scores below or above the 
reference mean scores 
 
 
Correlations between FCI-II raw scores and PedMIDAS scores 
As outlined in table 3.6.5, there were no significant (p≤ 0.05) correlations between any of 
the FCI-II subscales and PedMIDAS migraine severity scores. For this reason the hypothesis 
that “the FCI-II subscale scores (high fat/sweet/carbohydrate/fast food fats) will have a 
significantly (p≤ 0.05) positive correlation with the PedMIDAS (migraine severity) scores” 
was rejected.   
Correlations between FCI-II raw scores and monthly headache frequency  
As outlined in table 3.6.5, none of the FCI-II subscales were significantly (p≤ 0.05) correlated 
with the monthly headache frequency values. For this reason the hypothesis that “the FCI-II 
subscale scores (high fat/sweet/carbohydrate/fast food fats) will have a significantly (p≤ 
0.05) positive correlation with the monthly headache frequency values” was rejected.               
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FCI-II subscale PedMIDAS  
rs (p-value) 
Headache Frequency  
rs (p-value) 
FCI-II- High Fats -0.03 (0.83) -0.02 (0.90) 
FCI-II- Sweets 0.07 (0.59) 0.01 (0.93) 
FCI-II- Carbohydrates 0.12 (0.37) -0.09 (0.48) 
FCI-II- Fast Food Fats 0.05 (0.71) -0.05 (0.71) 
Table 3.6.5- Spearman’s rank correlation results between the FCI-II subscale raw scores and 
the PedMIDAS migraine severity scores/ monthly headache frequency values  
  
 
Distribution of raw scores according to the migraine groups  
Mean FCI-II subscale scores were grouped according to the four grades of PedMIDAS 
migraine severity and the three groups of monthly headache frequency. Histograms were 
drawn to illustrate the distributions of FCI-II subscale scores according to these migraine 
groups, which can be seen in figures 3.6.5 to 3.6.12.  
High fat FCI-II scores showed little variation in mean values when grouped according to the 
four migraine severity grades and three headache frequency groups (figures 3.6.5 and 
3.6.6). Figure 3.6.8 shows the highest mean FCI-II sweets score was in grade II (mild 
migraine severity; 11-30 PedMIDAS scores), whilst in figure 3.6.7, the highest FCI-II sweets 
score was in monthly headache frequency group 3 (>10 monthly headaches). Figure 3.6.9 
shows that the highest FCI-II carbohydrate foods score was in the lowest headache 
frequency group (< 4 monthly headaches). Figure 3.6.10 shows the highest FCI-II 
carbohydrate food scores were in the second and third migraine severity grades. Mean FCI-II 
fast food fat scores decreased with every headache frequency group as illustrated by figure 
3.6.11, but increased with every migraine severity grade up until grade III, as outlined by 
figure 3.6.12.      
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Figure 3.6.5  
A histogram to display the distribution of the high fat food (FCI-II) scores according to the 
three headache frequency groups 
 
                                                                Less than 4                        Between 4 to 10                 More than 10 
                                                                 (Group 1)                               (Group 2)                    (Group 3) 
Monthly headache frequency 
 
 
Figure 3.6.6  
A histogram to display the distribution of the high fat food (FCI-II) scores according to the 
four migraine severity grades 
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Figure 3.6.7  
A histogram to display the distribution of the sweet food (FCI-II) scores according to the 
three headache frequency groups 
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Figure 3.6.8  
A histogram to display the distribution of the sweet food (FCI-II) scores according to the 
four migraine severity grades 
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Author: Shashi Singh                 
 ~ 112 ~ 
 
Figure 3.6.9 
A histogram to display the distribution of the carbohydrate food (FCI-II) scores according 
to the three monthly headache frequency groups  
 
              Less than 4                  Between 4 to 10                     More than 10 
                                                                          (Group 1)                            (Group 2)                                  (Group 3) 
Monthly headache frequency 
 
 
Figure 3.6.10  
A histogram to display the distribution of the carbohydrate food (FCI-II) scores according 
to the four migraine severity grades 
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Figure 3.6.11  
A histogram to display the distribution of the fast food fat (FCI-II) scores according to the 
three monthly headache frequency groups  
 
            Less than 4                         Between 4 to 10                         More than 10 
                                                     (Group 1)               (Group 2)                  (Group 3) 
Monthly headache frequency 
 
 
Figure 3.6.12 
A histogram to display the distribution of the fast food fat (FCI-II) scores according to the 
four migraine severity grades 
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          PedMIDAS scores (migraine severity grades) 
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Comparison of the FCI-II subscale scores between the four migraine severity 
grades   
As can be seen in table 3.6.6, the chi-square values for each FCI-II subscale were insignificant 
at the corrected probability level of 0.006. For this reason the hypothesis that “the FCI-II 
subscale scores (high fat/sweets/carbohydrates/fast food fats) will significantly differ 
between the four different grades of PedMIDAS migraine severity”, was rejected.       
 
Comparison of the FCI-II subscale scores between the three monthly 
headache frequency groups 
As can be seen in table 3.6.6, the chi-square values for each FCI-II subscale were insignificant 
at the corrected probability level of 0.006. For this reason the hypothesis that “the FCI-II 
subscale scores (high fat/sweets/carbohydrates/fast food fats) will significantly differ 
between the three monthly headache frequency groups”, was rejected.      
 
FCI-II subscale 
 
PedMIDAS (migraine severity) grades Monthly Headache Frequency categories 
Chi-square (p-value) Chi-square (p-value) 
High Fats  1.99 (0.57) 0.12 (0.94) 
Sweets  0.95 (0.81) 0.88 (0.65) 
Carbohydrates 2.78 (0.43) 0.19 (0.91) 
Fast Food Fats  3.63 (0.30) 0.09 (0.96) 
Table 3.6.6- Kruskal-Wallis test results for the comparison of FCI-II subscale scores between 
the four PedMIDAS migraine severity grades and the three monthly headache frequency 
groups 
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FCI-II Correlations with the Child Behaviour Checklist (CBCL) T-scores 
As outlined in table 3.6.7, none of the FCI-II subscales were significantly (p≤ 0.05) correlated 
with any of the CBCL subscale T-scores. Based on this finding the hypothesis that “the FCI-II 
subscale scores will have a significantly positive correlation with all of the CBCL subscale T-
scores (externalised/ internalised/ total)” was rejected.     
FCI-II Subscale 
 
CBCL Externalised T-scores 
rs (p-value) 
CBCL Internalised T-scores 
rs (p-value) 
CBCL Total T-scores 
rs (p-value) 
High Fats 0.14 (0.30) 0.02 (0.91) 0.09 (0.48) 
Sweets 0.08 (0.52) 0.08 (0.53) 0.10 (0.43) 
Carbohydrates 0.15 (0.25) 0.04 (0.77) 0.12 (0.36) 
Fast Food Fats 0.07 (0.62) 0.07 (0.61) 0.07 (0.58) 
Table 3.6.7- Spearman’s rank correlation results for the CBCL subscale T-scores and FCI-II 
subscale scores 
 
 
Chapter 3.7 
Food Intake Questionnaire (FIQ) results 
 
 
Distribution of raw scores  
All 60 patients that were recruited in this pilot study completed the FIQ tool. It must be 
noted that the FIQ scores represented the number of food items eaten in each FIQ subscale. 
It must also be noted that the FIQ negative marker subscale was a combination of the 
negative sugary food subscale and negative fatty food subscale. Table 3.7.1, lists the mean 
raw score for each FIQ subscale as calculated from the total sample of 60 patients. The 
mean FIQ score of 8 for the negative marker food subscale was very close to the respective 
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median value of 7. In the negative marker food subscale the minimum score reported was 
zero and a maximum score reported was 26; this produced the greatest range of scores 
compared with any other FIQ subscale, which was expected considering the negative 
marker food subscale contained the most number of food items. The mean negative sugary 
and negative fatty scores were both the same at a value of 4. The mean positive fibre food 
score was very low (mean= 1). The mean positive marker food subscale score was equal to 
the respective median value (mean/median= 4).  
 
Statistical 
description 
Neg- marker 
foods 
Neg- sugary 
foods 
Neg-  fatty 
foods 
Pos+ marker 
foods 
Pos+ fibre 
foods 
Mean (s.d) 
8 (4) 4 (2) 4 (3) 4 (2) 1 (1) 
Median 7 3 3 4 0 
Minimum 0 0 0 0 0 
Maximum 26 9 14 12 4 
Table 3.7.1- Distributions of FIQ subscale scores 
 
Mean raw scores were plotted on box plots to display the distribution of data for each FIQ 
subscale. Figures 3.7.2 (negative sugary foods) and 3.7.5 (positive high fibre foods) each 
display a positively skewed distribution of FIQ scores. The box plot for negative fatty food 
scores (figure 3.7.2) illustrates a mild negatively skewed distribution of FIQ scores. Figures, 
3.7.1 (negative marker foods) and 3.7.4 (positive marker foods), do not have a skewed 
appearance of FIQ scores. Data for the negative sugary food and positive marker food 
subscales each followed a parametric distribution. Data for the other FIQ subscales followed 
a non-parametric distribution.    
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Figure 3.7.1 -Box plot to display the distribution of Negative marker food scores 
 
 
 
Figure 3.7.2- Box plot to display the distribution of negative sugary food scores 
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Figure 3.7.3- Box Plot to display the distribution of Negative marker Fatty Food scores           
 
 
 
Figure 3.7.4- Box plot to show the distribution of positive marker food scores     
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Figure 3.7.5- Box plot to show the distribution of Positive high fibre food scores 
 
 
 
Raw scores according to age and gender 
As can be seen in table 3.7.2, the mean FIQ negative sugary food score for children aged 13 
to 16 years (mean= 4) was slightly higher than that for children aged 5 to 12 years (mean= 
3). Conversely, the mean FIQ positive marker food score for children aged 13 to 16 years 
(mean= 3) was slightly lower than that for children aged 5 to 12 years (mean= 4). The mean 
negative sugary foods score for boys (mean= 4) was slightly higher than that for girls (mean= 
3). None of the mean scores from the other subscales differed according to age and gender 
groupings. 
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Categories 
 
Neg- marker 
mean (s.d) 
Neg- Sugary 
mean (s.d) 
Neg- Fatty 
mean (s.d) 
Pos+ marker 
mean (s.d) 
 
Pos+ Fibre 
mean (s.d) 
5-12 years 8 (5) 3 (2) 4 (3) 4 (2) 1 (1) 
13-16 years 
8 (4) 4 (2) 4 (3) 3 (2) 1 (1) 
Female 
8 (5) 3 (2) 4 (3) 4 (3) 1 (1) 
Male 
8 (3) 4 (1) 4 (3) 4 (2) 1 (1) 
Table 3.7.2- Distribution of FIQ subscale scores according to age and gender 
 
Frequency of patients with FIQ raw scores below/above reference mean 
FIQ data from this pilot study were compared with reference data from a study that tested 
the validity of the FIQ. The reference data was based on a sample of 98 children aged 13-14 
years attending two schools in deprived areas of Liverpool, England174. Table 3.7.4 outlines 
the reference values. Table 3.7.3 lists the frequency of patients in this pilot study with a FIQ 
score that was above or below the references mean values. It shows that for each FIQ 
subscale the majority of patients in this pilot study had a FIQ raw score that was below the 
reference mean. However for negative fatty foods, 29 patients (48%) had a FIQ raw score 
that was higher than the reference mean.     
 
FIQ subscale 
 
Frequency of patients below reference mean 
N (% of N= 60) 
Frequency of patients above reference mean 
N (% of N= 60) 
Neg- marker  53 (88) 7 (12) 
Neg- Sugary  58 (97) 2 (3) 
Neg- fatty 31 (52) 29 (48) 
Pos+ marker 49 (82) 11 (18) 
Pos+ fibre 56 (93) 4 (7) 
Table 3.7.3- Frequency of patients with a raw score above or below the reference mean  
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FIQ Subscale No of food items in each subscale Mean reference values 
Neg- marker 29 13 
Neg- sugary 12 8 
Neg- fatty 16 3 
Pos+ marker 18 6 
Pos+ fibre 4 2 
Table 3.7.4- A list of mean reference values for each FIQ subscale 
*Reference values were extrapolated from a FIQ validity study by Johnson et al174    
 
Correlation between FIQ subscale scores and PedMIDAS scores  
As outlined in table 3.7.5, none of the FIQ subscale scores were significantly (p≤ 0.05) 
correlated with the PedMIDAS scores. For this reason the hypothesis that “the PedMIDAS 
scores will have a significantly (p≤ 0.05) positive correlation with the FIQ negative marker, 
negative sugary and negative fatty food scores” was rejected. The hypothesis that “the 
PedMIDAS scores will have a significantly (p≤ 0.05) negative correlation with the FIQ positive 
marker and positive fibre food scores”, was also rejected.   
 
Correlation between FIQ subscale scores and monthly headache frequency 
As outlined in table 3.7.5, there was a weak but significant (p≤ 0.05) positive correlation 
between the FIQ negative marker food subscale and monthly headache frequency (rs= 0.27; 
p-value= 0.04). Based on this finding the hypothesis that “negative marker FIQ scores will 
have a significant (p≤ 0.05) positive correlation with monthly headache frequency” was 
accepted. On advice from the statistician involved in this pilot study, a correlation 
coefficient equal to or greater than 0.7 was considered a strong correlation. Given that the 
correlation coefficient (rs) was 0.27 the correlation between the FIQ negative marker food 
subscale and monthly headache frequency was considered to be quite weak. This point is 
further demonstrated in figure 3.7.6 by the weak association of dots in the scatter graph of 
FIQ negative marker food scores plotted against the monthly headache frequency values.  
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Figure 3.7.6- Scatter graph of the FIQ negative marker food scores plotted against the 
monthly headache frequency values  
 
 
 
As can be seen in table 3.7.5 the remaining FIQ subscale scores were not significantly (p≤ 
0.05) correlated with the monthly headache frequency values. For this reason the 
hypothesis that “the monthly headache frequency values will have a significant (p≤ 0.05) 
positive correlation with the FIQ negative sugary and the negative fatty food scores” was 
rejected. The hypothesis that “the monthly headache frequency values will have a 
significant (p≤ 0.05) negative correlation with the FIQ positive marker food scores and the 
positive fibre foods scores” was also rejected.          
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FIQ subscale PedMIDAS 
rs (p-value) 
Headache Frequency 
rs (p-value) 
Negative Marker foods 0.05 (0.71) 0.27 (0.04)
* 
Negative maker sugary foods 0.08 (0.54) 0.25 (0.06) 
Negative marker fatty foods -0.11 (0.41) 0.17 (0.18) 
Positive Marker foods 0.05 (0.73) 0.18 (0.17) 
Positive marker fibre foods 0.10 (0.43) 0.01 (0.97) 
Table 3.7.5- Results for Spearman’s rank correlations made between the FIQ subscale scores 
and monthly headache frequency/ PedMIDAS severity scores. *= significant finding (p≤ 0.05) 
 
Distribution of the FIQ subscale scores according to the migraine groups 
Mean raw scores were calculated for each FIQ subscale according to the four migraine 
severity grades and the three monthly headache frequency groups; these can be seen in 
figures, 3.7.7 to 3.7.16. When grouped according to the migraine severity grades, the 
highest mean negative marker score was found in the fourth migraine severity grade (>50 
PedMIDAS scores) as illustrated by figure 3.7.7. The highest mean in the negative sugary 
food and the negative fatty food subscales were each found in the third migraine severity 
grade, as can be seen in figures 3.7.8 and 3.7.9.  The mean values for the positive marker 
food (figure 3.7.10) and the positive high fibre food (figure 3.7.11) subscales increase with 
each increment in migraine severity grade, up until grade III.  
When categorised according to the monthly headache frequency groups, the mean scores 
for the negative marker food, negative sugary food and positive marker food subscales 
increased with each increment in monthly headache frequency group number; this is 
represented on the respective histograms (figures 3.7.12, 3.7.13 and 3.7.15) as a negatively 
skewed appearance. Figure 3.7.14 for the negative fatty food subscale shows the mean 
score peaks in the 4 to 10 monthly headache frequency group. Figure 3.7.16 for the positive 
high fibre food subscale shows the mean score peaks in the first monthly headache 
frequency group (< 4 headaches per month).         
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Figures, 3.7.7 and 3.7.12, show that the highest mean FIQ negative marker score was found 
in the 4th  migraine severity grade (> 50 PedMIDAS scores) and in the 4 to 10 monthly 
headache frequency group. Mean scores for the negative sugary, negative fatty, positive 
marker and positive fibre food subscales were highest in the third migraine severity grade 
(31-50 PedMIDAS scores).  
 
 
Figure 3.7.7 
A histogram to show the distribution of the FIQ negative marker food scores according to the four 
migraine severity grades 
  
                                                         0 to 10                        11 to 30                                 31 to 50               Greater than 50 
                                                       (Grade I)                                (Grade II)                               (Grade III)                            (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
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Figure 3.7.8 
A histogram to show the distribution of the FIQ negative sugary food scores according to the four 
migraine severity grades 
 
              0 to 10           11 to 30        31 to 50              Greater than 50 
             (Grade I)                    (Grade II)                   (Grade III)                  (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
 
 
Figure 3.7.9 
A histogram to show the distribution of the FIQ negative fatty food scores according to the four 
migraine severity grades 
  
               0 to 10            11 to 30       31 to 50             Greater than 50 
              (Grade I)                    (Grade II)                  (Grade III)               (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
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Figure 3.7.10 
A histogram to show the distribution of the FIQ positive marker food scores according to the four 
migraine severity grades                     
 
         0 to 10      11 to 30                     31 to 50               Greater than 50 
       (Grade I)                     (Grade II)                   (Grade III)                    (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
 
Figure 3.7.11 
A histogram to show the distribution of the FIQ positive high fibre food scores according to the 
four migraine severity grades                                                
    
    0 to 10                       11 to 30                     31 to 50            Greater than 50 
  (Grade I)                       (Grade II)                    (Grade III)                   (Grade IV) 
          PedMIDAS scores (migraine severity grades) 
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Figure 3.7.12 
A histogram to show the distribution of the FIQ negative marker food scores according to the 
three monthly headache frequency groups                  
 
             Less than 4                      Between 4 to 10                      More than 10 
               (Group 1)                               (Group 2)             (Group 3) 
Monthly headache frequency 
 
 
Figure 3.7.13 
A histogram to show the distribution of the FIQ negative sugary food scores according to the three 
monthly headache frequency groups                  
       
                               Less than 4                    Between 4 to 10                      More than 10 
                                  (Group 1)     (Group 2)            (Group 3) 
Monthly headache frequency 
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Figure 3.7.14 
A histogram to show the distribution of the FIQ negative fatty food scores according to the three 
monthly headache frequency groups                  
 
              Less than 4               Between 4 to 10            More than 10 
           (Group 1)              (Group 2)                       (Group 3) 
Monthly headache frequency 
 
 
Figure 3.7.15 
A histogram to show the distribution of the FIQ positive marker food scores according to the three 
monthly headache frequency groups                  
 
                    Less than 4                       Between 4 to 10                       More than 10 
                       (Group 1)                                 (Group 2)              (Group 3) 
Monthly headache frequency 
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Figure 3.7.16 
A histogram to show the distribution of the FIQ positive high fibre food scores according to the 
three monthly headache frequency groups                  
 
                                                             Less than 4                                    Between 4 to 10                                     More than 10 
   (Group 1)                              (Group 2)                              (Group 3) 
Monthly headache frequency 
 
 
Comparison of the FIQ subscale scores between the four migraine severity 
grades  
As outlined by table 3.7.6, when the FIQ data was compared between the four migraine 
severity grades, the chi-square value for each FIQ subscale was insignificant at the corrected 
probability level of 0.005. For this reason the hypothesis of “the FIQ subscale scores (neg- 
marker, neg- sugary foods, neg- fatty foods, pos+ marker and pos+ high fibre foods) will 
significantly (p≤ 0.005) differ between the four migraine severity grades” was rejected.  
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Comparison of FIQ subscale scores between the three monthly headache 
frequency groups 
Based on the uncorrected p-value of 0.05, there were significant chi-square values for the 
comparison of negative marker food scores (chi-square= 5.95, p= 0.05), negative sugary 
food scores (chi-square= 6.76, p= 0.03) and negative fatty food scores (chi-square= 6.06, p= 
0.05), between the three monthly headache frequency groups. However based on the 
corrected probability level of 0.005, there were no significant chi-square values for any of 
the FIQ subscales. So based on the latter evidence the hypothesis of “the FIQ subscale 
scores (neg- marker, neg- sugary foods, neg- fatty foods, pos+ marker and pos+ high fibre 
foods) will significantly (p≤ 0.005) differ between the three monthly headache frequency 
groups” was rejected.    
FIQ Subscale 
 
PedMIDAS Migraine severity grades 
Chi-square value (p-value) 
Monthly Headache Frequency categories 
Chi-square (p-value) 
Neg- marker foods 2.39 (0.50) 5.95 (0.05) 
Neg- marker sugary foods 0.93 (0.82) 6.76 (0.03) 
Neg- marker fatty foods 4.67 (0.20) 6.06 (0.05) 
Pos+ marker foods 0.81 (0.85) 1.72 (0.42) 
Pos+ marker fibre foods 6.82 (0.08) 1.52 (0.47) 
Table 3.7.6- Kruskal-Wallis test results for the comparison of FIQ subscale scores between 
the migraine groups  
 
Food Intake Questionnaire (FIQ) and Child behaviour Checklist Correlations 
As outlined in table 3.7.7, none of the FIQ subscales were significantly (p≤ 0.05) correlated 
with any of the CBCL subscale T-scores. For this reason the hypothesis of “the FIQ negative 
marker, negative sugary and negative fatty food scores will have a significantly (p≤ 0.05) 
positive correlation with the CBCL subscale (internalising/ externalising/ total) T-scores” was 
rejected. The hypothesis of “the FIQ positive marker and positive high fibre foods scores will 
have a significantly (p≤ 0.05) negative correlation with CBCL subscale (internalising/ 
externalising/ total) T-scores” was also rejected.  
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FIQ Sub scale CBCL Externalised  
T-scores 
rs value (p-value) 
CBCL Internalised  
T-scores 
rs value (p-value) 
CBCL Total  
T-scores 
rs value (p-value) 
Negative marker foods 0.14 (0.30) 0.13 (0.34) 0.16 (0.22) 
Negative marker Sugary foods 0.15 (0.24) 0.22 (0.09) 0.21 (0.18) 
Negative Fatty foods 0.19 (0.14) 0.09 (0.50) 0.17 (0.20) 
Positive marker foods -0.21 (0.11) -0.01 (0.96) -0.15 (0.25) 
Positive fibre foods  0.15 (0.26) 0.02 (0.86) 0.07 (0.62) 
Table 3.7.7- Spearman rank correlation results between the FIQ subscale scores and CBCL 
subscale T-scores 
 
 
 
 
 
 
 
Chapter 3.8 
Child Behaviour Checklist (CBCL) results 
 
Distribution CBCL T-scores   
Raw scores produced from each subscale (internalising/externalising/total) of the Child 
Behaviour Checklist (CBCL) were converted to T-scores that were adjusted for age and sex. 
The reference range scores used to convert the raw scores to standardised T-scores were 
obtained from the CBCL Achenbach manual213.      
The histograms for the distribution of T-scores for each CBCL subscale, in figures 3.8.1 to 
3.8.3, display a non-skewed appearance. This is in keeping with the fact that the data for all 
three CBCL subscales were of a parametric distribution.     
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Figure 3.8.1- A histogram to display the distribution of externalised CBCL T-scores 
 
CBCL externalised T-scores 
 
Figure 3.8.2- A histogram to display the distribution of internalised CBCL T-scores 
 
CBCL internalised T-scores 
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Figure 3.8.3- A histogram to display the distribution of total CBCL T-scores  
 
CBCL total T-scores 
 
 
Distribution Internalising Externalising Total 
Mean (s.d) 57 (11) 52 (12) 47 (11) 
Median 58 53 48 
Mode 53 50 34 
Minimum 33 33 24 
Maximum 86 75 72 
Table 3.8.1- Distribution of CBCL T-scores 
 
The overall mean T-score for the entire study sample (n= 60) was calculated for each CBCL 
subscale, which can be seen in table 3.8.1. The mean T-scores for the internalising (mean= 
57, median = 58), externalising (mean= 52, median= 53) and total (mean= 47, median= 48) 
CBCL subscales were very similar to the respective median values. The internalising subscale 
showed the largest difference between the minimum and maximum T-scores reported 
(minimum value= 33; maximum value= 86).      
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 Subscale CBCL T-scores according to reference ranges 
The frequencies of patients with CBCL T-scores within the normal, sub clinical and clinical 
ranges have been plotted as histograms which can be seen in figures 3.8.4 to 3.8.6. The cut-
off limits used to assess the clinical status of CBCL scores (as outlined in tables 3.8.2 and 
3.8.3) were derived from the Achenbach manual213.  
As can be seen in figure 3.8.4, the majority of patients have an externalising CBCL T-score 
within the normal range profile (n= 46, 77%). As shown in figure 3.8.5, there was a higher 
percentage of patients with internalising T-scores in the clinical range (n= 23, 38.3%) 
compared with the percentage of patients with externalised T-scores in the clinical range 
(n= 12, 20%). Figure 3.8.6 illustrates that the majority of patients had total CBCL T-score 
within the normal (non-clinical) profile.    
 
 
CBCL Scale Normal Sub-clinical Clinical 
Internalising 0-10 11 - 13 14-64 
Externalising 0-11 12 - 15 16-70 
Total 0-35 36 - 44 45-134 
Table 3.8.2- Normal/sub-clinical/clinical cut off limits for CBCL T-scores in Girls 
 
 
CBCL Scale Normal Sub-clinical Clinical 
Internalising 0- 8 9 -11 12- 64 
Externalising 0- 11 12 – 15 16- 70 
Total 0- 39 40- 51 52- 134 
Table 3.8.3- Normal/sub-clinical/clinical cut off limits for CBCL T-scores in Boys 
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Figure 3.8.4 
A histogram to show the frequency of patients with an externalising CBCL T-score within the 
normal, clinical and sub-clinical ranges 
 
Clinical status according to CBCL externalised T-scores 
 
 
Figure 3.8.5 
A histogram to show the frequency of patients with an internalising CBCL T-score within the 
normal, clinical and sub-clinical ranges 
 
Clinical status according to CBCL internalised T-scores 
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Figure 3.8.6 
A histogram to show the frequency of patients with a total CBCL T-score within the normal, clinical 
and sub-clinical ranges 
 
Clinical status according to CBCL total T-scores 
 
 
 
CBCL T-score Correlations with the PedMIDAS scores and monthly headache 
frequency 
Spearman’s rank correlation test was used to assess the correlations between the CBCL 
subscales and PedMIDAS / monthly headache frequency. This was done on the basis that 
the data set for PedMIDAS scores was of a non-parametric distribution.     
As outlined in table 3.8.4, there were no significant (p≤ 0.05) correlations between any of 
the CBCL subscale T-scores and the monthly headache frequency values. For this reason the 
hypothesis of “the subscale CBCL T-scores will have a significantly (p≤ 0.05) positive 
correlation with the monthly headache frequency values” was rejected.  
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The internalising CBCL subscale (rs= 0.35, p= 0.01) and total CBCL subscale (rs= 0.27, p= 0.04) 
each had a weak but significantly (p≤ 0.05) positive correlation with the PedMIDAS scores. 
For this reason the hypothesis of “the internalising CBCL T-scores and the total CBCL T-
scores will have a significantly (p≤ 0.05) positive correlation with the PedMIDAS scores” was 
accepted.   
As outlined by table 3.8.4, the externalising T-scores were not significantly (p≤ 0.05) 
correlated with the PedMIDAS scores. For this reason the hypothesis of “the externalising 
CBCL T-scores will have a significantly (p≤ 0.05) positive correlation with the PedMIDAS 
scores” was rejected.  
CBCL Category PedMIDAS raw scores  
rs (p value) 
Monthly Headache Frequency  
rs (p value) 
Externalised  0.20 (0.12) 0.02 (0.87) 
Internalised  0.35* (0.01) 0.07 (0.62) 
Total  0.27*  (0.04) 
 
0.09 (0.48) 
Table 3.8.4- Spearman rank correlation results between CBCL subscale T-scores and 
migraine measures. *= significant finding (p ≤0.05)   
 
CBCL T-score Correlations with BMI z-scores 
Given that the data for the BMI z-scores and every CBCL subscale followed a parametric 
distribution, the correlations between the BMI z-scores and the CBCL subscale T-scores were 
assessed using the parametric Pearson’s correlation test. 
As can be seen from table 3.8.5, the internalising CBCL T-scores (r= 0.28, p= 0.03) and the 
total T-scores (r= 0.28, p= 0.03) both had a significantly (p≤ 0.05) positive correlation with 
the BMI z-scores. For this reason the hypothesis of “the BMI z-scores will have a significantly 
(p≤ 0.05) positive correlation with the CBCL internalising T-scores and the CBCL total T-
scores” was accepted.  
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As outlined in table 3.8.5, the externalising T-scores did not have a significantly (p≤ 0.05) 
positive correlation with the BMI z-scores (r =0.17, p= 0.18). For this reason the hypothesis 
of “the BMI z-scores will have a significantly (p≤ 0.05) positive correlation with the CBCL 
externalising T-scores” was rejected.  
CBCL subscale 
 
BMI z-scores 
r (p-value) 
Externalised Behaviours T-scores 0.17 (0.18) 
Internalised Behaviours T-scores 0.28 (0.03)* 
Total T-scores 0.28 (0.03)* 
Table 3.8.5- Pearson’s correlation test results for the correlation between BMI z-scores and 
CBCL subscale T-scores. *= significant finding (p ≤0.05) 
 
 
 
Chapter 3.9 
Overview of study results and their possible implications 
 
Significant findings Implication of result 
Desire to drink (DD) positively correlated with PedMIDAS 
raw scores (rs= 0.41, p= 0.01)
Desire to drink is positively associated with 
migraine severity 
FIQ negative marker foods significantly positively 
correlated with monthly headache frequency (rs= 0.27, p= 
0.04) 
Intake of negative unhealthy foods is 
positively associated with monthly 
headache frequency 
Significant correlation between PedMIDAS scores and 
internalised CBCL T-scores (rs = 0.35, p= 0.01) 
Internalising behavioural problems are 
positively associated with migraine severity 
Significant correlation between PedMIDAS scores and 
Total CBCL T-scores (rs= 0.27
 , p= 0.04) 
Overall Behavioural problems are 
associated with migraine severity 
 Significant correlation between BMI z-scores and 
internalised CBCL T-scores (r = 0.28, p= 0.03) 
Internalising behavioural problems are 
associated adiposity 
Significant correlations between BMI z-scores and total T-
scores (r = 0.28,  p= 0.03) 
Overall behavioural problems are 
associated with adiposity 
Table 3.51- List of significant study findings
  
Chapter 4.0- Discussion 
Chapter 4.1 
Desire to drink and Migraine Severity 
 
The desire to drink subscale of the CEBQ had a significantly (p≤ 0.05) positive correlation 
with the PedMIDAS scores (rs= 0.41, p= 0.01); as the PedMIDAS scores were used as a proxy 
for migraines severity this finding indicated children with higher severities of migraine have 
a greater desire to consume fluids.  
During acute migraine attacks there is a substantial rise in urine volume and reduction in 
excretion of urinary arginine vasopressin (AVP) due to the inhibition of AVP secretion from 
the hypothalamus. Hypothalamic activity is linked with cortical spreading depression, which 
may cause inhibition of neurotransmission along the supra-optic nucleus with consequent 
impairment of vasopressin secretion214,215. Dehydration is accepted as a potential trigger for 
headache attacks in some migraine patients. Increased water consumption given as 
preventive migraine therapy is associated with 21 hours worth of fewer headaches suffered 
compared with patients not given hydration treatment216. It can be purported that the 
significantly positive correlation observed between the desire to drink fluids and migraine 
severity (as measured by the PedMIDAS scores) was due to children with greater severities 
of migraine consuming larger amounts of fluids in aid to alleviate their headache pain.    
Hypothalamic dysfunction is associated with a lack of thirst perception. Osmoreceptors 
responsible for osmometric thirst are located in the anterior hypothalamus. Hypertonic 
injections of saline solutions into the hypothalamus are demonstrated to induce states of 
thirst217. PET scanning has shown there is increased hypothalamic activity during acute 
migraine attacks125. Given these findings it is possible that migraine patients express higher 
intensities of thirst through the mediating effects of hypothalamic osmo-regulation.  
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This pilot study did not detect a significant correlation between the CEBQ desire to drink 
subscale and BMI z-scores. However a previous study by Wardle et al has demonstrated a 
significant positive association between the CEBQ desire to drink subscale and BMI z-
scores218. In children, the consumption of high sugar containing drinks is associated with 
increased BMI levels and high obesity risk. 219. Children with a greater desire to drink may 
consume high calorie fluids which adversely increase adiposity levels. However it may be 
that the children in this pilot study with high desire to drink scores were not consuming high 
calorie drinks and hence also did not have high adiposity levels.   
The Food Intake Questionnaire (FIQ) could have been used to qualitatively assess what 
types of drinks were consumed by children in this pilot study. The frequency of patients that 
consumed high or low calorie drinks could have been assessed for associations with 
migraine severity (as measured by the PedMIDAS scores) and the desire to drink subscale of 
the CEBQ. However due to time constraints this analysis was not possible. Hence for the 
main future study it would be beneficial to analyse the relationship between fluid intake and 
migraine severity.    
The statistician involved in this pilot study advised that a correlation coefficient of 0.70 or 
larger indicates the presence of a strong correlative relationship; hence it must be noted 
that the correlation coefficient between the CEBQ desire to drink scores and PedMIDAS 
scores was very small (rs= 0.41), indicating a weak correlation. There was no supporting 
evidence that the CEBQ desire to drink z-scores significantly (p<0.003) differed between the 
four grades of migraine severity. A strong conclusion cannot be drawn from the results in 
this pilot study because of the very low power in sample size and high number of multiple 
tests. Hence based on results from this pilot study it can be concluded that there was a 
weak correlation between the desire to drink as measured by the CEBQ and migraine 
severity as measured by the PedMIDAS scores. A higher powered sample size would be 
needed to more accurately test the strength and significance of this relationship.           
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Chapter 4.2 
Food intake and Monthly Headache Frequency 
The Food Intake Questionnaire (FIQ) negative marker food scores had a significantly (p≤ 
0.05) positive correlation with the monthly headache frequency (rs= 0.27, p= 0.04). Given 
that the negative marker foods listed in the FIQ represented unhealthy foods high in sugar 
and fat174, it can be suggested that migraine patients with higher headache frequencies 
consume more unhealthy food items listed in the FIQ in one day.   
Although no significant findings for food cravings were observed in this pilot study, there is 
evidence of migraine patients suffering from cravings for chocolate, cheese and dry starchy 
foods during acute attacks91; these food items were also listed in the FIQ negative marker 
food subscale174. The foods consumed by migraine patients in this pilot study may have 
largely been a result of a hedonistic drive. Activation of the reward system as regulated by 
the hypothalamus and 5-HT neurotransmitters increase the ingestion palatable foods high in 
fat and simple sugars220,221. Hypothalamic activation, dopamine and serotonin dysfunction 
are associated with migraine pathology222. It is possible that children with migraine eat high 
fat sugary foods because of an increased activation of the reward system that is influenced 
by migraine associated pathological processes involving hypothalamic activation and 
serotonin dysfunction.            
In this pilot study, 39 (65%) of the 60 patients that were recruited suffered from anorexia as 
an associated feature of their acute migraine attacks. Thus in consideration of acute 
migraine attacks representing states of appetitive loss, the significant positive correlation 
between monthly headache frequency and the intake of unhealthy (FIQ negative marker) 
foods could indicate that the unhealthy foods were consumed inter-ictally as part of the 
chronic “trait” form of migraine. However it must be noted that the results from the FIQ 
reflected dietary habits over a period of one day (i.e. the previous day to when the child was 
recruited into the pilot study). Hence for this reason it would not be possible to conclude 
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whether the relationship that the FIQ negative marker data had with monthly headache 
frequency was based on a chronic interaction between diet and migraine.     
Headaches can develop in response to the consumption of cheese products that result in 
abnormal tyramine concentrations223. Chocolate can act as a trigger for headache onset in 
some migraine patients due to the release of phenylethylamine, caffeine and catechin, 
which can alter cerebral blood flow224. Fatty acids are speculated to be involved in migraine 
mechanisms as suggested by raised serum levels of free fatty acids and blood lipids during 
acute attacks225. Given that chocolate, cheese and caffeine products were listed as food 
items under the FIQ negative marker subscale174, its relationship with headache frequency 
may be through mediating roles as a headache trigger; hence one possibility is that the 
greater ingestion of high fat sugary foods may have provoked more frequent migraine 
attacks. However given that this pilot study did not investigate food intake in relation to the 
acute onset of migraine attacks, it is not possible to form a conclusion about the role of 
negative marker (“unhealthy foods”) as a migraine trigger. Instead this particular issue 
would require further research, with the use of a more robust dietary measure that is able 
to assess regular food intake for a time period that is longer than one day (i.e. not the FIQ).           
The statistician involved in this pilot study advised that a correlation coefficient of 0.70 or 
larger indicates the presence of a strong correlative relationship; hence it must be noted 
that the correlation coefficient between the FIQ negative marker food scores and monthly 
headache frequency was very small (rs= 0.27), indicating a weak correlation. There was no 
supporting evidence that the FIQ negative marker food scores significantly (p<0.005) 
differed between the three monthly headache frequency groups. A strong conclusion 
cannot be drawn from the results in this pilot study because of the very low power in 
sample size and high number of multiple tests. Hence based on results from this pilot study 
it can be concluded that there was a weak correlation between the intake of unhealthy 
“negative marker foods” as measured by the FIQ and monthly headache frequency. A higher 
powered sample size would be needed to more accurately test the strength and significance 
of this relationship.           
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Chapter 4.3 
Behavioural problems, Migraine and Adiposity 
 
The internalising CBCL T-scores had a significantly (p≤ 0.05) positive correlation with the 
PedMIDAS scores (rs= 0.35, p= 0.01). However because the correlation coefficient was below 
the level of 0.70, it was considered a weak correlation. The total CBCL T-scores had a 
significantly (p≤ 0.05) positive correlation with the PedMIDAS scores (rs= 0.266, p=0.04). 
However because the correlation coefficient was below the level of 0.70, it was considered 
a weak correlation. 
Sixty-nine different correlation tests were performed with the CBCL measure (23 for each 
CBCL subscale), see table 4.3.1. Hence according to the Bonferroni test the corrected p-
value for correlations made with the CBCL would have been equal to 0.00072 
(0.05/69=0.00072). Total CBCL T-scores and internalising CBCL subscale T-scores were not 
significantly correlated with PedMIDAS scores at the corrected probability level of 0.00072. 
Hershey et al found that internalising CBCL scores were higher among migraine patients 
compared with controls126. Although this pilot study had a very low power in sample size, it 
can be concluded that in support of Hershey et al126, behavioural problems as measured by 
the CBCL were weakly correlated with migraine severity as measured by the PedMIDAS. 
However a higher powered sample size would be needed to more accurately test the 
strength and significance of this relationship.                    
The internalising CBCL T-scores had a significantly positive correlation with the BMI z-scores 
(r= 0.276, p= 0.03). However because the correlation coefficient was below the level of 0.70, 
it was considered a weak correlation. The total CBCL T-scores had a significantly positive 
correlation with the BMI z-scores (r= 0.28, p= 0.029). However because the correlation 
coefficient was below the level of 0.70, it was considered a weak correlation. It must be 
noted that at the corrected probability level of 0.00072, neither the internalising nor total 
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CBCL subscale T-scores were significantly correlated with the BMI z-scores. Vila et al127 
found obese children had higher levels of internalising behaviour problems compared with 
normal weight controls. Although this pilot study had a very low power in sample size, it can 
be concluded that in support of Villa et al127, behavioural problems as measured by the CBCL 
were weakly correlated with adiposity as measured by the BMI z-scores. However a higher 
powered sample size would be needed to more accurately test the strength and significance 
of this relationship.           
Variable/measure 
 
 
Number of subscales for 
each variable/measure 
 
Number of CBCL 
correlations made with 
each subscale 
Total  number of CBCL 
correlations made with 
each variable/measure 
Migraine measures 2 3 6 
DEBQ 3 3 9 
CEBQ 8 3 24 
FIQ 5 3 15 
FCI-II 4 3 12 
BMI z-scores 1 3 3 
 
TOTAL 
 
69 
    Table 4.3.1- The number of correlation tests performed with the CBCL tool 
 
 
Chapter 4.4 
Eating behaviours and Migraine 
With the exception of the CEBQ desire to drink subscale, none of the eating behaviour 
subscales (as measured by the DEBQ for adolescents, DEBQ-C and CEBQ) were significantly 
(p≤ 0.05) correlated with migraine severity (as measured by the PedMIDAS scores) or 
monthly headache frequency. The eating behaviours did not significantly (p≤ 0.008 for the 
DEBQ results and p≤ 0.003 for the CEBQ results) differ according to the four migraine 
severity grades or three monthly headache frequency groups. Possible reasons for why 
these results were insignificant are now discussed.           
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Puberty as a confounding factor 
This pilot study recruited a wide age range of children at different stages of pubertal 
development. Teenage girls can develop suppressed appetite levels in relation to cyclic peri-
ovulatory oestradiol secretion. Testosterone can increase appetite levels by increasing meal 
frequency.226. Menstrual migraine related to abrupt falls in serum oestradiol concentrations 
is responsive to oestrogen replacement therapy. Oral contraceptive pills worsen migraine 
attacks in up to 55% of cases. Migraine symptoms can improve during pregnancy and after 
menopause227. This suggests there can be some oestrogen driven pathology among female 
migraine patients. Leptin levels that suppress appetite can increase in girls and decrease in 
boys after Tanner stage 2, when pubertal development proceeds228. Hence individual 
differences in pubertal developmental that affect oestrogen and leptin physiology228,229 may 
have significantly confounded the migraine-eating behaviour relationship. To overcome this 
issue in the main future study it may be useful to assess the stage of pubertal development 
of each child recruited. The Tanner scale is widely accepted as a face valid criterion for 
assessing stages of pubertal development. It grades the stage of pubertal development 
according to pubic hair distributions and genital maturation (breast growth in girls and 
testicular/penis growth in boys)229. However by implementing the Tanner scale the ethics 
approval of the main future study would have to be severely revised due to the disclosure of 
highly sensitive information on genital anatomy.                    
 
Emotional eating and migraines  
The theory of emotional eating posits that excessive food consumption occurs in response 
to high emotional arousal which in the long term increases adiposity levels70. However the 
threshold for emotional arousal that stimulates over-eating has not been outlined in the 
eating behaviour literature71. Migraine cases in this pilot study were quite emotionally 
stable based on the Child Behaviour Checklist T-scores. Of the total 60 patients 51 subjects 
(85%) displayed normal behavioural traits and only 6 children (10%) had behavioural 
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problems within the clinical range. Given that 85% of the child recruits displayed normal 
behavioural tendencies, they may also be quite emotionally stable, meaning they were not 
able to reach a certain threshold of consistent emotional arousal72 needed to induce states 
of emotional eating.  
 
Restrained eating and migraine 
Pre-pubertal children often report a heightened sense of body dissatisfaction and may begin 
dieting from as young as 9 years old209. Restrained eating is the abandonment of the usual 
cognitive resolve to diet caused by states of dis-inhibition72. Particular triggers for dis-
inhibition such as alcohol consumption are not present in early childhood as well as other 
possible triggers such as emotional instability. Thus it is possible that restrained eating levels 
were normal in the younger children recruited. There is no current literature that outlines 
the minimum age in which high restrained eating levels can develop73. This issue must be 
taken into consideration as it may account for why there was no significant relationship 
detected between migraines and restrained eating.            
 
External eating and migraines 
Strict parental control on diet can motivate rule breaking behaviour in children which 
encourages them to consume foods not usually accepted by parents. Up to 61% of families 
with children under the age of 18 have parents that both work and 72% of single parents 
that work full time230. If parents are busy with employment responsibilities, children have a 
greater freedom in dietary food choices. Hence children do not have to oppose strict 
parental rules on diet and do not develop rule breaking behaviour81. It may be that patients 
recruited into this study did not respond to externalised food cues as readily, due to a lack 
of urge for breaking strict parental rules on diet.   
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CEBQ and migraines 
Food responsiveness, enjoyment of food, satiety responsiveness, speeds of eating, food 
fussiness and emotional over/under eating are all subject to food hedonism as a factored 
determinant60. High levels of food responsiveness and enjoyment of eating are both 
associated with strong levels of hedonism for high fat foods. The consumption of highly 
palatable foods is associated with slow eating speeds to savour food flavours231.  
Emotional instability leads to the consumption of highly palatable foods that provide 
comfort, indicating emotional eating has a hedonistic eating component. Food hedonism is 
influenced by foods available in the environment, social factors, somato-psychic state, 
subjective experiences and preparatory activities232. As none of these factors were 
accounted for in this pilot study it is possible they may have affected eating behaviours 
measured by the CEBQ.  
Children with social companionship whilst eating tend to develop a larger appetite and eat 
larger food servings. Children told “not to leave food on their plate when finished eating”, 
are less sensitive to physiological satiety cues234. Strict authoritarian parental feeding 
practices are associated with the consumption of “forbidden foods” even when satiated 
from a prior full meal59. Hence unaccounted factors such as familial eating practices and 
social interactions may have affected the eating behaviour results in this pilot study through 
mediating effects on hedonism153.          
The results in this pilot study suggest that eating behaviours were not associated with 
migraines. However a strong conclusion cannot be drawn from these results because of the 
very low power in sample size, high number of multiple tests, pubertal confounding factors 
and unaccounted factors that affect levels of food hedonism. A future study is needed to 
test the relationship between migraines and eating behaviours based on a much larger 
sample size.  
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Chapter 4.5 
Migraine and Adiposity 
In this pilot study, BMI z-scores were not significantly (p≤ 0.05) correlated with the 
PedMIDAS scores (migraine severity) or monthly headache frequency. BMI z-scores also did 
not significantly (p≤ 0.025) differ between the four migraine severity grades or between the 
three monthly headache frequency groups. Possible reasons for why these results were 
insignificant are now discussed.    
Migraine is controlled by a complex interaction between genetic and environmental 
determinants233. Parental weight is positively correlated with the body mass index of their 
children and is a predictor of childhood obesity. Children with at least one overweight 
parent have a 3 fold risk of becoming overweight and children with an obese parent have a 
5 fold risk of becoming overweight107. The FTO gene is strongly associated with obesity108. 
FTO mRNA highly expressed within regulatory appetite centres of the hypothalamus, 
increase adipose fat levels and lower lean mass by desensitising responses to internal 
satiety cues and increasing appetite. No specific common gene with shared effects on 
migraine and adiposity has yet been identified109. However migraine, eating behaviours and 
adiposity are each influenced by genetic traits104 that may have affected the migraine-
adiposity relationship tested in this pilot study.  
Based on large population samples, body mass index is a validated measure of adiposity 
across the age of 2 to 18 years234. However BMI is an indirect measure of adiposity and has 
not yet been validated in small sample size studies235. Hence BMI z-scores in this pilot study 
may not have accurately reflected adiposity levels because of the very small sample size. To 
resolve this issue for the main future study a much larger sample size would need to be 
recruited. Alternatively adiposity could be measured using a different measurement 
technique.  
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As all of the patients recruited into this pilot study were approached at their first clinic visit, 
the severity of their migraine illness may have been in the early stages of progression as the 
underlying pathology may not have reached its full potential. Migraine progression is 
measured clinically by headache frequency, with the chronic form of migraine representing 
the more severe spectrum of migraine progression1. Only 6 of the patients recruited in this 
pilot study met the criteria for a chronic migraine diagnosis (greater than 15 monthly 
headaches) suggesting that 90% of the patients recruited still had potential to progress from 
an episodic to a chronic form of migraine5. Bigal et al identified a migraine-adiposity 
relationship based on chronic daily headache patients with a late progression of migraine41; 
this supports the possibility that migraine pathology has to reach a certain threshold before 
it is able to influence adiposity levels.      
The results in this pilot suggest that BMI z-scores were not associated with migraine severity 
or headache frequency. However a firm conclusion cannot be drawn from these results 
based on unaccounted genetic influences, questionable validity of BMI as an adiposity 
measure in such a small sample size population and short length of study. Hence a future 
study is needed to test the relationship between migraines and adiposity based on a much 
larger sample size with adequate length of study period.  
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Chapter 4.6 
Migraine and food cravings 
None of the FCI-II subscale raw scores were significantly (p≤ 0.05) correlated with the 
PedMIDAS scores (migraine severity) or the monthly headache frequency values. FCI-II 
subscale raw scores did not significantly (p≤ 0.006) differ between the four migraine severity 
grades or three monthly headache frequency groups, indicating that food cravings were not 
associated with migraines. Previous studies have only reported food cravings during acute 
migraine attacks146, and not in the chronic trait form of migraine as investigated in this pilot 
study. In addition to this the sample size was not adequately powered and so a firm 
conclusion cannot be made about the relationship between food cravings and migraines.     
 
 
Chapter 4.7 
Critical appraisal of questionnaires 
 
Critical appraisal of the DEBQ for adolescents and the DEBQ-C 
The Children’s Dutch Eating Behaviour Questionnaire (DEBQ-C) presented some difficulties 
when used in the clinical field. Patients were frequently unable to grasp the meaning of 
some of the DEBQ-C questions. The recruiting researcher had to use familiar examples and 
create hypothetical scenarios to aid the child’s understanding of the question. However by 
doing so the answer given may not have been face valid to the original question asked.    
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Both the DEBQ for adolescents and the DEBQ-C were subject to recall bias, especially with 
the emotional eating questions, that required a recollection of prior moments when 
emotional arousal induced states of hunger. Question 2 of the DEBQ-C (“if you feel 
depressed or lonely do you get a desire for food”), created problems as sometimes the child 
was unaware when they had previously felt depressed or lonely, and found it difficult to 
correlate such states of emotional arousal with feelings of hunger.  
The 3-point answer scale in the DEBQ-C (“no”, “sometimes” or “yes”) was clear and 
appropriate to understand for children aged 7-12 years, causing no major problems. 
However some children found it difficult to use the 5-point answer scale in the DEBQ for 
adolescents (“never”, “rarely”, “sometimes”, “often” or “always”). Some children were 
unsure of which option to choose, in the end stating “sometimes” as a neutral answer. This 
may have invalidated the DEBQ (for adolescents) results to a certain extent.    
Patients found it difficult to report on some of the external eating questions such as “do you 
feel like eating when you walk past a snack bar?” This is because some children did not 
know whether food had to be consumed within a specific time frame from when exposed to 
the food cue.  
 
Critical appraisal of the Child Eating Behaviour Questionnaire (CEBQ) 
Parents were confused with the meaning of some of the statements used in the CEBQ. The 
first enjoyment of food statement (“my child loves food”) made parents contemplate 
whether this meant the child likes to eat a lot or just enjoy eating all kinds of food. Many 
parents were very unsure about how to comment on the statement, “if given the choice my 
child would eat most of the time”, as this is based on a hypothetical situation rather than an 
actual experience. Parents found it difficult to comment on item 35 (“my child eats more 
and more slowly throughout a meal”) because this statement describes a progressive action 
that has to be carefully observed, which many parents had never done. It was difficult to 
comment on the statement, “my child eats more when annoyed/ anxious”, because many 
children did not discuss whether they had feelings of angst or annoyance with their parents.   
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Critical appraisal of FCI-II 
As food cravings are a hypothetical construct by definition and are not directly measurable. 
Thus inherent problems can arise in any tool measuring food cravings. The definition of a 
craving used by the food craving inventory (FCI-II) was “an intense desire to consume a 
particular food or food type that is difficult to resist”. Some children asked about how strong 
the desire must be to be defined as a craving, but because further details on this point were 
not delineated in the FCI-II tool the recruiting agent had to provide his own interpretation of 
the question. Many children found it difficult to distinguish the difference between a food 
craving and the actual consumption of food, especially in the younger age group below 10 
years. As the FCI-II is an American based tool, certain food items listed were unfamiliar to 
English cuisine such as “corn bread” of the high fats subscale and “cinnamon rolls” of the 
sweets subscale. Thus for such food items the response was always “has never been 
craved”, which may have slightly invalidated craving results for the corresponding food 
groups. Children had to respond to a 5 point-scale with the options of “never”, “rarely”, 
“sometimes”, “often” and “always/ everyday”. Many children who were unsure of their day 
to day frequency of food cravings chose “sometimes” as a neutral answer, which may have 
invalidated results.            
 
Critical appraisal of the Food Intake Questionnaire (FIQ)      
The FIQ was subject to recall bias. Children found it difficult to recall whether certain foods 
were eaten the day before and many times the parent had to provide help. It is possible that 
the parent provided biased answers by overstating the consumption of healthy “positive 
marker” foods and understating the consumption of unhealthy “negative marker” foods. 
The FIQ has only been used in large sample size studies involving usually greater than 100 
participants. This pilot study was the first to implement the FIQ tool in a small sample size 
with 60 patients. Hence the FIQ may not have been valid or reliable for use in this pilot 
study because its previous applications are based on large scale population samples.     
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Critical appraisal of the CBCL 
The second chapter of the CBCL included questions on whether the child exhibited 
particular signs of behavioural dysfunction. Parents found some of the statements quite 
strange, such as “bowel movements outside the toilet”, and had to clarify their 
interpretation of the question. Some parents of young pre-adolescent boys were unable to 
comment on sexual statements such as “my child thinks about sex too much” or “my child 
suffers from sexual problems”, as this type of information was not usually disclosed to the 
parent.  
 
Critical appraisal of the PedMIDAS tool 
The PedMIDAS tool has been widely used in various headache studies and has been cited as 
a sensitive, reliable and valid measure of headache induced disability185,188. In terms of the 
practicalities of the PedMIDAS there were particular issues raised when used in the clinical 
field that requires discussion.  
The PedMIDAS enquired about the number of days missed from daily social, school and 
domestic activities over the past 3 months. In the early recruitment stages from October 
2009 to November 2009, children had not been at school long enough to report the number 
of headache related school absences in the past 3 months. Hence the PedMIDAS results 
produced from children during the early stages of recruitment may be under represented in 
contrast to those recruited after the November 2009 period.   
The second PedMIDAS question asked about the number of headache related partial day 
school absences. How much of a school day that has to be missed in order to constitute a 
partial day absence was not stated in the PedMIDAS. Many children were sent home just 
before the end of a school day or arrived late. For these reasons many patients found it very 
difficult to answer question two. The recruiting agent had to make a decision to include all 
school days in which the expected number of hours attended in school was affected by 
headaches. However by doing so it is possible that the PedMIDAS scores were 
overestimated. 
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The third question asked “how many days did you function at less than half your ability in 
school due to headaches?” If school performance (i.e. ability to concentrate/focus in the 
classroom and complete work) was affected by headaches, it was difficult to quantify the 
reduction in functionality. Unable to do so, the presence of any headache associated 
functional deterioration was used as a marker for the number of school days the child 
functioned at less than half their ability. However by doing so the answers for question 3 
may have been overstated.      
Question four asked “how many days were you not able to do things at home (i.e. chores, 
homework, etc) due to a headache?” Many children were not accustomed to domestic 
chore work and were thus unable to provide valid response, because an answer of zero 
would not have been a true reflection of what was asked. Alternative activities such as 
reading and social networking were provided. However providing diverse examples of 
domestic activities may have jeopardised the construct validity of question four. 
Question five (“how many days have you been unable to participate in other activities due 
to headaches?”) was found to be clear and well understood. Conversely, in question 6 (“how 
many days did you participate in these other activities but functioned at less than half your 
ability?”) it was again difficult to quantify functionality. All days where functional ability in 
“other activities” was affected by headaches were included in the answer.             
The PedMIDAS required an apt memory of the number of activities affected by headaches in 
the last 3 months, and for this reason was highly subject to recall bias. On numerous 
occasions the child and parent would simply calculate the number of monthly absences and 
then multiply that by 3 to produce a rough estimated answer. Thus the answers provided 
were not always an accurate response to the questions asked.  
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Chapter 4.8  
Adjustments for future study 
In light of the limitations outlined in the previous discussion chapters there are certain 
adjustments and improvements recommended for the main future study on migraines, 
eating behaviours and adiposity, which will now be discussed.     
Only 6 patients in this pilot study suffered from greater than 15 monthly headaches, 
indicating that chronic daily headache migraine patients were under-represented. Only 11 
patients scored a PedMIDAS mark greater than 50 indicating severe migraines were also 
under-represented. Hence the under representation of severe and chronic daily headache 
migraine patients may have reduced the spectrum of migraine disease that was analysed in 
this pilot study. A wider range in disease spectrum that included a high representation of 
mild, moderate and severe migraine patients, may have allowed a more accurate 
assessment of correlation analyses with the eating behaviour and adiposity variables. For 
this reason it would be advisable to recruit a study sample that consists of similar 
proportions of mild, moderate and severe migraine severity, as well as similar proportions 
of chronic daily headache and episodic headache migraine patients. For this to happen, a 
larger sample of patients would need to be recruited.         
The primary study objective to compare eating behaviours between migraine cases and 
non-migraine headache controls could not be fulfilled because an insufficient number of 
non-migraine control patients were recruited. As there was no comparison control group, 
the power to detect a significant relationship between eating behaviours and migraines was 
greatly reduced.   
Previous studies that detected significant associations between migraines and adiposity 
were based on very large sample sizes39-45. Using such a small sample size in this pilot study 
reduced the power to detect any significant results which was a major limitation. Sixty 
patients was considered an appropriate sample size for the primary outcomes of this study 
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and was feasible for the 8 month recruitment phase. However for the main future study a 
larger sample size would be needed to increase the power of the study, calculations for 
which can be seen in table 4.8.1.   
The minimum clinically important difference (MCID) required for sample size calculation was 
based on the restrained eating subscale of the Dutch Eating Behaviour Questionnaire for 
adolescents, because it is the most utilised and validated eating behaviour scale of the DEBQ 
(for adolescents)73. Although the level of restrained eating behaviour may be low in young 
children, it has been evidenced to be high among adolescents, particularly teenage girls74.  
As the future study would assess the relationship between migraines and eating behaviours, 
the MCID would be the minimum difference in restrained eating scores between two 
migraine severity grades (or two headache frequency groups) that represents a clinically 
significant difference in restrained eating levels. Using data from this pilot study two broad 
migraine severity groups were thus created for the purpose of comparing restrained eating 
scores. The PedMIDAS grades I and II were combined to create migraine severity group 1 
(i.e. PedMIDAS scores 0 to 30). The PedMIDAS grades III and IV were then combined to 
create migraine severity group 2 (i.e. PedMIDAS scores greater than 31). The Mann-Whitney 
U test was used to compare the DEBQ (adolescent version) restrained eating scores (that 
were of non-parametric distribution) between these 2 migraine severity groups. As can be 
seen in table 4.8.1 there was no significant difference (p≤ 0.05) in restrained eating raw 
scores between the two migraine severity groups.  
 
Test Statistic DEBQ- Restrained eating raw mean scores 
Mann-Whitney U 94.50 
Wilcoxon W 28.45 
Z-value -0.43 
p-value 0.67 
Table 4.8.1- Mann-Whitney test results for comparison of DEBQ (for adolescsents) 
restrained eating raw scores  
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As this pilot study was the first study ever to investigate eating behaviours and migraines, 
no other data were available from which to extrapolate a minimum clinical difference in 
restrained eating scores with respect to migraines. Consequently a literature search was 
done to find a minimum clinical difference among non-migraine studies. However no study 
was identified that defined what minimum change in DEBQ restrained eating raw scores 
indicated the presence of clinically significant restrained eating behaviour. Although a 
minimum clinical difference has not yet been defined for restrained eating, previous studies 
have demonstrated various differences in DEBQ (adolescence version) restrained eating 
scores that represent clinically significant restrained eating behaviour (these can be seen in 
table 4.8.2). The studies from which the MCID values listed in table 4.8.2 were extrapolated 
are now discussed.  
The MCID in mean DEBQ (adolescent version) restrained eating raw scores between obese 
and non-obese female college students (mean age = 23 years) in a study by Allison et al was 
0.1236. In another study by Halvarsson et al237 (sample= 117 girls aged 9 to 10 years) the 
clinically significant difference in DEBQ (adolescent version) restrained eating raw scores 
between groups of dieters and non-dieters was 0.7. It is purported that migraine will not 
have as strong an effect on restrained eating as dieting behaviour, so the MCID will be less 
than 0.7, but greater than 0.1. Following discussions with the statistician involved in the 
pilot study it has been decided to use a range of different MCID values to calculate different 
sample sizes. The values used for the minimum clinically important difference in restrained 
eating scores ranged from 0.1 to 0.7. The software “Stats Direct” was used to calculate the 
estimated sample based on a power of 0.8, alpha value (p-value) of 0.05 and a standard 
deviation of 0.96 (this was the s.d value for the DEBQ for adolescents restrained eating raw 
scores from this pilot study).     
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MCID 
(based on  mean DEBQ for adolescents restrained eating raw scores) 
No. of controls 
 
No. of cases 
 
0.1 1448 1448 
0.2 363 363 
0.3 162 162 
0.4 92 92 
0.5 59 59 
0.6 42 42 
0.7 31 31 
Table 4.8.2- Sample size calculations based on different MCID values  
Power= 0.8, Alpha (P-value) = 0.05, Standard Deviation= 0.96 
 
Given that the recommended target sample size calculation will be based on an estimate of 
what is considered the MCID in restrained eating scores among migraine patients, there is 
no way to prove what the exact sample size should be for the main future study. Instead the 
aim is to ensure that the sample size chosen is based on a calculation from the most 
appropriate MCID value. The largest sample calculated which is practically achievable for 
recruitment is one of the criteria for choosing the most appropriate sample size for the main 
future study. Given that the MCID is purported to be below the level of 0.7 (as defined by 
Halvarsson et al237), but greater than the value of 0.1 (as defined by Allison et al236), a value 
of 0.3 would seem an appropriate estimate for the MCID value.  As outlined in table 4.8.2, a 
sample size calculation based on a MCID value of 0.3 produces an estimated sample of 162 
migraines cases and 162 controls. This is a large population size which would be feasible to 
recruit over a 2 year period (roughly 6 to 7 patients a month would have to be recruited). 
For these reasons it is recommended that for the main future study, a sample of 162 
migraine cases and 162 controls be used as a target sample size.     
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The majority of headache patients referred to clinics at Alder Hey children’s Hospital 
suffered from migraine. There was a lack of patients that fitted the control criteria for a non-
migraine headache diagnosis and consequently enough control patients were not available 
for recruitment. For the future study it would be recommended to use a different target 
population from which to select control non-migraine patients. To avoid possible 
neurobiological overlap between migraines and non-migraine headaches14, a suitable 
alternative would be to use headache free subjects as controls. This would mean expanding 
the study to include the recruitment of normal (headache-free) controls matched for age 
and sex from a school local to each migraine case. 
There were many instances when numerous patients eligible for recruitment attended 
different clinics at the same time. Considering there was only one recruiting agent, it was 
not possible to recruit numerous patients all at once and in addition there was a lack of 
facilities (few rooms were available to accommodate the simultaneous recruitment of more 
than one patient). To help resolve this issue in the main future study, it would be 
recommended to have more than one recruiting agent and more rooms available for 
recruitment to take place. This would to allow the simultaneous recruitment of numerous 
patients.     
There was a 28% refusal rate for patients approached to participate in this pilot study, which 
prolonged the time taken to recruit the target 60 migraine patients. The primary reason why 
26 patients were unable to take part in the study was because parents were unable to spare 
45 minutes for the recruitment phase. Some parents recommended that the researcher 
could make a home visit for patient recruitment. Although this is a possibility for the main 
future study, this method of home recruitment would be very time consuming and would 
require a more complicated revision of the study ethics approval.     
Height and weight as used to calculate BMI was convenient but not necessarily the most 
accurate measure of adiposity in such a small population study200. With adequate funding 
more robust adiposity measurement techniques such as abdominal visceral fat MRI 
scanning could have been used, which is a relatively safe gold standard for determining 
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adiposity levels195. If this were to be incorporated into the future study design, more funding 
would be required and greater time investment needed per patient at recruitment.  
The FIQ was not the most robust method of assessment of daily food intake because 
children were highly susceptible to recall bias when reporting on the FIQ. A prospective 
method of assessment of food intake such a food diary would avoid the problem of recall 
bias because patients would hopefully keep a record of foods eaten as they are eaten at 
each mealtime. Hence for the future study it is recommended that patients keep a 
prospective dietary record (food diary) of foods eaten each day167. As food diaries can be 
quite demanding of subjects, initial records are quite complete but this soon starts to 
deteriorate as time progresses238. To help avoid this it would be advisable to keep a food 
diary for only a short space of time (e.g. 5 days) which includes at least a weekend day 
(because food consumption on the weekend is usually different to that on a weekday238). 
Using this method of assessment for food intake would require following up each patient 
upon completion of the food diary and hence a longer duration of study period would be 
required. This method might provide more robust data with regards to exact types and 
amounts of foods eaten as well as the calculation of specific nutritional intake167.         
Based on the evidence to suggest a neurobiological overlap between migraines, appetite 
and adiposity, a study is needed to investigate the role of eating behaviours as a function of 
migraine pathology118. For this to be feasible a reliable and valid biomarker for migraine 
severity is required. Given that calcitonin gene related peptide levels increase during acute 
migraine attacks119, CGRP could be used as a biomarker of migraine severity. Serum leptin 
levels as a biomarker for appetite could then be assessed for associations with CGRP levels 
alongside eating behaviours monitored in an ingestive laboratory122. As the hypothalamus is 
a common site of expression for neuropeptides involved in appetite and migraines, a future 
study could investigate the relationship between hypothalamic activity, serum CGRP/leptin 
levels, eating behaviours and migraine severity124,125. However these methods would involve 
using laboratory based methods for tracking biomarker levels and expensive neuro-imaging 
techniques (e.g. PET scans)124 for identifying hypothalamic activity.                
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To find a significant relationship between migraines, eating behaviours and adiposity a 
prospective follow up of patients over a long term period of time may be required. No study 
has ever investigated the long term follow up of migraine patients to assess adiposity levels. 
The “Avon Longitudinal Study of Parents and Children” (ASPAC) initially set up in 1991 at 
Bristol University have followed up children from 14,000 pregnant women since birth. It 
contains data from two family generations. It has gathered information on all-of-life data 
including repeated measures of height, weight, dietary intake, social circumstances, medical 
conditions including recurrent headaches disorders such as migraines, and biophysical 
measures of physical activity and adiposity. Researchers of the ALSPAC study have already 
been contacted about sharing data on migraines, adiposity and diet to compare with data in 
the main future study. As the ASLPAC study has recorded data since birth, the temporal 
relationship between migraine development and obesity onset can be analysed whilst 
identifying confounding factors239.      
This cross-sectional pilot study found that the CEBQ desire to drink subscale had a weak but 
significantly positive correlation with the PedMIDAS scores and the FIQ negative marker 
subscale scores had a weak but significantly positive correlation with monthly headache 
frequency. Both the internalising subscale of the CBCL and the total CBCL scale had a weak 
but significantly positive correlation with the PedMIDAS scores and BMI z-scores. Eating 
behaviours, food cravings and adiposity shared no significant relationship with either of the 
migraine measures used in this pilot study (migraine severity/monthly headache frequency). 
Although no firm conclusions can be drawn due to limitations in the methodology, this pilot 
study provides a foundation for future research on migraines, eating behaviours, thirst 
levels and food intake.  
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Chapter 5.1.0- Appendix 
Chapter 5.1.1a 
Search strategy used to identify headache-obesity studies reviewed 
in chapter 1.1 (Migraines- Migraine and adiposity). 
 
 
Articles were searched using the various electronic data bases listed in table 5.1. MeSH 
terms (see table 5.2) were used to begin broad searches for any current literature available 
on headaches and obesity. The results from various MeSH terms were later combined to 
provide a more narrow and focussed search strategy. For example the following MeSH 
terms were combined; “migraine”, “headaches” and “obesity” to gain search results for 
studies which contained all three key items (see tables 5.3 and 5.4).        
 
 
Resources Description 
Data base searches 
Medline was searched using:  
Ovid,  
Pub med and the  
BMA's search engine. 
Secondary sources 
Cochrane library,  
Google Scholar,  
Books from University of Liverpool library and 
Internet resources. 
Cross referencing 
Reference lists from review articles were used to find the 
desired journals. 
 
Electronic online journals 
These were searched by accessing the specific journal 
contents, using the library catalogue at Liverpool University. 
Table 5.1- Resources used to search for headache-obesity studies 
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MeSH terms Limits applied 
Headache Full text + 1990-2010 
Migraine Full text + 1990-2010 
Obesity Full text + 1990-2010 
Adiposity Full text + 1990-2010 
Children/ Paediatric Full text + 1990-2010 
Chronic daily headache Full text + 1990-2010 
Appetite Full text + 1990-2010 
Table 5.2- MeSH terms used to search for headache-obesity articles 
 
 
 
# Search History Results Display 
1 Migraine.mp. [mp=title, abstract, full text, caption text] 7692  DISPLAY  
2 limit 1 to yr="2000 - 2010" 492  DISPLAY  
3 Headache.mp. [mp=title, abstract, full text, caption text] 13020  DISPLAY  
4 limit 3 to yr="2000 - 2010" 9731  DISPLAY  
5 Obesity.mp. [mp=title, abstract, full text, caption text] 8820  DISPLAY  
6 limit 5 to yr="2000 - 2010" 5964  DISPLAY  
7 Adiposity] 749  DISPLAY  
8 limit 7 to yr="2000 - 2010" 52  DISPLAY  
Table 5.3- Number of hits displayed for each MeSH term used 
 
 
 
# Search History Results Display 
9 2 or 4 13674  DISPLAY  
10 6 or 8   82  DISPLAY  
11 9 and 10 46  DISPLAY  
Table 5.4- Number of hits displayed for each MeSH term used 
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Chapter 5.1.1b  
The STROBE criteria 
  
Criteria Item No Recommendation 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 
(b) Provide in the abstract an informative and balanced summary of what was done and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data 
collection 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of participants 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if 
applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe 
comparability of assessment methods if there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and 
why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 
(d) If applicable, describe analytical methods taking account of sampling strategy 
(e) Describe any sensitivity analyses 
Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, 
confirmed eligible, included in the study, completing follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential 
confounders 
(b) Indicate number of participants with missing data for each variable of interest 
Outcome data 15* Report numbers of outcome events or summary measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence 
interval). Make clear which confounders were adjusted for and why they were included 
(b) Report category boundaries when continuous variables were categorized 
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and 
magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from 
similar studies, and other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on 
which the present article is based 
Table 5.5- Criteria used to review the headache-obesity studies in chapter 1.1.1 as adapted 
from the STROBE criteria 
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Chapter 5.1.2 
Patient information sheet 
 
A study on the link between migraine, appetite behaviours and obesity. 
 
We would like to invite you and your child to participate in our research study. Before you 
decide to participate, we shall explain below why we are doing this study, and what it will 
involve for you and your child. 
Please take time to read the following information and discuss it with others if you wish. 
You can ask us for further information (see contact details at the end of this sheet). 
 
Why are we doing this study?  
Migraine can be a very disabling disease, and it is very common in children. There has 
recently been research in adults to suggest there is a link between severe migraine and 
obesity, which can cause worse headaches. Obesity is becoming very common in children, 
with 25% of children classified as obese. We therefore think it is important to investigate if 
severe migraine can cause poor eating in children leading to obesity. We aim to see if 
particular appetite behaviours can be seen in migraine patients, so that they can be 
addressed, and doctors can devise ways in which to change them to prevent the onset of 
obesity and worsening the migraine.  
 
Why have you and your child been chosen? 
Based on the records at Alder Hey Children’s Hospital, your child was noted to either have 
suspected migraine or have been diagnosed with migraine. You may remember meeting the 
leader of this study (Dr Ram Kumar) at a previous clinic appointment for your child’s 
headache. We would like some information on how your child is doing from a health and 
education point-of-view. 
 
Do I have to take part? 
It is up to you whether you take part in this research study. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If you 
decide to take part you are still free to withdraw at any time and without giving a reason.  A 
decision to withdraw at any time, or a decision not to take part, will not affect any future 
medical care. 
 
What do my child and I have to do if we take part? 
We would like to invite you to attend the neurology department for a clinic appointment 
with the researchers. Whilst your child is attending for their appointment with the 
consultant, either prior to or after the appointment, the researcher will take you into a 
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separate room, where firstly he will explain what the research is about and why we would 
like your child to be involved. Then we will explain the types of questions we are going to 
ask you and your child. Then we will ask you if you have any questions. Then we would ask 
whether you would like to take part. If you agree to do so, we will ask you, and your child to 
sign a consent form. Then we will ask you and your child all the questions from the 
questionnaires. This will take no more than one hour to complete. This is all we need you to 
do, once the study is finished, if you should wish, we will send you results of the study.  
 
What are the possible benefits of taking part? 
You and your child will be contributing to improving the care and health of other children in the 
future who are also diagnosed with migraine.  
 
What are the possible disadvantages and risks of taking part? 
We do not foresee any disadvantage to you or your child if you decide to take part in the study. 
There are no risks involved to you or your child, and no pain or discomfort will be caused. If you or 
your child become upset by any of the issues that arise from the questionnaires the consultant will 
happily give you counselling about them. Furthermore, if you have any concerns about the way in 
which you were approached or treated throughout the course of the research you can contact the 
hospital research department to voice your concerns (Details below). 
 
Will my taking part in this study be kept confidential? 
We will keep all records from your child’s questionnaire confidential. Only the named members (at 
the end of this sheet) of the research study team will have access to the records. 
 
What will happen to the results of the research study? 
We will analyse the results from all the participants in this study at the end of the study period. We 
will publish a report on our conclusions in a well-reviewed medical journal. In addition, we will send 
you a copy of the report if you would like one. 
 
Who is organising and funding the research? 
This research study has been organised by the paediatric neurology department, Alder Hey 
Children’s NHS Foundation Trust. There is no external funding for this study; the primary researcher 
has been funded to conduct the study by the Neurodisability trust.  
 
Who has reviewed the study? 
The Cheshire Research Ethics Committee has reviewed this study. 
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Chapter 5.1.3 
Migraine pro-forma 
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Chapter 5.1.4 
Children’s Eating Behaviour Questionnaire (CEBQ) 
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Chapter 5.1.5a  
Dutch Eating Behaviour Questionnaire (DEBQ) for adolescents (12- 16 years) 
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Chapter 5.1.5b 
Children’s Dutch Eating Behaviour Questionnaire (DEBQ-C) 
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Chapter 5.1.6  
Food Intake Questionnaire (FIQ) 
 
 
 
Liverpool John Moores University 
Faculty of Education, Community and Leisure 
Centre for Consumer Education & Research 
What did YOU eat and drink yesterday? 
These questions are very important.  Please answer them very carefully. 
   All your answers will be kept secret.     Please leave blank: 
ID:  [   ] [  ] [  ] [  ] [  ] 
Date:    ___________, 200_             [   ] [  ] [  ] [  ] [  ] 
 
About yourself: 
What is your name? (eg Alex Smith)   ___________________________ 
 
How old are you (numbers only)?   ___________________________ 
 
Are you a boy or a girl (B or G)?   ___________________________ 
 
What is your postcode (e.g. L23 6JT)?  ___________________________ 
 
What school do you go to?    ___________________________ 
 
Do you get a free school meal? (Please tick the box)                Yes [  ] No [  ] 
 
Please tick a box to answer Yes or No or leave box empty. 
 
Yesterday, did you have anything at all:      Yes No 
 to eat or drink before leaving home to come to school?   [  ]  [  ] 
 to eat or drink on your way to school?      [  ]  [  ] 
 
Yesterday, did you: 
 Eat or drink nothing at lunch time?      [  ] [  ] 
 Eat a school lunch?       [  ]  [  ] 
 Eat a packed lunch from home?      [  ]  [  ] 
 Go home for your lunch?        [  ]  [  ] 
 Eat out of school but not at home?       [  ]  [  ] 
 
 
 
Did you at any time yesterday eat any amount of any of the following: 
Breakfast cereals: 
Frosties or Sugar Puffs, Ricicles, Coco Pops?   Negative Sugary  [  ]  [  ] 
Branflakes or Weetabix, Allbran, Branbuds, Sultana Bran, Fruit 'n' fibre? Positive Fibrous [  ]  [  ] 
Muesli or Shredded Wheat, Porridge, Ready Brek?  Positive Fibrous  [  ]  [  ] 
Rice Krispies or Cornflakes, Puffed Wheat, Pufa Pufa Rice?  *****  [  ]  [  ] 
 
Bread: 
White bread (slices or buns)?    *****   [  ]  [  ] 
Brown or wholemeal bread any type (slices or buns)?  Positive Fibrous  [  ]  [  ] 
 
Butter or margarine (including on bread, crispbread, potatoes or vegetables etc)? 
     If you had any butter or margarine yesterday do you think that it was: 
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 Butter:       Negative Fatty [  ]  [  ] 
 Hard margarine: eg Stork, Echo?    Negative Fatty [  ]  [  ] 
 Ordinary soft margarine: eg Blue Band, Summer County? Negative Fatty [  ] [  ] 
 Polyunsaturated spread: eg Vitalite or Flora?   Positive  [  ]  [  ] 
 Low fat spread: eg Outline, Gold, Freeway, Hi-life or Delight? Positive  [  ]  [  ]
Did you at any time yesterday eat any amount of any of the following:  Yes No 
 
Biscuits: 
Plain biscuits eg malted milk, Digestives, Rich Tea etc? Negative Sugary  [  ]  [  ] 
Any biscuits which were covered all over in chocolate: eg  Kit-Kat, Penguin, United etc? 
Negative Sugary   [  ]  [  ] 
 
Cakes and puddings: 
Any sort of cake, Swiss roll (plain or chocolate), doughnuts Negative Sugary  
 scones, individual pies, jam tarts, custard tarts etc?    [  ]  [  ] 
Any sort of pudding: Fruit pie, sponge pudding, tinned fruit, jelly, trifle, lemon meringue, 
 cheesecake, milk pudding (like rice, semolina, tapioca, custard etc) etc? Negative Sugary  [  ] 
 
Sweets & chocolates: 
Sweets such as: boiled sweets, fruit gums or pastilles, liquorice, Negative Sugary  
 jelly sweets, chews, toffees, chewing gum etc?    [  ]  [  ] 
Chocolates or chocolate bars like: Quality Street, Rolos, Mars Bar, Twix? Negative Sugary[  ]  [  ] 
Ice cream, choc-ices, ice lollies, ice-pops? Negative Sugary    [  ]  [  ] 
 
Sugar: 
Sugar (white or brown) in any drink such as tea, coffee, cocoa etc Negative Sugary [  ]  [  ] 
Sugar (white or brown) on any food such as cornflakes or pancakes? Negative Sugary [  ]  [  ] 
An artificial sweetener (like saccharin, sweetex, sweet'n'low, canderel etc)? Positive [  ]  [  ] 
 
Potatoes: 
Boiled potatoes?   *****      [  ]  [  ] 
Mashed potatoes?  *****      [  ]  [  ] 
Baked or jacket potatoes?  Positive  High fibre   [  ]  [  ] 
Roast potatoes?   Negative Fatty     [  ]  [  ] 
Chips?    Negative Fatty     [  ]  [  ] 
Crisps (any type or flavour)? Negative Fatty     [  ]  [  ] 
 
Fruit: 
Any fresh fruit such as apples, oranges (any type), pears, bananas, plums etc? Positive [  ]  [  ] 
 
Vegetables: 
Baked beans?   *****      [  ]  [  ] 
Any type of salad such as:  celery, tomatoes, lettuce, cucumber, celery etc? Positive [  ]  [  ] 
Any fried vegetables eg  Fried onions, fried mushrooms or fried tomatoes etc? Negative Fatty[  ] [ ] 
Any other vegetables eg Peas, cabbage, carrots, leeks, green beans, kidney beans, Positive 
 parsnips, tinned tomatoes, cauliflower, leeks, turnips or sprouts etc?  [  ]  [  ] 
 
Meat 
Ordinary burger?   Negative Fatty     [  ]  [  ] 
Ordinary sausages?  Negative Fatty       [  ]  [  ] 
Low fat burger?   Positive      [  ]  [  ] 
Low fat sausages?  Positive      [  ]  [  ] 
Meat pie, Cornish pastie or sausage roll etc? Negative Fatty   [  ]  [  ] 
Any other type of meat eg Minced meat, steak, ham, chicken etc?   [  ]  [  ] 
 
Fish 
Fish fried in batter?   Negative Fatty    [  ]  [  ] 
Any other types fish eg fish fingers or tinned - sardines, tuna, pilchards, etc? Positive [  ]  [  ] 
Did you at any time yesterday eat any amount of any of the following:  Yes No 
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Eggs 
Boiled or Poached??        [  ]  [  ] 
Scrambled or Fried?  Negative Fatty     [  ]  [  ] 
 
Cheese 
Cheese eg Cheddar, Leicester, Cheshire?  Negative Fatty   [  ] [  ] 
Soft cheese eg Philadelphia, Dairy Lea?  Negative Fatty   [  ]  [  ] 
Low fat cheese eg Shape or Philidelphia lite? Positive     [  ] [  ] 
 
Take-away food 
Chip shop food or Chinese, Indian, Curries, Pizza, Kebabs etc? Negative Fatty [  ]  [  ] 
 
Did you put any Salt on your food?   Negative   [  ]  [  ] 
 
Fizzy drinks (like: lemonade, soda stream, Coca-Cola, Pepsi, 7-UP, Fanta etc): 
If you had any fizzy drink yesterday do you think that it was: 
 Diet or low calorie sort of fizzy drink? Positive    [  ]  [  ] 
 Regular or ordinary fizzy drink?  Negative Sugary   [  ]  [  ] 
 
Still cordials (which you add water to like: orange squash, Ribena, Barley water etc)? 
If you had any still cordial yesterday do you think that it was: 
 Diet or low calorie sort of still drink? Positive    [  ]  [  ]  Regular or 
ordinary still drink?  Negative Sugary   [  ]  [  ] 
 
Milk (including milk in tea, coffee, milkshakes, flavoured milk, cocoa or on cereals etc)? 
If you had any milk yesterday do you think that it was: 
 Ordinary full fat milk?   Negative Fatty   [  ]  [  ] 
 Semi-skimmed or skimmed milk?  Positive    [  ]  [  ] 
 
Water      Positive    [  ]  [  ] 
 
Alcoholic drinks: 
Beer, lager or cider        [  ]  [  ] 
Wine          [  ]  [  ] 
Sherry, Port, Martini, Cinzano, Pony, Cherry-B     [  ]  [  ] 
Spirits such as whiskey, gin, brandy, vodka, rum Bacadi or Pernod   [  ]  [  ] 
 
Many Thanks For Your Help! 
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Chapter 5.1.7  
Food Cravings Inventory (FCI-II) 
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Chapter 5.1.8  
Child Behaviour Checklist (CBCL) tool 
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Appendix 5.1.9  
The International Classification of Headache Disorders 
Second Edition  
(ICHD-II) 
 
1. MIGRAINE 
 1.1 Migraine without aura 
 1.2 Migraine with aura 
1.2.1 Typical aura with migraine headache 
1.2.2 Typical aura with non-migraine headache 
1.2.3 Typical aura without headache 
1.2.4 Familial hemiplegic migraine (FHM) 
1.2.5 Sporadic hemiplegic migraine 
1.2.6 Basilar-type migraine 
 1.3 Childhood periodic syndromes that are commonly precursors of migraine 
1.3.1 Cyclical vomiting 
1.3.2 Abdominal migraine 
1.3.3 Benign paroxysmal vertigo of childhood 
 1.4 Retinal migraine 
 1.5 Complications of migraine 
1.5.1 Chronic migraine 
1.5.2 Status migrainosus 
1.5.3 Persistent aura without infarction 
1.5.4 Migrainous infarction 
1.5.5 Migraine-triggered seizures 
 1.6 Probable migraine 
1.6.1 Probable migraine without aura 
1.6.2 Probable migraine with aura 
1.6.5 Probable chronic migraine 
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Coded elsewhere: 
Migraine-like headache secondary to another disorder (symptomatic migraine) is coded 
according to the disorder. 
 
General comment 
Primary or secondary headache or both? 
When a headache with migraine characteristics occurs for the first time in close temporal 
relation to another disorder that is a known cause of headache, it is coded according to the 
causative disorder as a secondary headache. When pre-existing migraine is made worse in 
close temporal relation to another disorder that is a known cause of headache, there are 
two possibilities, and judgment is required. The patient can either be given only the 
migraine diagnosis or be given both the migraine diagnosis and a secondary headache 
diagnosis according to the other disorder. Factors that support adding the latter diagnosis 
are: a very close temporal relation to the disorder, a marked worsening of the migraine, 
very good evidence that the disorder can cause or aggravate migraine, and improvement or 
resolution of migraine after relief from the disorder. 
 
Introduction  
Migraine is a common disabling primary headache disorder. Epidemiological studies have 
documented its high prevalence and high socio-economic and personal impacts. It is now 
ranked by the World Health Organization as number 19 among all diseases world-wide 
causing disability. 
Migraine can be divided into two major sub-types. 1.1 Migraine without aura is a clinical 
syndrome characterised by headache with specific features and associated symptoms. 1.2 
Migraine with aura is primarily characterised by the focal neurological symptoms that 
usually precede or sometimes accompany the headache. Some patients also experience a 
premonitory phase, occurring hours or days before the headache, and a headache 
resolution phase. Premonitory and resolution symptoms include hyperactivity, hypoactivity, 
depression, craving for particular foods, repetitive yawning and other less typical symptoms 
reported by some patients. 
When a patient fulfils criteria for more than one subtype of migraine, all subtypes should be 
diagnosed and coded. For example, a patient who has frequent attacks with aura but also 
some attacks without aura should be coded as 1.2 Migraine with aura and 1.1 Migraine 
without aura. 
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1.1 Migraine without aura 
Previously used terms: 
Common migraine, hemicrania simplex 
Description: 
Recurrent headache disorder manifesting in attacks lasting 4-72 hours. Typical 
characteristics of the headache are unilateral location, pulsating quality, moderate or severe 
intensity, aggravation by routine physical activity and association with nausea and/or 
photophobia and phonophobia. 
Diagnostic criteria: 
A. At least 5 attacks1 fulfilling criteria B-D 
B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated)2;3;4 
C. Headache has at least two of the following characteristics: 
1. unilateral location5;6 
2. pulsating quality7 
3. moderate or severe pain intensity 
4. aggravation by or causing avoidance of routine physical activity (eg, walking 
or climbing stairs) 
D. During headache at least one of the following: 
1. nausea and/or vomiting 
2. photophobia and phonophobia8 
E. Not attributed to another disorder9 
 
 
 
Notes: 
 Differentiating between 1.1 Migraine without aura and 2.1 Infrequent episodic tension-
type headache may be difficult. Therefore at least 5 attacks are required. Individuals who 
otherwise meet criteria for 1.1 Migraine without aura but have had fewer than 5 attacks 
should be coded 1.6.1 Probable migraine without aura. 
 When the patient falls asleep during migraine and wakes up without it, duration of the 
attack is reckoned until the time of awakening. 
 In children, attacks may last 1-72 hours (although the evidence for untreated durations 
of less than 2 hours in children requires corroboration by prospective diary studies). 
 When attacks occur on 15 days/month for >3 months, code as 1.1 Migraine without 
aura and as 1.5.1 Chronic migraine. 
 Migraine headache is commonly bilateral in young children; an adult pattern of 
unilateral pain usually emerges in late adolescence or early adult life. 
 Migraine headache is usually frontotemporal. Occipital headache in children, whether 
unilateral or bilateral, is rare and calls for diagnostic caution; many cases are attributable to 
structural lesions. 
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 Pulsating means throbbing or varying with the heartbeat. 
 In young children, photophobia and phonophobia may be inferred from their behaviour. 
 History and physical and neurological examinations do not suggest any of the disorders 
listed in groups 5-12, or history and/or physical and/or neurological examinations do 
suggest such disorder but it is ruled out by appropriate investigations, or such disorder is 
present but attacks do not occur for the first time in close temporal relation to the disorder. 
 
Comments: 
1.1 Migraine without aura is the commonest subtype of migraine. It has a higher average 
attack frequency and is usually more disabling than 1.2 Migraine with aura. 
Migraine without aura often has a strict menstrual relationship. In contrast to the first 
edition of The International Classification of Headache Disorders, this edition gives criteria 
for A1.1.1 Pure menstrual migraine and A1.1.2 Menstrually-related migraine, but in the 
appendix because of uncertainty over whether they should be regarded as separate entities. 
Very frequent migraine attacks are now distinguished as 1.5.1 Chronic migraine provided 
that there is no medication overuse. Migraine without aura is the disease most prone to 
accelerate with frequent use of symptomatic medication, resulting in a new headache which 
is coded as 8.2 Medication-overuse headache. 
Regional cerebral blood flow shows no changes suggestive of cortical spreading depression 
during attacks of migraine without aura although blood flow changes in the brainstem may 
occur, as may cortical changes secondary to pain activation. This contrasts with the 
pathognomonic spreading oligaemia of migraine with aura. In all likelihood spreading 
depression is therefore not involved in migraine without aura. On the other hand the 
messenger molecules nitric oxide (NO) and calcitonin-gene-related peptide (CGRP) are 
clearly involved. While the disease was previously regarded as primarily vascular, the 
importance of sensitisation of perivascular nerve terminals, and the possibility that attacks 
may originate in the central nervous system, have gained increasing attention over the last 
decades. At the same time the circuitry of migraine pain and several aspects of 
neurotransmission in this system have been recognised. A significant contribution has been 
made by the advent of the triptans, 5HT1B/D receptor agonists. These drugs have remarkable 
efficacy in acute attacks and, in view of their high receptor-specificity, their mechanism of 
action provides new insight into migraine mechanisms. It is now clear that migraine without 
aura is a neurobiological disorder and clinical as well as basic neuroscience currently 
advances our knowledge of migraine mechanisms at an increasing speed. 
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1.2 Migraine with aura 
Previously used terms: 
Classic or classical migraine, ophthalmic, hemiparaesthetic, hemiplegic or aphasic migraine, 
migraine accompagnée, complicated migraine 
 
 
Coded elsewhere: 
13.17 Ophthalmoplegic “migraine”. 
Description: 
Recurrent disorder manifesting in attacks of reversible focal neurological symptoms that 
usually develop gradually over 5-20 minutes and last for less than 60 minutes. Headache 
with the features of migraine without aura usually follows the aura symptoms. Less 
commonly, headache lacks migrainous features or is completely absent. 
Diagnostic criteria: 
A. At least 2 attacks fulfilling criterion B 
B. Migraine aura fulfilling criteria B and C for one of the subforms 1.2.1-1.2.6 
C. Not attributed to another disorder1 
 
Note: 
1. History and physical and neurological examinations do not suggest any of the 
disorders listed in groups 5-12, or history and/or physical and/or neurological 
examinations do suggest such disorder but it is ruled out by appropriate 
investigations, or such disorder is present but attacks do not occur for the first time 
in close temporal relation to the disorder. 
Comments: 
The aura is the complex of neurological symptoms that occurs just before or at the onset of 
migraine headache. Most patients with migraine have exclusively attacks without aura. 
Many patients who have frequent attacks with aura also have attacks without aura (code as 
1.2 Migraine with aura and 1.1 Migraine without aura). 
Premonitory symptoms occur hours to a day or two before a migraine attack (with or 
without aura). They include various combinations of fatigue, difficulty in concentrating, neck 
stiffness, sensitivity to light or sound, nausea, blurred vision, yawning and pallor. The terms 
prodrome and warning symptoms are best avoided because they are often mistakenly used 
to include aura. 
The majority of migraine auras are associated with headache fulfilling criteria for 1.1 
Migraine without aura. For this reason the entity 1.2.1 Typical aura with migraine headache 
has been singled out below. Migraine aura is sometimes associated with a headache that 
does not fulfil criteria for migraine without aura and, in other cases, migraine aura may 
occur without headache. These two subforms are also now distinguished. 
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Aura with similar features has also been described in association with other well-defined 
headache types, including cluster headache; the relationships between aura and headache 
are not fully understood. 
Before or simultaneously with the onset of aura symptoms, regional cerebral blood flow is 
decreased in cortex corresponding to the clinically affected area and often including an even 
wider area. Blood flow reduction usually starts posteriorly and spreads anteriorly and is 
usually above the ischaemic threshold. After one to several hours, gradual transition into 
hyperaemia occurs in the same region. Cortical spreading depression of Leão has been 
implicated. 
Systematic studies have demonstrated that many patients with visual auras occasionally 
have symptoms in the extremities. Conversely patients with symptoms in the extremities 
virtually always also suffer visual aura symptoms. A distinction between migraine with visual 
aura and hemiparaesthetic migraine is probably artificial and therefore is not recognised in 
this classification. Patients with motor weakness are classified separately because of the 
dominantly inherited form, 1.2.4 Familial hemiplegic migraine, and because of clinical 
differences. The genetic relationship between migraine with aura and familial hemiplegic 
migraine has not been established. 
The previously-defined syndromes migraine with prolonged aura and migraine with acute-
onset aura have been abandoned. The great majority of patients with such attacks have 
other attacks that fulfil criteria for one of the subforms of 1.2 Migraine with aura and should 
be coded to that diagnosis. The rest should be coded to 1.6.2 Probable migraine with aura, 
specifying the atypical feature (prolonged aura or acute-onset aura) in parenthesis. 
 
 
 
 
1.2.1 Typical aura with migraine headache 
Description: 
Typical aura consisting of visual and/or sensory and/or speech symptoms. Gradual 
development, duration no longer than one hour, a mix of positive and negative features and 
complete reversibility characterise the aura which is associated with a headache fulfilling 
criteria for 1.1 Migraine without aura. 
Diagnostic criteria: 
A. At least 2 attacks fulfilling criteria B–D 
B. Aura consisting of at least one of the following, but no motor weakness: 
 fully reversible visual symptoms including positive features (eg, flickering 
lights, spots or lines) and/or negative features (ie, loss of vision) 
 fully reversible sensory symptoms including positive features (ie, pins and 
needles) and/or negative features (ie, numbness) 
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 fully reversible dysphasic speech disturbance 
C. At least two of the following: 
1. homonymous visual symptoms1 and/or unilateral sensory symptoms 
2.  at least one aura symptom develops gradually over 5 minutes and/or 
different aura symptoms occur in succession over 5 minutes 
3. each symptom lasts 5 and 60 minutes 
D. Headache fulfilling criteria B-D for 1.1 Migraine without aura begins during the aura 
or follows aura within 60 minutes 
E. Not attributed to another disorder2 
 
Notes: 
1. Additional loss or blurring of central vision may occur. 
2. History and physical and neurological examinations do not suggest any of the 
disorders listed in groups 5-12, or history and/or physical and/or neurological 
examinations do suggest such disorder but it is ruled out by appropriate 
investigations, or such disorder is present but attacks do not occur for the first time 
in close temporal relation to the disorder. 
 
 
 
Comments: 
This is the most common migraine syndrome associated with aura. The diagnosis is usually 
evident after a careful history alone though there are rare secondary mimics including 
carotid dissection, arteriovenous malformation and seizure. 
Visual aura is the most common type of aura, often presenting as a fortification spectrum, 
ie, a zigzag figure near the point of fixation that may gradually spread right or left and 
assume a laterally convex shape with an angulated scintillating edge leaving variable 
degrees of absolute or relative scotoma in its wake. In other cases, scotoma without positive 
phenomena may occur; this is often perceived as being of acute onset but, on scrutiny, 
usually enlarges gradually. Next in frequency are sensory disturbances in the form of pins 
and needles moving slowly from the point of origin and affecting a greater or smaller part of 
one side of the body and face. Numbness may occur in its wake, but numbness may also be 
the only symptom. Less frequent are speech disturbances, usually dysphasic but often hard 
to categorise. If the aura includes motor weakness, code as 1.2.4 Familial hemiplegic 
migraine or 1.2.5 Sporadic hemiplegic migraine. 
Symptoms usually follow one another in succession beginning with visual, then sensory 
symptoms and dysphasia, but the reverse and other orders have been noted. Patients often 
find it hard to describe their symptoms in which case they should be instructed in how to 
time and record them. After such prospective observation the clinical picture often becomes 
clearer. Common mistakes are incorrect reports of lateralisation of headache, of sudden 
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onset when it is gradual and of monocular visual disturbances when they are homonymous, 
as well as incorrect duration of aura and mistaking sensory loss for weakness. After an initial 
consultation, use of an aura diary may clarify the diagnosis. 
1.2.2 Typical aura with non-migraine headache 
Description: 
Typical aura consisting of visual and/or sensory and/or speech symptoms. Gradual 
development, duration no longer than one hour, a mix of positive and negative features and 
complete reversibility characterise the aura which is associated with a headache that does 
not fulfil criteria for 1.1 Migraine without aura. 
Diagnostic criteria: 
A. At least 2 attacks fulfilling criteria B–D 
B. Aura consisting of at least one of the following, but no motor weakness: 
1. fully reversible visual symptoms including positive features (eg, flickering 
lights, spots or lines) and/or negative features (ie, loss of vision) 
2. fully reversible sensory symptoms including positive features (ie, pins and 
needles) and/or negative features (ie, numbness) 
3. fully reversible dysphasic speech disturbance 
C. At least two of the following: 
1. homonymous visual symptoms1 and/or unilateral sensory symptoms 
2.  at least one aura symptom develops gradually over 5 minutes and/or 
different aura symptoms occur in succession over 5 minutes 
3. each symptom lasts 5 and 60 minutes 
D. Headache that does not fulfil criteria B-D for 1.1 Migraine without aura begins during 
the aura or follows aura within 60 minutes 
E. Not attributed to another disorder2 
 
Notes: 
1. Additional loss or blurring of central vision may occur. 
2. History and physical and neurological examinations do not suggest any of the 
disorders listed in groups 5-12, or history and/or physical and/or neurological 
examinations do suggest such disorder but it is ruled out by appropriate 
investigations, or such disorder is present but attacks do not occur for the first time 
in close temporal relation to the disorder. 
Comment: 
In the absence of headache fulfilling criteria for 1.1 Migraine without aura, precise diagnosis 
of aura and its distinction from mimics that may signal serious disease (eg, transient 
ischaemic attack) become much more important. 
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1.2.3 Typical aura without headache 
Description: 
Typical aura consisting of visual and/or sensory symptoms with or without speech 
symptoms. Gradual development, duration no longer than one hour, a mix of positive and 
negative features and complete reversibility characterise the aura which is not associated 
with headache. 
Diagnostic criteria: 
A. At least 2 attacks fulfilling criteria B–D 
B. Aura consisting of at least one of the following, with or without speech disturbance 
but no motor weakness: 
1. fully reversible visual symptoms including positive features (eg, flickering 
lights, spots or lines) and/or negative features (ie, loss of vision) 
2. fully reversible sensory symptoms including positive features (ie, pins and 
needles) and/or negative features (ie, numbness) 
C. At least two of the following: 
1. homonymous visual symptoms1 and/or unilateral sensory symptoms 
2.  at least one aura symptom develops gradually over 5 minutes and/or 
different aura symptoms occur in succession over 5 minutes 
3. each symptom lasts 5 and 60 minutes 
D. Headache does not occur during aura nor follow aura within 60 minutes 
E. Not attributed to another disorder2 
 
 
 
Notes: 
 Additional loss or blurring of central vision may occur. 
2. History and physical and neurological examinations do not suggest any of the 
disorders listed in groups 5-12, or history and/or physical and/or neurological 
examinations do suggest such disorder but it is ruled out by appropriate 
investigations, or such disorder is present but attacks do not occur for the first time 
in close temporal relation to the disorder. 
Comments: 
In some patients a typical aura is always followed by migraine headache, but many patients 
have, in addition, attacks with aura followed by non-migraine headache or even without 
headache. A small number of patients have 1.2.3 Typical aura without headache exclusively. 
More commonly, as patients with 1.2.1 Typical aura with migraine headache become older, 
their headache may lose migraine characteristics or disappear completely even though 
auras continue. Some individuals, primarily males, have 1.2.3 Typical aura without headache 
from onset. 
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In the absence of headache fulfilling criteria for 1.1 Migraine without aura, precise diagnosis 
of aura and its distinction from mimics that may signal serious disease (eg, transient 
ischaemic attack) become much more important. This distinction may require investigation. 
Especially if aura begins after age 40, if negative features (eg, hemianopia) are predominant, 
or if aura is prolonged or very short, other causes should be ruled out. 
 
 
1.2.4 Familial hemiplegic migraine (FHM) 
Description: 
Migraine with aura including motor weakness and at least one first- or second-degree 
relative has migraine aura including motor weakness. 
Diagnostic criteria: 
A. At least 2 attacks fulfilling criteria B and C 
B. Aura consisting of fully reversible motor weakness and at least one of the following: 
1. fully reversible visual symptoms including positive features (eg, flickering 
lights, spots or lines) and/or negative features (ie, loss of vision) 
2. fully reversible sensory symptoms including positive features (ie, pins and 
needles) and/or negative features (ie, numbness) 
3. fully reversible dysphasic speech disturbance 
C. At least two of the following: 
1. at least one aura symptom develops gradually over 5 minutes and/or 
different aura symptoms occur in succession over 5 minutes 
2. each aura symptom lasts 5 minutes and <24 hours 
3. headache fulfilling criteria B-D for 1.1 Migraine without aura begins during 
the aura or follows onset of aura within 60 minutes 
D. At least one first- or second-degree relative has had attacks fulfilling these criteria A-
E 
E. Not attributed to another disorder1 
 
Note: 
1. History and physical and neurological examinations do not suggest any of the 
disorders listed in groups 5-12, or history and/or physical and/or neurological 
examinations do suggest such disorder but it is ruled out by appropriate 
investigations, or such disorder is present but attacks do not occur for the first time 
in close temporal relation to the disorder. 
Comments: 
It may be difficult to distinguish weakness from sensory loss. 
New genetic data have allowed a more precise definition of FHM than previously. Specific 
genetic subtypes of 1.2.4 Familial hemiplegic migraine have been identified: in FHM1 there 
are mutations in the CACNA1A gene on chromosome 19, and in FHM2 mutations occur in 
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the ATP1A2 gene on chromosome 1. If genetic testing is done, the genetic subtype should 
be specified parenthetically. 
It has been shown that FHM1 very often has basilar-type symptoms in addition to the typical 
aura symptoms and that headache is virtually always present. During FHM1 attacks, 
disturbances of consciousness (sometimes including coma), fever, CSF pleocytosis and 
confusion can occur. FHM1 attacks can be triggered by (mild) head trauma. In 
approximately 50% of FHM1 families, chronic progressive cerebellar ataxia occurs 
independently of the migraine attacks. 
FHM is very often mistaken for epilepsy, and (unsuccessfully) treated as such. 
 
1.2.5 Sporadic hemiplegic migraine 
Description: 
Migraine with aura including motor weakness but no first- or second-degree relative has 
aura including motor weakness. 
Diagnostic criteria: 
A. At least 2 attacks fulfilling criteria Band C 
B. Aura consisting of fully reversible motor weakness and at least one of the following: 
1. fully reversible visual symptoms including positive features (eg, flickering 
lights, spots or lines) and/or negative features (ie, loss of vision) 
2. fully reversible sensory symptoms including positive features (ie, pins and 
needles) and/or negative features (ie, numbness) 
3. fully reversible dysphasic speech disturbance 
C. At least two of the following: 
1. at least one aura symptom develops gradually over 5 minutes and/or 
different aura symptoms occur in succession over 5 minutes 
2. each aura symptom lasts 5 minutes and <24 hours 
3. headache fulfilling criteria B-D for 1.1 Migraine without aura begins during 
the aura or follows onset of aura within 60 minutes 
D. No first- or second-degree relative has attacks fulfilling these criteria A-E 
E. Not attributed to another disorder1 
 
Note: 
1. History and physical and neurological examinations do not suggest any of the 
disorders listed in groups 5-12, or history and/or physical and/or neurological 
examinations do suggest such disorder but it is ruled out by appropriate 
investigations, or such disorder is present but attacks do not occur for the first time 
in close temporal relation to the disorder. 
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Comments: 
Epidemiological studies have shown that sporadic cases occur with approximately the same 
prevalence as familial cases. The attacks have the same clinical characteristics as those in 
1.2.4 Familial hemiplegic migraine. 
Sporadic cases always require neuroimaging and other tests to rule out other cause. A 
lumbar puncture is also necessary to rule out pseudomigraine with temporary neurological 
symptoms and lymphocytic pleocytosis. This condition is more prevalent in males and often 
associated with transient hemiparesis and aphasia. 
 
 
1.2.6 Basilar-type migraine 
Previously used terms: 
Basilar artery migraine, basilar migraine 
Description: 
Migraine with aura symptoms clearly originating from the brainstem and/or from both 
hemispheres simultaneously affected, but no motor weakness. 
Diagnostic criteria: 
A. At least 2 attacks fulfilling criteria B-D 
B. Aura consisting of at least two of the following fully reversible symptoms, but no 
motor weakness: 
1. dysarthria 
2. vertigo 
3. tinnitus 
4. hypacusia 
5. diplopia 
6. visual symptoms simultaneously in both temporal and nasal fields of both 
eyes 
7. ataxia 
8. decreased level of consciousness 
9. simultaneously bilateral paraesthesias 
C. At least one of the following: 
1.  at least one aura symptom develops gradually over 5 minutes and/or 
different aura symptoms occur in succession over 5 minutes 
2. each aura symptom lasts 5 and 60 minutes 
D. Headache fulfilling criteria B-D for 1.1 Migraine without aura begins during the aura 
or follows aura within 60 minutes 
E. Not attributed to another disorder1 
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Note: 
1. History and physical and neurological examinations do not suggest any of the 
disorders listed in groups 5-12, or history and/or physical and/or neurological 
examinations do suggest such disorder but it is ruled out by appropriate 
investigations, or such disorder is present but attacks do not occur for the first time 
in close temporal relation to the disorder. 
Comments: 
Basilar-type attacks are mostly seen in young adults. Many patients who have basilar-type 
attacks also report attacks with typical aura (code for both disorders). 
If motor weakness is present, code as 1.2.4 Familial hemiplegic migraine or 1.2.5 Sporadic 
hemiplegic migraine. Patients with 1.2.4 Familial hemiplegic migraine have basilar-type 
symptoms in 60% of cases. Therefore, 1.2.6 Basilar-type migraine should be diagnosed only 
when no motor weakness occurs. 
Many of the symptoms listed under criterion B are subject to misinterpretation as they may 
occur with anxiety and hyperventilation. 
Originally the terms basilar artery migraine or basilar migraine were used but, since 
involvement of the basilar artery territory is uncertain (ie, the disturbance may be 
bihemispheric), the term basilar-type migraine is preferred. 
 
 
 
 
1.3 Childhood periodic syndromes that are commonly precursors of migraine 
 
1.3.1  Cyclical vomiting 
Description: 
Recurrent episodic attacks, usually stereotypical in the individual patient, of vomiting and 
intense nausea. Attacks are associated with pallor and lethargy. There is complete 
resolution of symptoms between attacks. 
Diagnostic criteria: 
A. At least 5 attacks fulfilling criteria Band C 
B. Episodic attacks, stereotypical in the individual patient, of intense nausea and 
vomiting lasting from 1 hour to 5 days 
C. Vomiting during attacks occurs at least 4 times/hour for at least 1 hour 
D. Symptom-free between attacks 
E. Not attributed to another disorder1 
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Note: 
1. In particular, history and physical examination do not show signs of gastrointestinal 
disease. 
Comment: 
Cyclical vomiting is a self-limiting episodic condition of childhood, with periods of complete 
normality between episodes. This disorder was not included as a childhood periodic 
syndrome in the first edition of The International Classification of Headache Disorders. The 
clinical features of this syndrome resemble those found in association with migraine 
headaches, and multiple threads of research over the last years have suggested that cyclical 
vomiting is a condition related to migraine. 
 
 
1.3.2  Abdominal migraine 
Description: 
An idiopathic recurrent disorder seen mainly in children and characterised by episodic 
midline abdominal pain manifesting in attacks lasting 1-72 hours with normality between 
episodes. The pain is of moderate to severe intensity and associated with vasomotor 
symptoms, nausea and vomiting. 
Diagnostic criteria: 
A. At least 5 attacks fulfilling criteria B-D 
B. Attacks of abdominal pain lasting 1-72 hours (untreated or unsuccessfully treated) 
C. Abdominal pain has all of the following characteristics: 
1.  midline location, periumbilical or poorly localised 
2. dull or “just sore” quality 
3.  moderate or severe intensity 
D. During abdominal pain at least 2 of the following: 
1. anorexia 
2. nausea 
3. vomiting 
4. pallor 
E. Not attributed to another disorder1 
 
Note: 
1. In particular, history and physical examination do not show signs of gastrointestinal 
or renal disease or such disease has been ruled out by appropriate investigations. 
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Comments: 
Pain is severe enough to interfere with normal daily activities. 
Children may find it difficult to distinguish anorexia from nausea. The pallor is often 
accompanied by dark shadows under the eyes. In a few patients flushing is the predominant 
vasomotor phenomenon. 
Most children with abdominal migraine will develop migraine headache later in life. 
 
 
1.3.3  Benign paroxysmal vertigo of childhood 
Description: 
This probably heterogeneous disorder is characterised by recurrent brief episodic attacks of 
vertigo occurring without warning and resolving spontaneously in otherwise healthy 
children. 
Diagnostic criteria: 
A. At least 5 attacks fulfilling criterion B 
B. Multiple episodes of severe vertigo1, occurring without warning and resolving 
spontaneously after minutes to hours 
C. Normal neurological examination; audiometric and vestibular functions between 
attacks 
D. Normal electroencephalogram 
 
Note: 
1. Often associated with nystagmus or vomiting; unilateral throbbing headache may 
occur in some attacks. 
 
1.4 Retinal migraine 
Description: 
Repeated attacks of monocular visual disturbance, including scintillations, scotomata or 
blindness, associated with migraine headache. 
Diagnostic criteria: 
A. At least 2 attacks fulfilling criteria B and C 
B. Fully reversible monocular positive and/or negative visual phenomena (eg, 
scintillations, scotomata or blindness) confirmed by examination during an attack or 
(after proper instruction) by the patient’s drawing of a monocular field defect during 
an attack 
C. Headache fulfilling criteria B-D for 1.1 Migraine without aura begins during the visual 
symptoms or follows them within 60 minutes 
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D. Normal ophthalmological examination between attacks 
E. Not attributed to another disorder1 
 
Note: 
1. Appropriate investigations exclude other causes of transient monocular blindness. 
Comment: 
Some patients who complain of monocular visual disturbance in fact have hemianopia. 
Some cases without headache have been reported, but their migrainous nature cannot be 
ascertained. Other causes of transient monocular blindness (amaurosis fugax), such as optic 
neuropathy or carotid dissection, must be excluded. 
 
 
1.5 Complications of migraine 
Comment: 
Code separately for both the antecedent migraine subtype and for the complication. 
 
1.5.1 Chronic migraine 
Description: 
Migraine headache occurring on 15 or more days per month for more than 3 months in the 
absence of medication overuse. 
Diagnostic criteria: 
A. Headache fulfilling criteria C and D for 1.1 Migraine without aura on 15 days/month 
for >3 months 
B. Not attributed to another disorder1;2 
 
Note: 
1. History and physical and neurological examinations do not suggest any of the 
disorders listed in groups 5-12, or history and/or physical and/or neurological 
examinations do suggest such disorder but it is ruled out by appropriate 
investigations, or such disorder is present but headache does not occur for the first 
time in close temporal relation to the disorder. 
2. When medication overuse is present and fulfils criterion B for any of the subforms of 
8.2 Medication-overuse headache, it is uncertain whether this criterion B is fulfilled 
until 2 months after medication has been withdrawn without improvement (see 
Comments). 
Comments: 
Most cases of chronic migraine start as 1.1 Migraine without aura. Therefore, chronicity 
may be regarded as a complication of episodic migraine. 
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As chronicity develops, headache tends to lose its attack-wise (episodic) presentation 
although it has not been clearly demonstrated that this is always so. 
When medication overuse is present (ie, fulfilling criterion B for any of the subforms of 8.2 
Medication-overuse headache), this is the most likely cause of chronic symptoms. Therefore, 
the default rule is to code such patients according to the antecedent migraine subtype 
(usually 1.1 Migraine without aura) plus 1.6.5 Probable chronic migraine plus 8.2.7 Probable 
medication-overuse headache. When these criteria are still fulfilled 2 months after 
medication overuse has ceased, 1.5.1 Chronic migraine plus the antecedent migraine 
subtype should be diagnosed, and 8.2.7 Probable medication-overuse headache discarded. If 
at any time sooner they are no longer fulfilled, because improvement has occurred, code for 
8.2 Medication-overuse headache plus the antecedent migraine subtype and discard 1.6.5 
Probable chronic migraine. 
These criteria require further study. 
 
 
 
1.5.2 Status migrainosus 
Description: 
A debilitating migraine attack lasting for more than 72 hours. 
Diagnostic criteria: 
A. The present attack in a patient with 1.1 Migraine without aura is typical of previous 
attacks except for its duration 
B. Headache has both of the following features: 
 unremitting for >72 hours 
 severe intensity 
C. Not attributed to another disorder 
 
Comment: 
Interruption during sleep is disregarded. Short-lasting relief due to medication is also 
disregarded. Status may often be caused by medication overuse and should be coded 
accordingly. Non-debilitating attacks lasting 72 hours but otherwise meeting these criteria 
are coded as 1.6.1 Probable migraine without aura. 
1.5.3 Persistent aura without infarction  
Description: 
Aura symptoms persist for more than 1 week without radiographic evidence of infarction. 
Diagnostic criteria: 
A. The present attack in a patient with 1.2 Migraine with aura is typical of previous 
attacks except that one or more aura symptoms persists for >1 week 
B. Not attributed to another disorder 
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Comments: 
Persisting aura symptoms are rare but well documented. They are often bilateral and may 
last for months or years. Reliably effective treatment is not known though acetazolamide 
and valproic acid have helped in a few cases. 
Exclude posterior leukoencephalopathy by diffusion MRI among other things. Exclude 1.5.4 
Migrainous infarction by MRI. 
 
 
1.5.4 Migrainous infarction 
Description: 
One or more migrainous aura symptoms associated with an ischaemic brain lesion in 
appropriate territory demonstrated by neuroimaging. 
Diagnostic criteria: 
A. The present attack in a patient with 1.2 Migraine with aura is typical of previous 
attacks except that one or more aura symptoms persists for >60 minutes 
B. Neuroimaging demonstrates ischaemic infarction in a relevant area 
C. Not attributed to another disorder 
 
Comments: 
Ischaemic stroke in a migraine sufferer may be categorised as cerebral infarction of other 
cause coexisting with migraine, cerebral infarction of other cause presenting with symptoms 
resembling migraine with aura, or cerebral infarction occurring during the course of a typical 
migraine with aura attack. Only the last fulfils criteria for 1.5.4 Migrainous infarction. 
Increased risk for stroke in migraine patients has been demonstrated in women under age 
45 in several studies. Evidence for an association between migraine and stroke in older 
women and in men is inconsistent. 
 
 
1.5.5 Migraine-triggered seizure 
Description: 
A seizure triggered by a migraine aura. 
Diagnostic criteria:  
A.  Migraine fulfilling criteria for 1.2 Migraine with aura 
B. A seizure fulfilling diagnostic criteria for one type of epileptic attack occurs during or 
within 1 hour after a migraine aura 
 
Comment: 
Migraine and epilepsy are prototypical examples of paroxysmal brain disorders. While 
migraine-like headaches are quite frequently seen in the postictal period, sometimes a 
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seizure occurs during or following a migraine attack. This phenomenon, sometimes referred 
to as migralepsy, has been described in patients with migraine with aura. 
1.6 Probable migraine 
Previously used terms: 
Migrainous disorder 
Coded elsewhere: 
Migraine-like headache secondary to another disorder (symptomatic migraine) is coded 
according to that disorder. 
Description: 
Attacks and/or headache missing one of the features needed to fulfil all criteria for a 
disorder coded above (1.6.3 Probable childhood periodic syndromes that are commonly 
precursors of migraine and 1.6.4 Probable retinal migraine are not currently recognised). 
 
 
1.6.1 Probable migraine without aura 
Diagnostic criteria: 
A. Attacks fulfilling all but one of criteria A-D for 1.1 Migraine without aura 
B.  Not attributed to another disorder 
 
Comment: 
Do not code as 1.6.1 Probable migraine without aura if the patient fulfils the criteria for 
1.5.1 Chronic migraine or 1.5.2 Status migrainosus. 
 
 
1.6.2 Probable migraine with aura 
Diagnostic criteria: 
A. Attacks fulfilling all but one of criteria A-D for 1.2 Migraine with aura or any of its 
subforms 
B. Not attributed to another disorder 
 
 
1.6.5 Probable chronic migraine 
Diagnostic criteria: 
A. Headache fulfilling criteria C and D for 1.1 Migraine without aura on 15 days/month 
for >3 months 
B. Not attributed to another disorder1 but there is, or has been within the last 2 
months, medication overuse fulfilling criterion B for any of the subforms of 8.2 
Medication-overuse headache 
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Note: 
1. History and physical and neurological examinations do not suggest any of the 
disorders listed in groups 5-12 (other than 8.2 Medication-overuse headache), or 
history and/or physical and/or neurological examinations do suggest such disorder 
but it is ruled out by appropriate investigations, or such disorder is present but 
headache does not occur for the first time in close temporal relation to the disorder. 
Aggravating factors 
Migraine may be aggravated by a number of factors. That is, in a person who already meets 
criteria for migraine, particular factors may be associated with a relatively long-term (usually 
weeks to months) increase in the severity or frequency of attacks. Examples of commonly-
reported aggravating factors include: psychosocial stress, frequent intake of alcoholic 
beverages, other environmental factors. 
Trigger factors (precipitating factors) 
Trigger factors increase the probability of a migraine attack in the short term (usually <48 
hours) in a person with migraine. Though some trigger factors have been reasonably well 
studied epidemiologically (eg, menstruation) or in clinical trials (eg, chocolate, aspartame), 
causal attribution in individual patients may be difficult. 
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